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ABSTRACT: 
The heritability of chronic obstructive pulmonary disease (COPD) cannot be fully explained by 
recognized genetic risk factors identified as achieving genome-wide significance.  In addition, the 
combined contribution of genetic variation to COPD risk has not been fully explored.   We sought 
to determine 1) whether studies of variants from previous studies of COPD or lung function in a 
larger sample could identify additional associated variants, particularly for severe COPD, and 2) 
the impact of genetic risk scores on COPD.   We genotyped 3,346 single nucleotide polymorphisms 
(SNP) in 2,588 cases (1,803 severe COPD) and 1,782 controls from four cohorts, and performed 
association testing with COPD, combining these results with existing genotyping data from 6,633 
cases (3,497 severe COPD) and 5,704 controls. Additionally, we developed genetic risk scores 
from SNPs associated with lung function and COPD and tested their discriminatory power for 
COPD-related measures.  We identified significant associations between SNPs near PPIC 
(p=1.28x10-8) and PPP4R4/SERPINA1 (p=1.01x10-8) and severe COPD; the latter association may 
be driven by recognized variants in SERPINA1.  Genetic risk scores based on SNPs previously 
associated with COPD and lung function had a modest ability to discriminate COPD (AUC ~0.6), 
and accounted for a mean 0.9-1.9% lower FEV1 percent-predicted for each additional risk allele.  
In a large genetic association analysis, we identified associations with severe COPD near PPIC and 
SERPINA1.  A risk score based on combining genetic variants had modest but significant effects on 
risk of COPD and lung function. 
 
 
Key Words: chronic obstructive pulmonary disease, genetic epidemiology, genetic risk factors, 
alpha-1 antitrypsin, genetic risk score  
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Introduction 
Chronic obstructive pulmonary disease (COPD), a progressive lung disease characterized by 
irreversible airflow obstruction, is a leading cause of morbidity and mortality worldwide(1, 2). 
While cigarette smoking is the major determinant of COPD susceptibility in the industrialized 
world (3-5),  pulmonary response to cigarette smoking is highly variable(6).  Genetic factors 
contribute to variability in response to smoking, and multiple studies have identified genetic 
variants associated with increased COPD susceptibility(7-12).  Nonetheless, the majority of 
estimated heritability for risk to COPD remains unexplained(13). In addition, the effect of several 
recognized risk alleles on lung function or risk of COPD , particularly in cohorts of severely 
affected subjects, has not been well studied. Meta-analysis of genetic associations across multiple 
cohorts has the advantage of improving power to detect additional susceptibility risk variants by 
combining information across studies, which may add to our understanding of disease 
mechanisms(14) as well as providing potential new targets for COPD therapy development(15, 
16).  
 
This study had two primary goals: First, we wished to investigate a panel of variants in a larger 
meta-analysis of cross-sectional data to increase our power to detect associations(17) with  
moderate-to-severe and severe COPD. The marker panel was composed of two groups of SNPs. 
The first group included top associations from previous GWAS studies including SNPs that did not 
reach genome-wide significance(18), and the second group included genetic variants 
hypothesized to affect COPD (19) including SNPs previously associated with lung function(20-22).  
We hypothesized some of these loci would reach pre-defined levels of statistical significance with 
our additional sample size in this meta-analysis. 
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 Since genetic variation is fixed at birth, genetic risk scores in cross-sectional data may offer a way 
to consolidate genetic information(23) into a clinically meaningful tool that could help clinicians 
to predict disease susceptibility, progression, and outcomes(24, 25). Our second goal was to 
determine the relevance of genetic risk scores to COPD by modeling the effect of COPD- and lung 
function-associated risk alleles on clinical status, severe COPD-affection status, and forced 
expiratory volume in one second (FEV1) percent predicted.  We hypothesized a combined risk 
score composed of SNPs shown to influence risk to COPD and lung function would explain the 
genetic contribution to COPD-related outcomes in a clinically useful manner. 
 
Materials and Methods 
We performed genetic meta-analysis using eight cohorts, including a total of 16,707 subjects 
(Table 1).  We genotyped 3,346 SNPs (see Supplement) in 5358 subjects from four cohorts: the 
Transcontinental COPD Genetics Study (TCGS)-Korea and TCGS-Poland(26), The International 
COPD Genetics Network (ICGN)(27, 28), and the Boston Early-Onset COPD Study (EOCOPD)(29).  
To maximize power for meta-analysis, we combined these results with existing data from five 
additional cohorts with: COPDGene non-Hispanic Whites (NHW) and African-Americans (AA), 
(30), Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-Points 
(ECLIPSE)(31), National Emphysema Treatment Trial (NETT)(32)/Normative Aging Study 
(NAS)(33), and Genetics of COPD in Norway (GenKOLS)(34). Detailed description of these cohorts 
have been previously published(35).   
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 All subjects were current or former cigarette smokers with and without COPD, except for EOCOPD 
which included a small number of non-smokers. We defined “moderate to severe” COPD as 
GOLD(2) spirometric Grade 2-4 COPD (post-bronchodilator FEV1/FVC <0.7, FEV1 <80% 
predicted), while “severe” COPD was defined as Grade 3-4 COPD (FEV1/FVC <0.7, FEV1 <50% 
predicted). Controls had normal spirometry (FEV1/FVC >0.7, FEV1 > 80%).  Previously diagnosed 
alpha-1 antitrypsin deficiency was an exclusion criterion for all cohorts.  
 
Genetic Analysis 
We used PLINK v1.9(36) and GWAF(37) for case-control and family-based data, respectively, to 
perform multiple logistic regression within each dataset and then performed fixed-effect meta-
analysis using METAL(38).  Given that many of our SNPs were chosen from top findings from prior 
GWAS (see Supplemental Table 1 for full list of SNPs and provenance), we required an overall P-
value of < 5x10-8 for statistical significance.  We also considered a more liberal suggestive 
threshold based on a Bonferroni correction for the number of tested SNPs (p<1.49x10-5).  
 
Genetic Risk Scores 
We used PLINK v1.9 to create genetic scores based on significant associations from prior genome-
wide association studies of COPD and lung function (Table 4 and Supplemental Table 5) (20, 21, 
39).  We oriented risk alleles to be consistent with prior reports, and gave each allele equal weight.  
We applied these scoring systems to the ICGN cohort, the largest individual cohort not used in the 
discovery of any of the risk score variants.   Risk scores were also applied to the COPDGene and 
TCGS Poland cohorts using analogous methods. 
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The resultant risk scores were used as predictors in a linear mixed model of FEV1 percent 
predicted, as well as logistic regression models of both moderate-to-severe and severe COPD 
incorporating generalized estimating equations.  Models were controlled for age, pack-years of 
smoking, principal components of genetic ancestry, and for familial correlation. In addition, we 
used the pROC(40) and GenAbel(41) packages in R to compare the accuracy of two models (i.e. 
model with genetic risk factors and clinical predictors versus the clinical predictors alone) 
through receiver operator characteristic (ROC) curves and net reclassification index (NRI). 
Subjects were divided into three tiers of COPD risk (low 0-33.3%, intermediate 33.4-66.7%, and 
high 66.8-100%) for NRI analysis to assess the discriminatory benefit of adding genetic 
information to the clinical risk model of age and pack-years of smoking alone.  
 
Additional details regarding the SNPs and cohorts used in this study;  genotype-, marker-, and 
subject-level quality control; and risk score modeling and NRI analysis are available in the 
Methods and Data Supplement. 
 
Results 
The baseline characteristics of all cohorts are shown in Table 1. Notably, the TCGS-Korea, TCGS-
Poland, and NETT/NAS studies were designed to contain only severe COPD cases, which is 
reflected in the low average FEV1 percent predicted seen among cases for these studies.  
 
Genetic Association Analysis 
The moderate-to-severe analysis included 9,221 cases and 7,486 controls, and confirmed signals 
in the previously described TGFB2, FAM13A, HHIP, CHRNA3/CHRNA5/IREB2, and RIN3 regions; in 
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addition, a SNP in 16p11.2, recently described in an exome chip analysis of these same 
cohorts(42), was associated with moderate-to-severe COPD (rs40834, p=1.90x10-8, estimated 
OR=1.17, Supplemental Table 2).  The analysis of severe COPD (Table 2) included 5,300 cases and 
7,486 controls. We confirmed significance of SNPs in the TGFB2, FAM13A, HHIP, MMP3/MMP12, 
and CHRNA3/CHRNA5/IREB2 regions. We also identified two SNPs at loci not previously described 
as genome-wide significant: 5q23.2 between the PRDM6 and PPIC genes (rs6860095, p=1.01x10-8, 
estimated OR=1.24), and an intronic SNP within the PPP4R4 gene (rs112458284, p=1.28x10-8, 
estimated OR=1.69) in 14q32.13.  
 
We examined these loci using the GTEx eQTL database(43) and Haploreg v4.1(44). SNP 
rs6860095 affected gene expression levels of PPIC, snoU13, SNX2 and RN7SL689P in multiple 
tissues, although not in lung tissue. No significant eQTLs were found for SNP rs112458284; 
however, it lies approximately 200kb away from SERPINA1, which encodes the protein 
responsible for alpha-1 antitrypsin deficiency(45, 46).  
 
We investigated whether rs112458284 could be tagging alleles of SERPINA1 known to contribute 
to risk of COPD (e.g. the Z-allele rs28929474 or S-allele rs17580).  rs112458284 showed LD with 
the Z-allele in directly genotyped (i.e. not imputed) samples from COPDGene NHW subjects (r2= 
0.41, D’= 0.78) and, to a lesser extent, the S-Allele (r2= 8.63x10-5, D’= 0.25).  Consistent with this 
hypothesis, the Z-allele was associated with COPD at near-genome-wide significance in our 
primary analysis using imputed data in COPDGene (p=1.53x10-7, OR=1.78, CI=1.44-2.21); this 
signal improved using genotyping data (p=2.05x10-8, OR=1.84, CI=1.49-2.27), although 
rs112458284 was still the strongest association signal in the region.  To further investigate 
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whether there was any association signal at the rs112458284 that was independent from the Z-
allele, we also conditioned on the Z-allele in a meta-analysis model, and found that the association 
signal for rs112458284 was attenuated (p=0.0087).   
 
Known alpha-1 antitrypsin deficiency was an exclusion criterion in our study; however, our 
genotyping (and imputed data) identified three previously unrecognized Z-allele homozygotes in 
the Poland cohort(35) and six additional Z-allele homozygotes in the ECLIPSE cohort(47). After 
removing these subjects, the rs112458284 association was only mildly attenuated (p=7.22x10-8), 
as was the association with the Z-allele (p=9.29x10-8, OR=1.80, CI=1.45-2.23). Thus, heterozygous 
carriers of the Z-allele appear to be driving a large proportion of the association, consistent with 
prior studies showing an increased risk of COPD for MZ heterozygotes(48). In addition, these 
results suggest if we had not specifically excluded subjects with known alpha-1 antitrypsin 
deficiency in our other populations, the association with SNP rs112458284 would likely be even 
more extreme(49). Allele frequencies for the Z-allele in each cohort are provided in the 
Supplemental Table 3.  The poor imputation quality of the S-allele in our cohorts prevented us 
from further assessing its impact on the rs112458284 association.   
 
We next examined our other SNPs, at a more liberal P-value threshold.  Using a Bonferroni 
significance threshold for 3,346 SNPs (p<1.49x10-5), we identified suggestive associations at three 
loci.  All of these (THSD4, AGER/PPT2, and ADAM19) were in regions previously associated in 
genome-wide association studies of lung function.  We then examined linkage disequilibrium 
within each candidate locus to further explore whether these associations represented the same 
variants as previous associations.  We defined "lead SNP" as the association yielding the lowest p-
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value in a given region, and the "candidate SNP" as the previously described variant.  In 14 of these 
lead SNPs, LD with the candidate SNP measured by D' was >0.8, while eight also had an r2 >0.3 
(Table 3).  Notably, SNPs associated with lower lung function showed a directionally consistent 
increased risk for COPD in 23 of 25 previously reported SNPs directly genotyped in our meta-
analysis (binomial for enrichment, p=9.7x10-6). These 23 lung function risk alleles included 12 
showing a nominally statistically significant (p<0.05) effect on COPD risk (see Table 3); only lung 
function risk-alleles in the ZKSCAN3 and NCR3-AIF1 genes showed a directionally discordant effect 
on COPD susceptibility (lower risk of COPD), though these discordant association results were not 
statistically significant.   Additional results for other variants are reported in Supplemental Table 
4.  
 
Genetic Risk Scores 
We next examined the ability of genetic risk scores to explain both FEV1 percent predicted and 
COPD affection status.  Based on our results above, we constructed risk scores using genome-wide 
significant SNPs associated with COPD (COPD7 score) and also including genome-wide significant 
SNPs associated with lung function in population-based studies (LUNG 30); Table 4 describes the 
loci involved in each score.  We evaluated the risk scores using the ICGN cohort, the largest 
available cohort not used in the discovery of these risk loci.  Results from the unadjusted model 
are shown in Figure 1.  In a linear mixed model adjusting for age, pack-years of smoking, principal 
components of ancestry, and a within-family component, we found the COPD7 risk score (ranging 
from 0 to 14 possible alleles) was associated with a 1.86% reduction in FEV1 percent predicted for 
each additional risk allele carried (Table 5a). Using generalized estimating equations for models of 
moderate-to-severe and severe COPD (Table 5b), each additional risk allele in the COPD7 risk 
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score was associated with an odds ratio (OR) of 1.18 for moderate-to-severe COPD and 1.19 for 
severe COPD (p=4.1x10-8 and p=4.4 x10-8, respectively).  We found nearly identical results for a 
standard logistic regression (OR=1.17 and OR=1.19, respectively) without family adjustment, and 
therefore used these simpler models to generate receiver operator characteristic (ROC) curves for 
affection status using genetic variants alone, age and pack-years, and the combination of age, pack-
years, and genetic information. The area under the curve (AUC) for the genetic model was 0.58 for 
moderate-to-severe COPD and 0.59 for severe COPD.  Additionally, adding genetic risk scores 
(COPD7) only modestly increased the AUC (Figure 2) over the AUC of the clinical model. Three-
tiered categorical analysis of reclassification(50) after addition of the COPD7 risk score and 
adjustment for genetic components of ancestry into the clinical model (containing only age and 
pack-years of smoking) resulted in a NRI of 0.053 (p=2.32x10-3) for the combined model risk 
stratification of moderate-to-severe COPD, and an NRI of 0.047 for risk stratification of severe 
COPD (p=0.01).  For the expanded LUNG30 score, we found a lower per-allele effect, but larger 
overall effect because more factors went into the score (Tables 5a and 5b).  We also tested risk 
scores in the TCGS Poland and COPDGene cohorts and found comparable results (see Methods and 
Data Supplement).  
 
Discussion 
Genetic association studies in COPD have identified well-replicated genome-wide associations 
with COPD, but the majority of genetic susceptibility remains unexplained.  In a large-scale genetic 
association meta-analysis of 9 cohorts, analyzing both moderate to severe and severe COPD, we 
identified two new associations at genome-wide significance with severe COPD, including one in 
strong LD with SERPINA1, and associations at a more liberal significance threshold in regions 
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previously associated with population-based lung function.  We found consistent directions of 
effect on risk to COPD in 23 previously identified markers associated with lung function, 
consistent with recent reports(7). We also constructed genetic risk scores that showed compelling 
relationships for quantitative measures of lung function and modest discrimination for COPD 
affection status. Our results further inform the discussion of how genetic variants could influence 
COPD susceptibility.   
 
The discovery that variants in LD with SERPINA1 are associated with severe COPD demonstrates 
how genetic association studies can confirm known disease mechanisms. This rs112458284 
variant is also in strong LD with rs45505795 near SERPINA10 (r2= 0.96 and D'= 1.0 in 1000 
Genomes EUR Phase I v3 data), which we recently described in a GWAS of quantitative measures 
of emphysema(47). The 5q23.2 region containing SNP rs6860095 is strongly associated with 
severe COPD risk.  Both PPIC and PRDM6 lie in this region. Peptidylprolyl Isomerase C (PPIC, also 
known as Cyclophilin C) has functions related to mitochondrial metabolism, inflammation, and 
immune response through its interactions with cyclosporine A. While the related protein 
Cyclophilin A has been associated with both COPD(51) and lung cancer(52), to our knowledge no 
prior study has shown significant association between PPIC and risk of COPD.  The PRDI-BF1 
and RIZ homology Domain Containing 6 (PRDM6) protein is involved in chromatin remodeling and 
transcriptional control of smooth muscle gene expression(53). Expression of PRDM6 has been 
implicated in the pseudoglandular and canalicular stages of lung morphogenesis in murine 
models, and expression has been documented in smooth muscle of the developing murine trachea, 
bronchi, and pulmonary trunk(53). Additional studies are needed to confirm association between 
markers in 5q23.2 and severe COPD. 
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 We examined genomic loci previously associated with FEV1, FEV1/FVC, and additional variants 
previously hypothesized to be associated with COPD(19). SNPs that met criteria for suggestive 
association were found in regions previously associated with lung function, including the 
AGER/PPT2 and the THSD4 regions. Additionally, the majority of variants associated with 
quantitative measures of lung function showed consistent directions of effect for both COPD and 
low lung function.  
 
Genetic risk scores using selected risk variants from COPD-based cohorts could provide a clinically 
relevant context to individual level genetic data, and could have applications in assessing risk to 
COPD and its severity (25). We investigated the ability of genetic risk scores to explain COPD risk 
and FEV1 percent predicted.  Genetic data alone only achieved an AUC of ~0.6 in our modeling of 
moderate-to-severe COPD risk.  This finding is comparable to the AUC of genetic risk scores in 
other complex diseases, such as coronary artery disease(54) and Type II diabetes(55).  This low 
AUC of our risk score may be due to the fact that genetic data does not account for the 
contributions to COPD of other significant risk factors such as age and environmental exposures 
like pack-years of smoking.  The addition of genetic data to the clinical model including age and 
pack-years of smoking resulted in statistically significant, but small, increases in AUCs and in 
statistically significant NRI values when classifying risk for severe COPD. Interpretation of the NRI 
is more straightforward for clinically-actionable consensus endpoints, such as primary prevention 
statin therapy for coronary artery disease outcomes, which are less well-defined for COPD.  
Despite these concerns, the clinical relevance of this model is most apparent in the risk score 
coefficient itself. The LUNG30 model implies that a subject with 35 risk alleles would show a 3-fold 
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increase in risk of COPD compared with a subject with a score of 25, all other variables being 
equal. 
 
Similarly, in our modeling of FEV1 percent predicted, we found a small, but detectable effect of 
each individual risk allele, though the cumulative effect of this score may be clinically relevant. For 
example, within the ICGN dataset we had subjects with as few as 16 and as many as 45 alleles in 
their LUNG30 score. Based on our model, this difference in alleles would account for an 
approximately 30% difference in FEV1 percent predicted, holding all other variables equal.  Such a 
30% FEV1 percent predicted difference implies that two people (with similar age and pack-years 
of smoking) may fall into different GOLD severity classes due to the effect of these risk alleles 
alone.  While the COPD-based ascertainment of the ICGN pedigrees may have led to enrichment of 
these risk-alleles in this cohort, the significance of the risk scores was robust when tested in two 
additional case-control cohorts. 
 
Despite having analyzed over 16,000 subjects, our study and the experience in other GWAS 
suggests power is still a major limitation in detecting additional COPD associations. The definition 
of COPD phenotypes and its severity by spirometric criteria alone(2) was consistent in our meta-
analysis; however, this does not address other aspects of heterogeneity in COPD that may be 
under genetic control (such as emphysema or exacerbations). The study was cross-sectional in 
design with lung function assessment at only one point of time, so we cannot assess the impact of 
lung function trajectories(56) in our models. This study was not a comprehensive survey of 
genome-wide data, and its ability to detect new associations was limited to previously identified 
loci and their surrounding regions. Four of the datasets in our meta-analysis were previously 
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investigated for genetic associations for COPD status(18), so our results are enriched for 
previously discovered associations.  Additionally, genotyping was performed before the results of 
recent COPD and lung function GWAS studies in the UK BiLeve group(7) and Soler Artigas et al(57, 
58) were published, and the additional risk loci for COPD and lung function found in these studies 
were not included in our analysis. We chose to use a simple model for our genetic (and clinical) 
risk scores.  More sophisticated models using these SNPs, based on genome-wide results, and 
incorporating additional clinical factors, may result in improved prediction.  In pathway analysis 
in Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and the Reactome (see 
Supplemental Methods and Results) the closest gene(s) to the LUNG30 risk score variants showed 
enrichment in gene sets related to structural components of lung development, control of lung 
development, inflammatory response, and response to steroid hormone, among others.  These 
enriched terms and pathways may help to provide insight into the pathophysiologic mechanisms 
of COPD pathogenesis that are represented by the LUNG30 association signal.  However, our risk 
scores focused on SNPs previously associated with lung function and COPD; most of the causal 
genes at these loci are not known, and these signals capture only a minority of relevant genetic 
mechanisms contributing to COPD pathogenesis. The performance of our genetic risk scores in 
other racial groups and in never-smokers has not been tested, although this is an area of interest 
for follow-up investigations.  While associations with SNPs rs112458284 and rs6860095 did 
achieve  genome-wide levels of significance in our severe COPD analysis, these results still need to 
be replicated in independent populations.  
  
In summary, we performed a meta-analysis of markers in selected genes and discovered two new 
SNPs associated with severe COPD that reached significance levels equivalent to accepted 
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thresholds of genome-wide significance, one of which tags recognized risk alleles in SERPINA1 . 
Our study is one of the largest genetic association studies of severe COPD, the first to identify 
SERPINA1 at genome-wide significance for COPD.  Our study supports the idea that loci associated 
with lung function play some role in susceptibility to COPD. We also showed the clinical 
applicability of simple genetic risk scores for explaining COPD spirometric severity in an 
independent cohort. This study adds to the growing body of genetic knowledge about COPD, 
including efforts at subtyping, prediction, and mechanistic investigation, which may ultimately 
inform patient counseling, clinical decision-making, and lead to new therapies for this disease.  
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Tables 
 
  COPDGene 
NHW 
COPDGene 
AA 
ICGN  (1103 
Pedigrees) 
ECLIPSE GenKOLS NETT/NAS EOCOPD (201 
pedigrees) 
TCGS 
Poland 
TCGS Korea 
Control N 2534 1749 696 178 808 435 560 307 219 
 Sex (% male) 49.3 58.1 48.3 57.9 50.1 100 41.6 67.4 96.8 
 Age 59.5 (± 8.7) 52.8 (± 6.0) 54.4 (± 8.9) 57.5 (± 9.4) 55.6 (± 9.7) 69.8 (± 7.5) 40.8 (± 17.5) 58.8 (± 7.3) 52.9 (± 8.41) 
 Pack-years 37.8 (± 20.3) 36.4 (± 20.1) 29.4 (± 19.8) 32.1 (± 24.8) 19.7 (± 13.6) 40.7 (± 27.9) 10.8 (± 18.4) 34 (± 15.2) 27.3 (± 14.9) 
 FEV1, % 
predicted 
96.8 (±11) 98.4 (± 12.2) 99.1 (± 14.4) 107.8 (± 
13.6) 
94.9 (± 9.2) 100.0 (± 
13.2) 
95.7 (± 11.5) 103 (± 12.7) 94.4 (± 9.4) 
Moderate  N 2812 821 1769 1764 863 373 366 304 149 
to Severe  Sex (% male) 55.7 55.2 58.6 67.0 60.1 63.8 39.9 70.1 99.3 
COPD  Age 64.7 (± 8.2) 59.0 (± 8.2) 59.2 (± 6.9) 63.6 (± 7.1) 65.5 (± 10.0) 67.5 (± 5.8) 53.2 (± 12) 62.6 (± 7.41) 68.9 (± 6.21) 
(GOLD II-IV) Pack-years 56.3 (± 28.0) 42.4 (± 23.0) 51.3 (± 28.2) 50.3 (± 27.4) 32.0 (± 18.5) 66.4 (± 30.7) 41.1 (± 24.4) 44.5 (± 22.4) 44.9 (± 24.5) 
 FEV1, % 
predicted 
49.6 (± 18.0) 52.2 (± 17.8) 40.5 (± 16.7) 47.6 (± 15.6) 50.6 (± 17.4) 28.1 (± 7.4) 35.1 (± 20) 29.1 (± 9.22) 33.8 (± 8.28) 
Severe  N 1390 352 1099 999 383 373 251 304 149 
COPD  Sex (% male) 57.8 58 60.9 69.9 61.5 63.8 33.1 70.1 99.3 
(GOLD III-IV) Age 65.2 (± 7.8) 60.6 (± 8.1) 59.2 (± 6.27) 63.5 (± 7.0) 66.7 (± 9.7) 67.5 (± 5.8) 51.3 (± 10.1) 62.6 (± 7.41) 68.9 (± 6.21) 
 Pack-years 58.7 (± 28.4) 43.9 (± 23.4) 53.6 (± 28.8) 50.7 (± 26.3) 33.0 (± 19.9) 66.4 (± 30.7) 41.7 (± 22.6) 44.5 (± 22.4) 44.9 (± 24.5) 
 FEV1, % 
predicted 
34.0 (± 9.9) 34.8 (± 10.4) 30 (± 9.96) 36.5 (± 8.6) 34.4 (± 10.3) 28.1 (± 7.4) 23.3 (± 9.44) 29.1 (± 9.22) 33.8 (± 8.28) 
Table 1. Baseline Characteristics of Meta-Analysis Cohorts        
ICGN = International COPD Genetics Network; ECLIPSE = Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points, GenKOLS = Genetics of Chronic  
Obstructive Lung Disease, Norway, NETT = National Emphysema Treatment Trial, NAS = Normative Aging Study, EOCOPD = Boston Early-Onset COPD Study, TCGS = 
Transcontinental COPD Genetics Study.  Number of subjects is presented as N, gender is presented as percent male. Mean values for age, pack-years, and FEV1 
 (% predicted) are shown as mean followed by standard deviation. Age is displayed in years. Moderate to Severe COPD represents GOLD II-IV COPD cases, while Severe  
COPD represents GOLD III-IV COPD cases. Number of pedigrees is presented adjacent to the study name for the pedigree-bases studies ICGN and EOCOPD. 
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rs ID Chromosome Base 
Position 
Effect 
Allele 
p-value Odds 
Ratio 
Lower 
95% CI 
Upper 
95% CI 
Effect Allele 
Frequency 
Nearest 
Gene(s) 
rs1890995 1 218604678 A 3.79x10
-11
 1.27 1.37 1.19 0.73 TGFB2 
rs4416442 4 89866713 T 5.38x10
-17
 1.32 1.39 1.23 0.43 FAM13A 
rs13141641 4 145506456 T 1.69x10
-21
 1.38 1.29 1.48 0.61 HHIP 
rs6860095 5 122405957 A 1.01x10
-8
 1.24 1.15 1.33 0.74 PRDM6/PPIC 
rs679620 11 102713620 T 1.87x10
-8
 1.19 1.12 1.27 0.54 MMP3/MMP12 
rs112458284 14 94672731 T 1.28x10
-8
 1.69 2.04 1.41 0.04 PPP4R4 
rs17486278 15 78867482 A 1.70x10
-27
 1.43 1.54 1.35 0.37 CHRNA5 
Table 2. Genome-wide significant Severe COPD Associations     
Significant associations for GOLD spirometric stage III-IV COPD, organized by chromosome. In each case, the lead SNP  
for the locus is presented.  Effect alleles represent the allele that is associated with the stated odds ratio for COPD-risk.  
Base Position was calculated using hg19 coordinates. 
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Previously Reported Variant 
Lead Variant in Meta-
Analysis Window 
Linkage Disequilibrium 
Between Previously 
Reported and Lead 
Variants 
Chromosome rsID Base Position 
Nearest 
Gene 
Meta-analysis 
p-value 
rsID 
Meta-
analysis          
p-value 
r
2 
D' 
1 rs2284746 17306675 MFAP2 0.12 rs3170740 0.10 0.91 0.98 
1 rs993925 218860068 
TGFB2-
LYPLAL1 
0.56 rs72738847 4.56x10
-6
 0.00 0.34 
2 
rs2571445 
(rs918949) 
218683153 TNS1 0.07 rs3791953 1.75x10
-2
 0.00 0.12 
2 rs7594321 230224031 DNER 0.09 rs12995479 0.02 0.00 0.02 
2 rs12477314 239877148 
HDAC4- 
FLJ43879 
2.37x10-3 rs35877146 1.26x10-3 0.72 0.90 
3 rs1529672 25520582 RARB 3.08x10-4 rs1529672 3.08x10-4 N/A N/A 
3 rs1344555 169300219 
MECOM / 
EVI1 
0.68 rs933607 2.29x10
-4
 0.03 0.24 
4 rs7671167 89883979 FAM13A 2.45x10-15 rs4416442 1.84x10-17 0.65 0.99 
4 rs10516526 106688904 
GSTCD/INT
S12/ NPNT 
7.39x10-4 rs11735213 5.12x10-5 0.67 0.91 
4 rs1032296 145434688 HHIP 4.13x10-10 rs13141641 1.26x10-18 0.41 0.89 
5 rs153916 95036700 
SPATA9- 
RHOBTB3 
2.90x10-3 rs153916 2.90x10-3 N/A N/A 
5 rs11168048 147842353 HTR4 0.01 rs17720155 4.41x10-4 0.33 0.78 
5 
rs11134779 
(rs1422795) 
156936766 ADAM19 7.98x10-3 rs62390771 4.16x10-7 0.02 0.38 
6 rs6903823ᶲ 28322296 ZKSCAN3 0.75 rs3800326 0.10 0.09 1.00 
6 rs2857595ᶲ 31568469 NCR3-AIF1 0.71 rs2844479 0.03 0.03 0.51 
6 rs2070600 32151443 
AGER/ 
PPT2 
7.05x10-6 rs2070600 7.05x10-6 N/A N/A 
6 rs7765379 32680928 HLA-DQB1 0.12 rs9275141 5.67x10
-3
 0.14 1.00 
6 rs2798641 109268050 ARMC2 1.15x10-4 rs2848598 2.06x10-5 0.31 0.89 
6 rs3817928 142750516 GPR126 5.71x10-3 rs9399401 1.91x10-4 0.63 0.96 
9 rs16909898 98231008 PTCH1 0.12 rs357523 7.77x10
-3
 0.47 0.73 
10 rs7068966 12277992 CDC123 0.05 rs10906083 0.03 0.01 0.13 
10 rs11001819 78315224 C10orf11 0.39 rs7904646 2.08x10
-3
 0.00 0.33 
12 rs11172113 57527283 LRP1 2.28x10-4 rs2122692 9.12x10-5 0.44 0.80 
12 
rs1036429 
(rs7307510) 
96271427 CCDC38 6.35 x10-3 rs7306887 7.35x10-4 0.13 0.87 
15 rs12899618 71645120 THSD4 0.01 rs10459646 4.37x10-7 0.09 1.00 
16 rs12447804 58075282 MMP15 0.16 rs2550370 9.55x10
-3
 0.03 0.63 
16 
rs2865531 
(rs4888380) 
75390315 CFDP1 3.09 x10-3 rs37586 4.88x10-4 0.13 1.00 
17 rs11654749 69125606 KCNJ2 0.39 rs35883109 0.01 0.00 0.08 
21 rs9978142 35652239 
KCNE2- 
LINC00310
/C21orf82 
0.98 rs73205216 8.96x10
-5
 0.02 1.00 
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Table 3. Lung Function Variants       
For each previously reported variant and lead variant, the p-value refers to the association with moderate-to-severe COPD in our  
analysis. Risk alleles showing a discordant association direction of effect for COPD risk and decreased lung function risk are  
marked with ᶲ. Nominally significant associations (p <0.05) among previously reported variants are shown in bold. Linkage   
disequilibrium values (r
2
) between the previously reported variant and the lead variant in meta-analysis window were obtained  
using data from 1000 Genomes Project Phase 1 v3. Proxies for variants not available in our dataset are in parentheses, and p-  
values displayed are for the proxy variant. D' represents the normalized coefficient of linkage disequilibrium, and r
2
 represents 
the between-locus correlation coefficient. 
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 CHRNA3 
rs12914385 
HHIP 
rs13141641 
DNER 
rs7594321 
RARB 
rs1529672 
ZKSCAN3 
rs6903823 
GPR126 
rs3817928 
RAB4B/ EGLN2/ 
MIA/CYP2A6 
rs7937 
FAM13A 
rs4416442 
HDAC4- 
FLJ43879 
rs12477314 
GSTCD/INTS12
/ NPNT 
rs10516526 
 
SPATA9- 
RHOBTB3 
rs153916 
TGFB2-
LYPLAL1 
rs993925 
RIN3 
rs754388 
PTCH1 
rs16909898 
MFAP2 
rs2284746  
NCR3-AIF1 
rs2857595 
MMP15 
rs12447804 
CDC123 
rs7068966 
TGFB2 
rs4846480 
C10orf11 
rs11001819 
ARMC2 
rs2798641 
MECOM/EVI1 
rs1344555 
HLA-DQB1 
rs7765379 
KCNE2- 
LINC00310/ 
C21orf82 
rs9978142 
MMP12 
rs626750 
HTR4 
rs11168048 
LRP1 
rs11172113 
AGER/PPT2 
rs2070600 
KCNJ2/ 
CASC17 
rs11654749 
THSD4 
rs12899618 
 
Table 4. Genetic Risk Score Loci 
Genetic risk scores were composed using previous COPD and lung function associated loci, here labeled by the closest gene (SNP 
identifier shown below gene).  The LUNG30 score included all of the loci listed in the above table, the COPD7 Score included only 
those in the gray boxes.  Loci names are based on previously reported SNP-associations annotated to the nearest gene or region. 
 
 
  
Page 33 of 133  AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
   
FEV1 % per Risk Allele 
(unadjusted) 
p-value 
FEV1 % per Risk 
Allele (adjusted) 
p-value 
 COPD7 -2.02 (-1.34, -2.70) 6.74x10
-9
 -1.86 (-1.24, -2.50) 7.90x10
-9
 
 LUNG30 -1.18 (-0.83,-1.53) 4.70x10
-11
 -1.10 (-0.78, -1.43) 3.78x10
-11
 
Table 5a: Genetic Risk Scores: Lung Function in ICGN   
For each risk score (COPD7 and LUNG30), the linear mixed model coefficient is presented with  
95% confidence interval in parentheses and p-value. Final model included adjustment for age, 
pack years, familial correlation, and principal components for genetic ancestry, while the unadjusted  
model was not adjusted for age and pack years. FEV1 % represents the unit change in FEV1 percent  
predicted . COPD7: 7 COPD risk SNPs (14 risk alleles); LUNG30: 30 COPD and lung function SNPs (60 risk 
alleles) 
 
 
      
  Moderate COPD  p-value Severe COPD  p-value 
COPD7 OR per Risk Allele 1.18 (1.11, 1.25) 4.10x10
-8
 1.19 (1.12, 1.27) 4.43x10
-8
 
 AUC 0.58 (0.56, 0.61)  0.59 (0.56, 0.61)  
 Total NRI 0.053 (0.019-0.086) 2.32x10
-3
 0.047 (0.01, 0.084) 1.32x10
-2
 
 Event NRI 0.23%  0.83%  
 Nonevent NRI 5.03%  3.88%  
LUNG30 OR per Risk Allele 1.12 (1.09, 1.15) 1.25x10
-13
 1.12 (1.09, 1.15) 1.25x10
-13
 
 AUC 0.60 (0.57, 0.62)  0.60 (0.57, 0.63)  
 NRI 0.090 (0.053, 0.126) 1.72x10
-6
 0.047 (0.007, 0.087) 2.22x10
-2
 
 Event NRI 2.35%  0.65%  
 Nonevent NRI 6.61%  4.67%  
Table 5b. Genetic Risk Scores: Affection Status in ICGN   
For each risk score (COPD7 and LUNG30), OR represents the odds ratio of each additional risk 
allele on the outcome of either Moderate COPD (GOLD II-IV) or Severe COPD (GOLD III-IV).  AUC 
represents Area Under the Curve of a model including only the genetic data of risk score alleles 
adjusted for principal components of genetic ancestry. NRI represents the three-tiered net 
reclassification index value of the model combining genetic risk score, age, pack-years of 
smoking, and principal components of genetic ancestry compared to the model containing age 
and pack-years alone.  Event NRI represents the percentage of subjects with the outcome of COPD adding  
correctly reclassified to a higher risk group after adding genetic data.  Nonevent NRI represents the 
percentage of subjects without the outcome of COPD correctly reclassified to a lower risk group after 
genetic data.  Data is presented with 95% confidence intervals in parentheses. COPD7: 14 COPD risk 
allelesLUNG30: 60 COPD and lung function risk alleles 
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Figures: 
Figure 1. Unadjusted FEV1 by number of COPD7 and LUNG 30 Risk Alleles 
 
 
 
Boxplots showing FEV1 percent predicted stratified by number of risk alleles in the ICGN pedigree-based 
cohort. The figure on the left shows the COPD7 risk score, while the figure on the right shows the LUNG30 
risk score. 
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Figure2: Severe COPD Diagnosis using COPD7 and LUNG30 
 
 
 
Receiver operator characteristic curves showing diagnostic accuracy of models based on clinical 
variables (age and pack-years of smoking alone, shown light blue), COPD7 or LUNG30 risk allele data 
alone (light green), and the combination of clinical and FX25 data (blue) for predicting GOLD spirometric 
stage III-IV COPD affection status in the ICGN cohort. The differences between the clinical and combined 
curves were statistically significant in both the COPD7 (difference 0.010, p-value 4.4x10-3) and the 
LUNG30 scores (difference 0.012, p-value  4.7x10-3). 
 
 
 
Page 36 of 133 AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
Genetic Association and Risk Scores in a COPD Meta-Analysis of 16,707 Subjects 
 
Methods and Data Supplement  
 
 
Authors: 
 
 
 
 
 
 
 
 
Affiliations: 
Robert Busch, MD1, Brian D Hobbs, MD1, Jin Zhou PhD2, Peter J Castaldi MD1, Michael J 
McGeachie PhD1, Megan E Hardin MD1, Iwona Hawrylkiewicz MD3, Pawel Sliwinski MD3, Jae-
Joon Yim MD4, Woo Jin Kim MD5, Deog K Kim MD6, Alvar Agusti MD7, Barry J Make 
MD8, James D Crapo MD8, Peter M Calverley DSc9, Claudio F Donner MD10, David A Lomas 
ScD11, Emiel F Wouters MD12, Jorgen Vestbo MD13, Ruth Tal-Singer MD14, Per Bakke 
MD15, Amund Gulsvik MD15, Augusto A Litonjua MD1, David Sparrow DSc16, Peter D Paré 
MD17, Robert D Levy MD17, Stephen I Rennard MD18, Terri H Beaty PhD19, John Hokanson 
PhD20, Edwin K Silverman MD1, and Michael H Cho MD1; for the NETT Genetics, ECLIPSE, 
ICGN, and COPDGene Investigators 
 
1 Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, 
MA/USA, 2 University of Arizona, Tucson, AZ/USA, 3 National Tuberculosis and Lung Disease 
Research Institute, Warsaw/PL, 4 Division of Pulmonary and Critical Care Medicine, 
Department of Internal Medicine, Seoul National University College of Medicine, 
Seoul/KR, 5Kangwon National University, Chuncheon/KR, 6 Seoul National University 
Boramae Medical Center, Seoul/KR, 7 Thorax Institute, Hospital Clinic, IDIBAPS, University of 
Barcelona, CIBERES, Barcelona/ES, 8 National Jewish Health, Denver, CO/US, 9 University of 
Liverpool, Liverpool/UK,10Mondo Medico di I.F.I.M. srl, Multidisciplinary and Rehabilitation 
Outpatient Clinic, Borgomanero, Novara/IT, 11University College London, London, 
UK 12University Hospital Maastricht, Maastricht/NL,13University of Manchester, 
Manchester/UK, 14GSK Research and Development, King Of Prussia, PA/USA, 15University of 
Bergen, Bergen/NO, 16Brigham and Women's Hospital and the VA Medical Center - Jamaica 
Plain, MA/USA,17Respiratory Division, Department of Medicine, University of British 
Columbia, Vancouver, BC/CA, 18University of Nebraska Medical Center, Omaha, NE/US, 19 
Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins 
University, Baltimore, MD/USA, 20 Department of Epidemiology, University of Colorado 
Anschutz Medical Campus, Aurora, CO/USA 
 
 
 
 
 
Supplemental Methods 
Study Populations 
The Boston Early Onset COPD (EOCOPD) study (ClinicalTrials.gov study NCT01177618) is a pedigree-based 
genetic study of severe, early-onset COPD that enrolled probands as well as first-degree and more extended 
relatives. Enrolled probands were less than 53 years of age, with FEV1 <40% predicted. The International COPD 
Genetics Network (ICGN) study is a multicenter pedigree-based trial of COPD probands, parents, and siblings. 
Probands were between the ages of 45-65 years and had a clinical diagnosis of COPD, spirometry with post-
bronchodilator values of FEV1 <60% predicted and FEV1/FVC ratio of <90% predicted. In both of the preceding 
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studies, investigation was limited to the non-Hispanic and Hispanic White subjects due to underrepresentation 
of other racial groups (<5% non-white). The Transcontinental COPD Genetics Study was a case-control study of 
severe COPD, with cohorts drawn from Poland (TCGS-Poland) and Korea (TCGS-Korea). Both of these cohorts 
included current or ex-smoking subjects between the ages of 40 and 80 years with >10 pack-years of smoking 
history. Cases were defined by the presence of severe or very severe COPD (FEV1 <50% predicted), while 
controls had normal spirometry.  The TCGS Poland cohort consisted of non-Hispanic White subjects, while the 
TCGS Korea cohort consisted of subjects with Korean ancestry.  
 
COPDGene (ClinicalTrials.gov NCT00608764) is a multicenter case-control study of current and former smokers 
with and without COPD, designed to investigate epidemiologic and genetic risk factors for COPD(1). 
COPDGene included subjects between the ages of 45-80, self-described as non-Hispanic White or African-
American. ECLIPSE (ClinicalTrials.gov NCT00292552) and GenKOLS (GSK code RES11080) were case-control 
studies of ever-smokers with and without COPD. The NETT/NAS cohort is composed of cases from NETT 
(ClinicalTrials.gov NCT00000606) and controls from NAS. Subjects in all cohorts completed lifestyle and 
symptom questionnaires, spirometry, and genotyping. Further details of study design, genotyping, imputation, 
and quality control have been previously described(1-7). 
 
All subjects in the COPDGene, ECLIPSE, GenKOLS, NETT/NAS, TCGS, and ICGN study were current or former 
cigarette smokers; EOCOPD included a small number of non-smokers, both with and without COPD. 
We classified subjects in each dataset using a consistent definition of case and control status.  We defined 
“moderate to severe” COPD as GOLD(8) spirometric Grade 2-4 COPD (post-bronchodilator FEV1/FVC <0.7, FEV1 
<80% predicted), while “severe” COPD was defined as Grade 3-4 COPD (FEV1/FVC <0.7, FEV1 <50% predicted). 
Controls had normal spirometry (FEV1/FVC >0.7, FEV1 > 80%).   
 
Genotyping 
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A total of 4900 non-Hispanic White subjects (ICGN= 3043, EOCOPD = 1198, TCGS-Poland = 659) and 458 
Korean subjects from TCGS-Korea were genotyped using the HumanExome v1.2 (Illumina, San Diego, CA) 
platform with the addition of a set of 3,346 custom markers. This custom content included top results from a 
previously published COPD GWAS(9), using results with P < 10
-4
 using PLINK ‘—clump’ on the COPDGene non-
Hispanic whites (NHW) to perform linkage disequilibrium pruning (r
2
 < 0.8), preferentially retaining both an 
imputed and genotyped top SNP at each locus. An additional set of candidate SNPs came from a previous 
analysis of COPD by Castaldi et al (10), which included both  genome-wide significant associations identified 
from population-based GWAS of spirometric lung function (11-14) and biological candidate gene regions; for 
the former, we included the lead SNP and SNPs within a 200kb region around that SNP pruned for variants 
with P < 0.01 and r
2
 < 0.8. A complete table of the SNPs considered for our analysis (and their provenance) is 
provided in Supplemental Table 1.  
 
Genotyping and imputation of the COPDGene, ECLIPSE, NETT/NAS, and Norway (GenKOLS) studies have been 
previously described(9) including information regarding quality control. In all cohorts, genotyping was 
performed using Illumina arrays, and imputation was performed using MaCH(15) and minimac. 1000 Genomes 
Phase I v3 EUR(16) served as a reference panel for the European ancestry cohorts, and cosmopolitan 
reference panels were used for the African-Americans (AA).  
 
Genotyping Quality Control 
Genotyping quality control at a subject level was identical to that used for the exome array analysis(17).  
Briefly, systematic evaluation of kinship errors was performed using KING relationship inference software.  
Further subject-level controls were performed using PLINK v1.07(18) and v1.9(19), including assessment of X-
chromosome heterozygosity (gender check), excess homozygosity (consanguinity check), assessment of 
overall subject genotyping success rate, and assessment of Mendelian transmission errors (EOCOPD study 
only).  For the pedigree-based studies, we manually reviewed errors in reported relationships using the 
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kinship2 package in R to draw all pedigrees that contained errors.  All kinship errors except those detailed 
below were dropped from the analysis.  Subjects with suspected non-paternity in the ICGN study were kept in 
the study as half-siblings.  Subjects with suspected non-paternity in the EOCOPD study were kept in the 
analysis if there was evidence of non-paternity when examining all first-degree relationships.  Relationship 
errors in the EOCOPD study that involved third-degree or more distant relatives of the probands were 
reviewed, and retained if relationships between these subjects and first- and second-degree relatives 
conformed to the predicted relationship values.  
 
Subject Quality Control 
We identified population outliers in the COPDGene, ECLIPSE, NETT/NAS, and GenKOLS cohorts using principal 
component analysis in smartpca.  Population outliers were identified in the EOCOPD, ICGN, TCGS-Poland, and 
TCGS-Korea studies using TRACE software using the HapMap as a reference group.  Marker quality control 
included discordances between subject replicates, markers out of Hardy-Weinberg equilibrium (p-value <1x10
-
8
) in controls, and call rate <95%. 
 
Marker Quality Control 
Markers were removed for discordances between subject replicates, markers out of Hardy-Weinberg 
equilibrium (p-value <1x10
-8
) in the controls of any cohort, and call rate <95% in any cohort.  
 
Genetic Analysis: Association Analysis 
PLINK v1.9(19) and GWAF(20) were used to perform multiple logistic regression within each dataset case-
control and pedigree dataset, respectively, adjusting for age, pack-years of smoking, and principal components 
of genetic ancestry as previously described. Family-based data were also adjusted for within-family variability 
using generalized estimating equations with an exchangeable correlation structure.  We performed fixed-
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effects meta-analysis across all studies using METAL(21).Family-based cohorts were analyzed together, with a 
covariate to indicate study.  
 
For our signal near SERPINA1, we repeated the analysis after excluding ZZ-homozygotes for alpha-1 antitrypsin 
deficiency  identified through our genotyping (three in the Poland cohort and six in the ECLIPSE cohort) to 
verify that the chromosome 14 association was robust to the removal of these subjects.  We also performed a 
meta-analysis of rs112458284 conditioning on the SERPINA1 Z-allele. 
 
For variants previously associated with FEV1 or FEV1/FVC that were not successfully genotyped, we identified 
proxies (within 250kb and r
2
>0·8) using 1000 Genomes data.  For lead SNPs previously reported to be 
associated with lung function, we additionally examined whether the direction of effect for COPD was 
consistent with the previously reported SNP's effect on spirometric phenotypes. 
 
Genetic Analysis: Genetic Risk Scores 
We used PLINK (v1.9) to create genetic scores based on prior genome-wide association studies of COPD and 
lung function.  We oriented risk alleles to be consistent with prior reports, and gave each allele equal weight.  
We applied the scoring systems to the ICGN cohort, the largest individual cohort not used in the discovery of 
any of the risk score variants.  The resulting combined risk scores were used as predictors in a linear mixed 
model of FEV1 percent predicted, as well as logistic regression models of both moderate-to-severe and severe 
COPD incorporating generalized estimating equations.  Models were controlled for age, pack-years of 
smoking, principal component of genetic ancestry, and for familial correlation. In addition, we used the 
pROC(22) and GenAbel(23) packages in R to compare the accuracy of two models (i.e. model with genetic risk 
factors and clinical predictors versus the clinical predictors alone) through receiver operator characteristic 
(ROC) curves and net reclassification index (NRI) at explaining risk to moderate-to-severe and severe COPD 
separately. In addition to examining ROC curves, we also used the net reclassification index (24) (NRI) to 
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characterize the efficacy of these risk scores.  The NRI evaluates risk in the decision-making context, and offers 
an alternative interpretation of classification results.  We used the NRI to evaluate the added discriminatory 
benefit of adding genetic information from genetic risk score SNPs to a clinical model by dividing subjects into 
three tiers of COPD risk (low 0-33.3%, intermediate 33.4-66.8%, and high 66.7-100%) under a clinical risk 
model based on age and pack-years of smoking alone. NRI was calculated using the PredictAbel package(25), 
and data are presented as total NRI as well as event NRI and non-event NRI components.  
 
Coefficient p-values for linear mixed models were calculated using effective degrees of freedom based on the 
Satterthwaite approximation(26).  The calculated genetic risk scores were used as predictors in linear mixed 
models of FEV1 percent predicted adjusted for age, pack-years of smoking, principal components of genetic 
ancestry, and family membership (as a random effect). The scores were also used as predictors in logistic 
regression models incorporating generalized estimating equations for both moderate-to-severe and severe 
COPD, controlling for age, pack-years of smoking, principal component of genetic ancestry, and adjustment for 
familial correlation. 
 
The net reclassification index (NRI) was used to evaluate the added benefit of the addition of genetic 
information on the risk score SNPs to the clinical model of age and pack-years of smoking using the method of 
Pencina, et al(24). Subjects were stratified into low (0-33% risk), medium (33-66% risk), and high (66-100% 
risk) risk groups for the outcome of COPD or severe COPD using only age and pack-years of smoking data; after 
addition of the risk score SNPs to the model, each subject was reclassified into low, medium, or high risk 
groups.  The event NRI was defined as the number of subjects with COPD who were appropriately reclassified 
to a higher risk group minus the number of subjects with COPD who were inappropriately reclassified to a 
lower risk group, divided by the total number of subjects with COPD.  The nonevent NRI was defined as the 
number of subjects without COPD who were appropriately reclassified to a lower risk group minus the number 
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of subjects without COPD who were inappropriately reclassified to a higher risk group, divided by the total 
number of subjects without COPD.  The sum of these two component NRI values yielded the total NRI.   
 
We performed pathway analysis of the LUNG30 score risk loci with ConsensusPathDB(27) and SNPsea(28).  We 
selected the closest gene(s) by distance to each variant of the LUNG30 score (listed in Table 4 of the 
manuscript), and these gene names were used as input for ConsensusPathDB hypergeometric testing in the 
Gene Ontology (GO) Biological Process(29) ontology (Level 1-5), Kyoto Encyclopedia of Genes and 
Genomes(30) (KEGG), and the Reactome(31).  We required a threshold for enrichment of three genes 
matching a given gene set, and filtered our results for a false discovery rate (FDR) adjusted q-value of 0.01.  
Using SNPsea software with default settings, we created a tissue-specific score for each gene in linkage-
disequilibrium with a LUNG30 score SNP.  This aggregate score for each tissue was then compared against the 
scores of random SNP sets of similar size to create a null distribution, and an association statistic for tissue-
specific enrichment of gene expression was calculated for each tissue. 
 
Supplemental Results: 
Genetic Analysis 
Genome-wide significant results of the moderate-to-severe COPD candidate SNP association meta-analysis are 
presented below in Supplemental table 2, while the genome-wide significant results of the severe COPD 
association were presented in the main manuscript.  Supplemental Table 3 shows effect allele frequencies 
stratified by case and control status for each cohort included in the meta-analysis.  Supplemental Table 4 
describes association results and LD characteristics of additional candidate regions identified in the work of 
Castaldi et al(10).   
 
Genetic Risk Scores 
The loci included in the COPD7 and LUNG30 risk scores are described in detail in Supplemental Table 5.   
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 The LUNG30 risk score had a smaller per-allele effect but was significantly associated with FEV1 percent 
predicted, moderate-to-severe and severe COPD prediction, and reclassification when added to a model 
composed of clinical data only.  The LUNG30 score (with a range of 0-60 possible alleles) also showed a 
statistically and clinically significant association with lung function in the ICGN cohort, with a 1.10% lower FEV1 
percent predicted per risk allele (p-value 3.8x10
-11
). For moderate-to-severe affection status, the NRI showed 
modest benefit (NRI = 0.090, p-value 1.72x10
-6
).  
 
Application of the COPD7, and LUNG30 risk scores on the COPDGene and TCGS Poland datasets are provided 
in Supplemental Table 6 and 7. 
 
Hypergeometric testing of the genes in the LUNG30 score against KEGG and Reactome gene sets yielded 
enrichment for terms related to the hedgehog signaling pathway, while testing against the Reactome database 
also yielded additional enrichments for processes that are potentially involved in COPD pathogenesis such as 
structural components of lung development like elastic fiber formation, collagen degradation, and 
extracellular matrix organization.  The LUNG30 genes also showed enrichment in Gene Ontology gene sets 
that could be related to COPD. Multiple sets were related to components of lung development such as the GO 
terms tube development, morphogenesis of an epithelium, epithelial cell proliferation, extracelular structure 
organization, smooth muscle proliferation, and branching morphogenesis of an epithelial tube. Others were 
related to response to stimuli that were potentially relevant for COPD including response to steroid hormone, 
response to organic substance, inflammatory response, and regulation of reactive oxygen species metabolic 
process.  We then used the SNPsea algorithm to identify tissue types that were likely to be affected by the risk 
loci in our LUNG30 score.  Using a p-value threshold of 0.1, we saw enrichment of the LUNG30 SNPs in fetal 
lung, trachea, and smooth muscle tissue, among others.  Results of KEGG, Reactome, and GO enrichment 
analysis are presented in Supplemental Table 8, and SNPsea results are presented in Supplemental Table 9. 
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 SUPPLEMENTAL TABLE 1 
CHR BP SNP Source 
1 7133059 rs147005162 GWAS Follow-Up 
1 9708688 rs6540985 GWAS Follow-Up 
1 9709735 rs4529711 GWAS Follow-Up 
1 9718087 rs6540991 GWAS Follow-Up 
1 17292223 rs78888579 GWAS Follow-Up 
1 17306675 rs2284746 Candidate 
1 17312743 rs3170740 GWAS Follow-Up 
1 17331676 rs3738814 GWAS Follow-Up 
1 17354297 rs33927012 GWAS Follow-Up 
1 17395480 rs2076599 GWAS Follow-Up 
1 18859887 rs35192516 GWAS Follow-Up 
1 18860592 rs12120885 GWAS Follow-Up 
1 18864374 rs68124995 GWAS Follow-Up 
1 27532529 rs12747236 GWAS Follow-Up 
1 27537101 rs6687674 GWAS Follow-Up 
1 33871246 rs12131910 GWAS Follow-Up 
1 54940234 rs115159278 GWAS Follow-Up 
1 57913227 rs12033655 GWAS Follow-Up 
1 62204308 rs12738921 GWAS Follow-Up 
1 68100394 rs629112 GWAS Follow-Up 
1 72455832 rs6677919 GWAS Follow-Up 
1 72458685 rs6661979 GWAS Follow-Up 
1 74470568 rs10890102 GWAS Follow-Up 
1 74522532 rs1072936 GWAS Follow-Up 
1 74699912 rs518769 GWAS Follow-Up 
1 78723269 rs1417100 GWAS Follow-Up 
1 78724748 rs34125922 GWAS Follow-Up 
1 78732801 rs4650408 GWAS Follow-Up 
1 78756602 rs12144203 GWAS Follow-Up 
1 78772046 rs11162456 GWAS Follow-Up 
1 90328483 rs12045824 GWAS Follow-Up 
1 90338129 rs17130908 GWAS Follow-Up 
1 92031009 rs11164953 Candidate 
1 92031175 rs925190 Candidate 
1 92032613 rs7549735 Candidate 
1 96749714 rs161989 GWAS Follow-Up 
1 96818456 rs325953 GWAS Follow-Up 
1 108572106 rs4915093 Candidate 
1 108578125 rs12119029 Candidate 
1 108580998 rs9787114 Candidate 
1 108584103 rs12409794 Candidate 
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1 108587458 rs4423038 Candidate 
1 108600490 rs78362906 Candidate 
1 108607992 rs12126230 Candidate 
1 108616858 rs10494088 Candidate 
1 108637557 rs12132365 Candidate 
1 108661569 rs12116716 Candidate 
1 108669146 rs56006067 Candidate 
1 108681944 rs12076095 Candidate 
1 109999838 rs1933182 GWAS Follow-Up 
1 110019439 rs62623713 GWAS Follow-Up 
1 110031188 rs12049330 GWAS Follow-Up 
1 110078434 rs501163 GWAS Follow-Up 
1 110082886 rs7550711 GWAS Follow-Up 
1 110119732 rs6537837 GWAS Follow-Up 
1 110151395 rs3738766 GWAS Follow-Up 
1 110163879 rs28362581 GWAS Follow-Up 
1 110186563 rs12745189 Candidate 
1 110279701 rs7483 GWAS Follow-Up 
1 110299691 rs11102001 GWAS Follow-Up 
1 110300441 rs3818562 GWAS Follow-Up 
1 110301260 rs6693815 GWAS Follow-Up 
1 110346355 rs7520172 GWAS Follow-Up 
1 110352477 rs10494112 GWAS Follow-Up 
1 110366083 rs484959 GWAS Follow-Up 
1 111306729 rs12118017 Candidate 
1 111318158 rs12084202 Candidate 
1 111320253 rs12127060 Candidate 
1 111832469 rs61803519 Candidate 
1 113240577 rs72701116 GWAS Follow-Up 
1 151456548 rs11204827 GWAS Follow-Up 
1 151457638 rs11590129 GWAS Follow-Up 
1 151458193 rs11204828 GWAS Follow-Up 
1 151699416 rs12402668 GWAS Follow-Up 
1 151700214 rs2275920 GWAS Follow-Up 
1 151703474 rs57696433 GWAS Follow-Up 
1 164733504 rs2789443 GWAS Follow-Up 
1 164735436 rs1780360 GWAS Follow-Up 
1 165958942 rs75331080 GWAS Follow-Up 
1 167454312 rs858558 GWAS Follow-Up 
1 167454346 rs858557 GWAS Follow-Up 
1 167454562 rs858555 GWAS Follow-Up 
1 167454914 rs858554 GWAS Follow-Up 
1 167455145 rs858553 GWAS Follow-Up 
1 168251144 rs12083107 Candidate 
1 168251333 rs3767480 Candidate 
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1 168251535 rs3767481 Candidate 
1 172450689 rs4916263 GWAS Follow-Up 
1 172451442 rs9425628 GWAS Follow-Up 
1 172451886 rs2032530 GWAS Follow-Up 
1 175276630 rs74566648 GWAS Follow-Up 
1 177411322 rs80065677 Candidate 
1 179130359 rs6672395 GWAS Follow-Up 
1 179290889 rs12031660 GWAS Follow-Up 
1 179302003 rs7531307 GWAS Follow-Up 
1 179306200 rs12039261 GWAS Follow-Up 
1 191153510 rs12756536 Candidate 
1 191156476 rs10920911 Candidate 
1 191167624 rs7554791 Candidate 
1 191320291 rs7550126 Candidate 
1 193938733 rs34990096 GWAS Follow-Up 
1 193938975 rs35168515 GWAS Follow-Up 
1 193942375 rs1323086 GWAS Follow-Up 
1 193942506 rs17548640 GWAS Follow-Up 
1 193970745 rs12725939 GWAS Follow-Up 
1 196686652 rs3753395 Candidate 
1 196687329 rs10465586 Candidate 
1 196701284 rs7540032 Candidate 
1 196702810 rs1329428 Candidate 
1 196704559 rs1329427 Candidate 
1 196880005 rs1409153 Candidate 
1 196937536 rs6428379 Candidate 
1 206834908 rs77013051 Candidate 
1 206836651 rs12042566 Candidate 
1 206879122 rs4072677 GWAS Follow-Up 
1 206939904 rs3024505 GWAS Follow-Up 
1 206943968 rs3024493 GWAS Follow-Up 
1 206944233 rs1554286 Candidate 
1 206944645 rs1518111 GWAS Follow-Up 
1 206946634 rs1800871 GWAS Follow-Up 
1 206970470 rs4845140 Candidate 
1 207015957 rs2243191 GWAS Follow-Up 
1 207074905 rs1150258 GWAS Follow-Up 
1 207106478 rs291102 GWAS Follow-Up 
1 207109116 rs2275531 GWAS Follow-Up 
1 207110936 rs291096 GWAS Follow-Up 
1 207134104 rs61729352 GWAS Follow-Up 
1 218274763 rs7536760 GWAS Follow-Up 
1 218274933 rs7550557 GWAS Follow-Up 
1 218563693 rs12129220 Candidate 
1 218571757 rs61823428 GWAS Follow-Up 
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1 218575202 rs1317681 Candidate 
1 218575887 rs10746379 GWAS Follow-Up 
1 218579985 rs1891467 GWAS Follow-Up 
1 218582778 rs17047804 GWAS Follow-Up 
1 218586132 rs2796822 Candidate 
1 218587636 rs2000220 Candidate 
1 218588279 rs10863398 GWAS Follow-Up 
1 218593037 rs12048582 GWAS Follow-Up 
1 218597632 rs72738830 GWAS Follow-Up 
1 218597859 rs1342586 Candidate 
1 218598328 rs4846478 GWAS Follow-Up 
1 218598410 rs4846479 Candidate 
1 218598469 rs4846480 GWAS Follow-Up 
1 218598484 rs4846481 Candidate 
1 218604678 rs1890995 GWAS Follow-Up 
1 218605609 rs10482795 Candidate 
1 218605635 rs10482796 GWAS Follow-Up 
1 218622319 rs1473527 GWAS Follow-Up 
1 218622639 rs12023953 Candidate 
1 218623888 rs72738834 GWAS Follow-Up 
1 218624533 rs10429950 Candidate 
1 218626620 rs7515360 GWAS Follow-Up 
1 218634362 rs6604615 GWAS Follow-Up 
1 218634787 rs1108548 GWAS Follow-Up 
1 218639589 rs7547759 GWAS Follow-Up 
1 218640261 rs2001552 Candidate 
1 218643940 rs725033 Candidate 
1 218645873 rs7526672 Candidate 
1 218656286 rs35450021 GWAS Follow-Up 
1 218656387 rs1845463 Candidate 
1 218657788 rs7534133 Candidate 
1 218666429 rs6656288 Candidate 
1 218670357 rs622912 Candidate 
1 218672807 rs72738842 Candidate 
1 218673257 rs11118112 GWAS Follow-Up 
1 218674236 rs72738843 Candidate 
1 218674597 rs72738844 GWAS Follow-Up 
1 218676444 rs72738847 GWAS Follow-Up 
1 218681971 rs796395 Candidate 
1 218683684 rs72738855 Candidate 
1 218689155 rs3009947 Candidate 
1 218690577 rs6665024 GWAS Follow-Up 
1 218698728 rs72738863 Candidate 
1 218701451 rs60831762 Candidate 
1 218730751 rs12022686 Candidate 
Page 48 of 133 AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
1 218738103 rs6666438 Candidate 
1 218739482 rs682483 Candidate 
1 218744152 rs17048147 Candidate 
1 218746863 rs62817 Candidate 
1 218756684 rs259471 Candidate 
1 218760982 rs259476 Candidate 
1 218775194 rs2929333 Candidate 
1 218798710 rs2993030 Candidate 
1 218827855 rs1481345 Candidate 
1 218832257 rs6690218 Candidate 
1 218833890 rs17048367 Candidate 
1 218835037 rs11488570 Candidate 
1 218838553 rs17505020 Candidate 
1 218860068 rs993925 Candidate 
1 218907657 rs17512596 Candidate 
1 218910704 rs57548624 Candidate 
1 218931976 rs7542694 Candidate 
1 218938564 rs9431104 Candidate 
1 218938961 rs6541199 Candidate 
1 218940576 rs17048556 Candidate 
1 218950403 rs2889809 GWAS Follow-Up 
1 218972552 rs12081079 Candidate 
1 218979635 rs116167583 Candidate 
1 218988754 rs17514738 Candidate 
1 219001663 rs6541234 Candidate 
1 219004755 rs2647119 Candidate 
1 219006382 rs2244622 Candidate 
1 219009835 rs2647116 GWAS Follow-Up 
1 219024035 rs17574573 Candidate 
1 219039895 rs80261364 Candidate 
1 219043164 rs79112139 Candidate 
1 219053082 rs17575281 GWAS Follow-Up 
1 221197094 rs61819230 GWAS Follow-Up 
1 221624945 rs74743345 GWAS Follow-Up 
1 221631207 rs17010062 GWAS Follow-Up 
1 221657985 rs77012522 GWAS Follow-Up 
1 221662052 rs76184324 GWAS Follow-Up 
1 222078600 rs4457591 Candidate 
1 222083595 rs11118892 Candidate 
1 225965803 rs3738037 Candidate 
1 226019633 rs1051740 GWAS Follow-Up 
1 226020988 rs2740168 GWAS Follow-Up 
1 226040404 rs1009668 GWAS Follow-Up 
1 226054333 rs45492299 GWAS Follow-Up 
1 233782353 rs6660631 GWAS Follow-Up 
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1 233782896 rs11576834 GWAS Follow-Up 
1 233805172 rs7552738 GWAS Follow-Up 
1 239079309 rs6676535 Candidate 
1 239090514 rs9970786 Candidate 
1 241400970 rs10926435 Candidate 
1 241405041 rs10926436 Candidate 
1 241421911 rs10926443 Candidate 
1 247278125 rs60176339 GWAS Follow-Up 
1 247348586 rs3820508 GWAS Follow-Up 
1 247348738 rs3738444 GWAS Follow-Up 
1 247348774 rs2068050 GWAS Follow-Up 
1 247352621 rs10754538 GWAS Follow-Up 
2 26940294 rs12468863 GWAS Follow-Up 
2 26941482 rs56083993 GWAS Follow-Up 
2 26942256 rs2384463 GWAS Follow-Up 
2 26948209 rs7595648 GWAS Follow-Up 
2 26948279 rs7586627 GWAS Follow-Up 
2 26953354 rs1731260 GWAS Follow-Up 
2 28778679 rs12618917 GWAS Follow-Up 
2 28782922 rs6725700 GWAS Follow-Up 
2 28785621 rs6738552 GWAS Follow-Up 
2 32891483 rs1807918 GWAS Follow-Up 
2 33809294 rs11066 Candidate 
2 33815384 rs6708570 Candidate 
2 42388003 rs56398784 GWAS Follow-Up 
2 42446076 rs6743809 GWAS Follow-Up 
2 42458640 rs10182302 GWAS Follow-Up 
2 44049795 rs55680582 GWAS Follow-Up 
2 45549305 rs12473388 GWAS Follow-Up 
2 61183525 rs7560570 GWAS Follow-Up 
2 61347626 rs1177292 GWAS Follow-Up 
2 61349446 rs1177284 GWAS Follow-Up 
2 61352163 rs1177287 GWAS Follow-Up 
2 61394851 rs2600671 GWAS Follow-Up 
2 61413723 rs1809028 GWAS Follow-Up 
2 61478497 rs4672428 GWAS Follow-Up 
2 61751642 rs3771262 GWAS Follow-Up 
2 61763207 rs9309337 GWAS Follow-Up 
2 61837947 rs4494731 GWAS Follow-Up 
2 61879276 rs6545894 GWAS Follow-Up 
2 69369989 rs115308740 GWAS Follow-Up 
2 79140196 rs73939929 GWAS Follow-Up 
2 79142387 rs17015845 GWAS Follow-Up 
2 85696551 rs12616455 Candidate 
2 85699750 rs7577642 GWAS Follow-Up 
Page 50 of 133 AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
2 85769711 rs1078004 GWAS Follow-Up 
2 85780536 rs699664 GWAS Follow-Up 
2 85794114 rs10187218 Candidate 
2 85798858 rs2121397 Candidate 
2 85809989 rs1561198 GWAS Follow-Up 
2 85824039 rs1127974 GWAS Follow-Up 
2 85824251 rs6643 GWAS Follow-Up 
2 85866118 rs17736515 Candidate 
2 85893741 rs1130866 GWAS Follow-Up 
2 85895338 rs2077079 GWAS Follow-Up 
2 85924729 rs11127 GWAS Follow-Up 
2 86010098 rs2001593 Candidate 
2 86010243 rs869778 Candidate 
2 86013029 rs13386681 Candidate 
2 86025331 rs6706567 GWAS Follow-Up 
2 86036870 rs13347170 Candidate 
2 86054300 rs56035936 Candidate 
2 86054301 rs56363459 Candidate 
2 86063044 rs13420465 Candidate 
2 86063465 rs11900847 Candidate 
2 104586416 rs78999012 Candidate 
2 108659330 rs2889821 GWAS Follow-Up 
2 108659446 rs35227180 GWAS Follow-Up 
2 108664582 rs35586373 GWAS Follow-Up 
2 108812855 rs12329189 Candidate 
2 108816885 rs6761157 Candidate 
2 113389232 rs908545 GWAS Follow-Up 
2 113405483 rs77746742 Candidate 
2 113468896 rs58533146 GWAS Follow-Up 
2 113496554 rs116342308 GWAS Follow-Up 
2 113498566 rs3811040 GWAS Follow-Up 
2 113513825 rs6731822 GWAS Follow-Up 
2 113514763 rs17042344 GWAS Follow-Up 
2 113520129 rs36093393 GWAS Follow-Up 
2 113529183 rs6542095 GWAS Follow-Up 
2 113537223 rs17561 GWAS Follow-Up 
2 113579866 rs3917386 Candidate 
2 113594387 rs1143627 GWAS Follow-Up 
2 113671410 rs3811047 GWAS Follow-Up 
2 113674721 rs2723183 GWAS Follow-Up 
2 113675269 rs2723187 GWAS Follow-Up 
2 113676219 rs2708947 GWAS Follow-Up 
2 113676381 rs2723192 GWAS Follow-Up 
2 113763575 rs895497 GWAS Follow-Up 
2 113765587 rs34817588 GWAS Follow-Up 
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2 113773561 rs1867831 Candidate 
2 113775573 rs4849140 Candidate 
2 113775749 rs7595507 Candidate 
2 113778642 rs6745709 Candidate 
2 113778986 rs6749299 Candidate 
2 113779206 rs13033574 Candidate 
2 113789316 rs2305150 GWAS Follow-Up 
2 113790258 rs11123155 GWAS Follow-Up 
2 113791482 rs2862772 GWAS Follow-Up 
2 113792419 rs11891020 GWAS Follow-Up 
2 182390953 rs3770107 GWAS Follow-Up 
2 182396032 rs6433921 GWAS Follow-Up 
2 182424718 rs12693280 GWAS Follow-Up 
2 182429735 rs10490687 GWAS Follow-Up 
2 182443391 rs11687348 GWAS Follow-Up 
2 182451737 rs10490684 GWAS Follow-Up 
2 182491014 rs6719421 GWAS Follow-Up 
2 182495701 rs1372119 GWAS Follow-Up 
2 182501005 rs62189989 GWAS Follow-Up 
2 187901064 rs6748392 GWAS Follow-Up 
2 187926271 rs10931269 GWAS Follow-Up 
2 187976717 rs9646745 GWAS Follow-Up 
2 189883851 rs58099040 GWAS Follow-Up 
2 189915813 rs61664338 GWAS Follow-Up 
2 189962098 rs73051214 GWAS Follow-Up 
2 189967528 rs73051217 GWAS Follow-Up 
2 194194121 rs77734878 GWAS Follow-Up 
2 202721424 rs2882324 GWAS Follow-Up 
2 204740171 rs10197010 GWAS Follow-Up 
2 204744097 rs231730 GWAS Follow-Up 
2 204744530 rs231731 GWAS Follow-Up 
2 204745132 rs11571299 GWAS Follow-Up 
2 218669225 rs61741262 GWAS Follow-Up 
2 218674697 rs918949 GWAS Follow-Up 
2 218683139 rs34291329 GWAS Follow-Up 
2 218712290 rs61746994 GWAS Follow-Up 
2 218713282 rs3796033 GWAS Follow-Up 
2 218713469 rs3815849 GWAS Follow-Up 
2 218725480 rs3791953 Candidate 
2 218732851 rs17790748 Candidate 
2 218732864 rs17790760 Candidate 
2 218734362 rs3791949 Candidate 
2 218734953 rs10204348 Candidate 
2 218739732 rs1424917 Candidate 
2 218795794 rs7585036 Candidate 
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2 218864319 rs6712327 GWAS Follow-Up 
2 224824617 rs11546405 GWAS Follow-Up 
2 224837600 rs12694624 GWAS Follow-Up 
2 224866427 rs34078713 GWAS Follow-Up 
2 224931733 rs282249 GWAS Follow-Up 
2 224947170 rs16865545 Candidate 
2 225047744 rs2629046 GWAS Follow-Up 
2 229502503 rs10498230 Candidate 
2 229510929 rs1435867 GWAS Follow-Up 
2 229533885 rs1881204 GWAS Follow-Up 
2 229552897 rs62201158 Candidate 
2 229561895 rs62202378 GWAS Follow-Up 
2 229581891 rs4973113 Candidate 
2 229590717 rs4973115 Candidate 
2 229591965 rs62202385 Candidate 
2 229723426 rs10206541 Candidate 
2 229729917 rs800736 Candidate 
2 229736292 rs55898636 Candidate 
2 229755868 rs60975031 Candidate 
2 229841213 rs74000792 Candidate 
2 229853850 rs2193390 Candidate 
2 229892748 rs7580152 Candidate 
2 229899441 rs34025994 Candidate 
2 229906421 rs12463741 Candidate 
2 229921340 rs111827343 Candidate 
2 229977915 rs2536217 GWAS Follow-Up 
2 230022826 rs11903631 Candidate 
2 230023296 rs4973164 Candidate 
2 230025158 rs12995479 Candidate 
2 230029966 rs9973934 Candidate 
2 230030405 rs4973171 Candidate 
2 230030822 rs72617162 Candidate 
2 230032055 rs2396618 Candidate 
2 230033560 rs1419958 Candidate 
2 230209923 rs2894676 Candidate 
2 230211114 rs6756789 Candidate 
2 230224031 rs7594321 Candidate 
2 233319911 rs1213008 GWAS Follow-Up 
2 233349588 rs1529874 GWAS Follow-Up 
2 239877148 rs12477314 Candidate 
2 239887220 rs35877146 Candidate 
2 239893783 rs35945722 Candidate 
2 239896861 rs10199914 GWAS Follow-Up 
3 2638138 rs9866546 GWAS Follow-Up 
3 3732283 rs2044094 GWAS Follow-Up 
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3 3733372 rs2165631 GWAS Follow-Up 
3 3733390 rs2165630 GWAS Follow-Up 
3 4400735 rs2819563 GWAS Follow-Up 
3 4843506 rs80129583 GWAS Follow-Up 
3 12504295 rs1699346 Candidate 
3 12507564 rs1699348 Candidate 
3 12622623 rs9849171 Candidate 
3 12626516 rs3729931 Candidate 
3 18111142 rs12488761 GWAS Follow-Up 
3 18133070 rs62240234 GWAS Follow-Up 
3 20112187 rs114491517 GWAS Follow-Up 
3 20275194 rs17191318 GWAS Follow-Up 
3 22020956 rs34866662 GWAS Follow-Up 
3 22021125 rs10510522 GWAS Follow-Up 
3 25320733 rs1825370 Candidate 
3 25325452 rs322659 Candidate 
3 25341251 rs12108115 Candidate 
3 25341255 rs185990320 Candidate 
3 25423265 rs9876345 GWAS Follow-Up 
3 25520582 rs1529672 GWAS Follow-Up 
3 25528376 rs1286662 GWAS Follow-Up 
3 25529280 rs1286664 Candidate 
3 25534688 rs35536382 Candidate 
3 25560231 rs1435703 GWAS Follow-Up 
3 25639828 rs61739570 GWAS Follow-Up 
3 31427154 rs12490017 GWAS Follow-Up 
3 31428425 rs17027566 GWAS Follow-Up 
3 31430001 rs55985928 GWAS Follow-Up 
3 31430754 rs9877237 GWAS Follow-Up 
3 31431024 rs9877602 GWAS Follow-Up 
3 31431722 rs12497875 GWAS Follow-Up 
3 31432835 rs17027580 GWAS Follow-Up 
3 31433240 rs10510650 GWAS Follow-Up 
3 31433893 rs9845596 GWAS Follow-Up 
3 31435901 rs9855940 GWAS Follow-Up 
3 63146329 rs72874557 GWAS Follow-Up 
3 69430452 rs62251411 GWAS Follow-Up 
3 69434402 rs34685652 GWAS Follow-Up 
3 69437171 rs981054 GWAS Follow-Up 
3 69438053 rs11717499 GWAS Follow-Up 
3 69440851 rs7648449 GWAS Follow-Up 
3 69443677 rs62251413 GWAS Follow-Up 
3 69460531 rs6549217 GWAS Follow-Up 
3 69471552 rs73109466 GWAS Follow-Up 
3 69498897 rs56840526 GWAS Follow-Up 
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3 69503920 rs62252290 GWAS Follow-Up 
3 72413687 rs4677155 GWAS Follow-Up 
3 72420023 rs35172111 GWAS Follow-Up 
3 73670346 rs6801447 GWAS Follow-Up 
3 73687663 rs4677321 GWAS Follow-Up 
3 75238423 rs79210092 GWAS Follow-Up 
3 75239485 rs76794935 GWAS Follow-Up 
3 85370873 rs9831374 Candidate 
3 85391672 rs9811546 Candidate 
3 85403892 rs28732378 Candidate 
3 85404030 rs62253107 Candidate 
3 85405501 rs9822731 Candidate 
3 85409313 rs9824178 Candidate 
3 85409353 rs9861451 Candidate 
3 85414291 rs7627971 Candidate 
3 85415875 rs73134727 Candidate 
3 85429172 rs13085170 Candidate 
3 85574891 rs73130304 Candidate 
3 85608137 rs1375547 Candidate 
3 100822032 rs35904383 GWAS Follow-Up 
3 100843733 rs62280585 GWAS Follow-Up 
3 109037249 rs2699984 GWAS Follow-Up 
3 109037738 rs2625619 GWAS Follow-Up 
3 109047928 rs1163439 GWAS Follow-Up 
3 109052935 rs1351737 GWAS Follow-Up 
3 109057397 rs1163448 GWAS Follow-Up 
3 112303559 rs79058794 GWAS Follow-Up 
3 122010679 rs35467281 GWAS Follow-Up 
3 122018967 rs13058991 GWAS Follow-Up 
3 122031859 rs4247197 GWAS Follow-Up 
3 127715196 rs17282209 Candidate 
3 127794248 rs11709060 Candidate 
3 127854527 rs35347185 Candidate 
3 127857933 rs11709725 Candidate 
3 127893564 rs11715394 Candidate 
3 127898783 rs2811477 Candidate 
3 127931340 rs2999090 GWAS Follow-Up 
3 127935159 rs2999089 GWAS Follow-Up 
3 127956188 rs2999082 Candidate 
3 127956272 rs2999081 Candidate 
3 127961305 rs2955084 Candidate 
3 127977978 rs2999068 Candidate 
3 127991527 rs2811415 Candidate 
3 127991938 rs2811416 GWAS Follow-Up 
3 128004531 rs4593050 Candidate 
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3 128012277 rs2811520 Candidate 
3 128039895 rs11708733 Candidate 
3 128044372 rs6772407 GWAS Follow-Up 
3 128067275 rs11709611 GWAS Follow-Up 
3 128072502 rs11711096 GWAS Follow-Up 
3 128097496 rs2293947 GWAS Follow-Up 
3 128103714 rs78360844 Candidate 
3 128106536 rs2977561 GWAS Follow-Up 
3 133575865 rs7644124 GWAS Follow-Up 
3 133577269 rs1534167 GWAS Follow-Up 
3 133578594 rs1467334 GWAS Follow-Up 
3 134098876 rs2052830 Candidate 
3 134099218 rs2052832 Candidate 
3 135313695 rs75027740 Candidate 
3 156492758 rs9818780 GWAS Follow-Up 
3 156493213 rs9878566 GWAS Follow-Up 
3 156512817 rs9859058 GWAS Follow-Up 
3 156524220 rs9818684 GWAS Follow-Up 
3 156532666 rs10936038 GWAS Follow-Up 
3 156533403 rs4680305 GWAS Follow-Up 
3 156601655 rs2321291 GWAS Follow-Up 
3 156619137 rs4680313 GWAS Follow-Up 
3 156626091 rs12638253 GWAS Follow-Up 
3 156645757 rs7637701 GWAS Follow-Up 
3 156655494 rs6784421 GWAS Follow-Up 
3 156696506 rs10936043 GWAS Follow-Up 
3 156704742 rs9829685 GWAS Follow-Up 
3 156707330 rs1032044 GWAS Follow-Up 
3 156733521 rs7637445 GWAS Follow-Up 
3 156734799 rs1600978 GWAS Follow-Up 
3 157232900 rs75703125 GWAS Follow-Up 
3 165070685 rs822719 GWAS Follow-Up 
3 165080780 rs7648573 GWAS Follow-Up 
3 169100899 rs448378 GWAS Follow-Up 
3 169300219 rs1344555 Candidate 
3 169316165 rs933607 Candidate 
3 169360455 rs16854266 Candidate 
3 169364599 rs34781085 Candidate 
3 169371036 rs11928083 Candidate 
3 169413590 rs6782665 Candidate 
3 169414042 rs10460793 Candidate 
3 169416247 rs59908764 Candidate 
3 169416569 rs16854319 Candidate 
3 169442363 rs9880534 Candidate 
3 169481271 rs12696304 GWAS Follow-Up 
Page 56 of 133 AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
3 169485588 rs34273285 GWAS Follow-Up 
3 169485639 rs2068178 GWAS Follow-Up 
3 169492101 rs10936599 GWAS Follow-Up 
3 183936680 rs2668193 GWAS Follow-Up 
3 185931624 rs57816510 Candidate 
3 186497254 rs62294445 GWAS Follow-Up 
3 186505900 rs1354091 GWAS Follow-Up 
3 186515844 rs3917117 GWAS Follow-Up 
3 186518652 rs3917110 GWAS Follow-Up 
3 187436079 rs59761878 GWAS Follow-Up 
3 187438897 rs55934024 GWAS Follow-Up 
4 3303976 rs994426 GWAS Follow-Up 
4 3312883 rs35720136 GWAS Follow-Up 
4 3313808 rs61211078 GWAS Follow-Up 
4 8234562 rs115561809 Candidate 
4 8276491 rs79614502 Candidate 
4 17062043 rs28479818 GWAS Follow-Up 
4 17062269 rs10022937 GWAS Follow-Up 
4 17062676 rs949587 GWAS Follow-Up 
4 17069489 rs7657395 GWAS Follow-Up 
4 17070309 rs28524821 GWAS Follow-Up 
4 17073543 rs1533361 GWAS Follow-Up 
4 17075697 rs10939704 GWAS Follow-Up 
4 17094967 rs73135080 GWAS Follow-Up 
4 17106331 rs2056393 GWAS Follow-Up 
4 17106462 rs2056392 GWAS Follow-Up 
4 17107945 rs955609 GWAS Follow-Up 
4 17113151 rs10008516 GWAS Follow-Up 
4 17113440 rs10018968 GWAS Follow-Up 
4 17168001 rs16894543 GWAS Follow-Up 
4 17171130 rs10019583 GWAS Follow-Up 
4 17172914 rs1108802 GWAS Follow-Up 
4 17173148 rs6838488 GWAS Follow-Up 
4 17173670 rs74837368 GWAS Follow-Up 
4 17174275 rs78326497 GWAS Follow-Up 
4 17176095 rs76785184 GWAS Follow-Up 
4 17176796 rs4698543 GWAS Follow-Up 
4 17178058 rs1522075 Candidate 
4 17187440 rs574427 GWAS Follow-Up 
4 17203295 rs10805352 GWAS Follow-Up 
4 17209596 rs12640889 GWAS Follow-Up 
4 17224847 rs57016776 GWAS Follow-Up 
4 17239066 rs4698557 GWAS Follow-Up 
4 17239151 rs4698174 GWAS Follow-Up 
4 23565305 rs58874680 GWAS Follow-Up 
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4 23565839 rs73105087 GWAS Follow-Up 
4 24790680 rs17622933 Candidate 
4 24796568 rs8192287 GWAS Follow-Up 
4 24796678 rs8192288 GWAS Follow-Up 
4 24796803 rs699473 GWAS Follow-Up 
4 24810094 rs74764772 GWAS Follow-Up 
4 24896658 rs12511068 GWAS Follow-Up 
4 24981689 rs764497 GWAS Follow-Up 
4 29929502 rs1503966 GWAS Follow-Up 
4 29940277 rs28368922 GWAS Follow-Up 
4 34973964 rs874936 GWAS Follow-Up 
4 34974596 rs58966196 GWAS Follow-Up 
4 34987181 rs4290912 GWAS Follow-Up 
4 34991642 rs55892081 GWAS Follow-Up 
4 42281021 rs116415202 GWAS Follow-Up 
4 72608383 rs2282679 GWAS Follow-Up 
4 72618323 rs4588 GWAS Follow-Up 
4 72618334 rs7041 GWAS Follow-Up 
4 72699705 rs9291163 Candidate 
4 72706235 rs1476272 GWAS Follow-Up 
4 72774077 rs1915189 Candidate 
4 72774622 rs72607837 Candidate 
4 72835953 rs1520503 GWAS Follow-Up 
4 82647939 rs6829367 Candidate 
4 84175235 rs4346637 GWAS Follow-Up 
4 84178980 rs57516559 GWAS Follow-Up 
4 84182361 rs61587542 GWAS Follow-Up 
4 89456219 rs7435410 GWAS Follow-Up 
4 89456677 rs11735201 GWAS Follow-Up 
4 89458051 rs11736472 GWAS Follow-Up 
4 89469328 rs10007151 GWAS Follow-Up 
4 89470295 rs78011872 GWAS Follow-Up 
4 89477002 rs11929822 GWAS Follow-Up 
4 89479382 rs58184736 GWAS Follow-Up 
4 89485105 rs72663434 GWAS Follow-Up 
4 89488231 rs6856119 GWAS Follow-Up 
4 89489489 rs58572875 GWAS Follow-Up 
4 89491528 rs3846283 GWAS Follow-Up 
4 89491616 rs3846284 GWAS Follow-Up 
4 89497079 rs6532072 GWAS Follow-Up 
4 89514572 rs6857847 GWAS Follow-Up 
4 89524695 rs17737045 GWAS Follow-Up 
4 89527323 rs17799056 GWAS Follow-Up 
4 89540209 rs10028621 GWAS Follow-Up 
4 89540939 rs28413084 GWAS Follow-Up 
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4 89541016 rs17014307 GWAS Follow-Up 
4 89542281 rs2869663 GWAS Follow-Up 
4 89579183 rs2915427 Candidate 
4 89581654 rs78232283 Candidate 
4 89584697 rs75177363 Candidate 
4 89586243 rs3852086 Candidate 
4 89588067 rs10516817 Candidate 
4 89599570 rs3017919 Candidate 
4 89599839 rs3017918 GWAS Follow-Up 
4 89603085 rs2972038 GWAS Follow-Up 
4 89606980 rs80288725 Candidate 
4 89612583 rs2904250 Candidate 
4 89613579 rs3756051 Candidate 
4 89617387 rs8605 Candidate 
4 89617931 rs28435799 Candidate 
4 89618837 rs710834 Candidate 
4 89619276 rs2972011 Candidate 
4 89621072 rs2604209 GWAS Follow-Up 
4 89624219 rs76432068 Candidate 
4 89644197 rs2924941 Candidate 
4 89647070 rs2860500 Candidate 
4 89665193 rs3775391 GWAS Follow-Up 
4 89667065 rs72870517 Candidate 
4 89667591 rs17014483 GWAS Follow-Up 
4 89667854 rs6855961 Candidate 
4 89668210 rs2278877 GWAS Follow-Up 
4 89670155 rs3756050 Candidate 
4 89672738 rs10428273 GWAS Follow-Up 
4 89685356 rs6857153 Candidate 
4 89695485 rs6841084 Candidate 
4 89704367 rs13118477 Candidate 
4 89706922 rs6847567 GWAS Follow-Up 
4 89708850 rs11725153 Candidate 
4 89710789 rs6825776 Candidate 
4 89717298 rs77140172 GWAS Follow-Up 
4 89718313 rs112542013 Candidate 
4 89718378 rs75621874 GWAS Follow-Up 
4 89724638 rs17747153 Candidate 
4 89725505 rs75581102 Candidate 
4 89727979 rs10516821 Candidate 
4 89734828 rs1817279 GWAS Follow-Up 
4 89736565 rs17014616 GWAS Follow-Up 
4 89737376 rs17014620 Candidate 
4 89739479 rs13131633 GWAS Follow-Up 
4 89739808 rs3775380 Candidate 
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4 89740128 rs13133548 GWAS Follow-Up 
4 89741269 rs3822072 Candidate 
4 89742764 rs2869950 GWAS Follow-Up 
4 89743780 rs2869951 Candidate 
4 89743821 rs3775373 Candidate 
4 89744242 rs2305934 Candidate 
4 89744825 rs3806788 GWAS Follow-Up 
4 89746220 rs35019968 Candidate 
4 89746849 rs73842249 Candidate 
4 89747394 rs71609539 GWAS Follow-Up 
4 89750361 rs10021465 GWAS Follow-Up 
4 89750668 rs13149209 GWAS Follow-Up 
4 89752276 rs57400569 GWAS Follow-Up 
4 89753225 rs4425336 GWAS Follow-Up 
4 89758524 rs72872126 Candidate 
4 89760151 rs74610824 Candidate 
4 89765661 rs7682431 GWAS Follow-Up 
4 89765872 rs9991039 Candidate 
4 89772301 rs7680970 GWAS Follow-Up 
4 89772321 rs115194267 GWAS Follow-Up 
4 89776246 rs11735482 Candidate 
4 89777081 rs6830970 Candidate 
4 89779698 rs2100679 Candidate 
4 89779909 rs2085600 Candidate 
4 89781164 rs11729108 Candidate 
4 89781166 rs11724744 Candidate 
4 89781277 rs10022272 Candidate 
4 89789067 rs922026 Candidate 
4 89789478 rs1979290 Candidate 
4 89789799 rs17815876 Candidate 
4 89791075 rs17815912 Candidate 
4 89791154 rs12649368 Candidate 
4 89797667 rs4693973 Candidate 
4 89803695 rs78366141 GWAS Follow-Up 
4 89810395 rs4693974 Candidate 
4 89811195 rs2609255 GWAS Follow-Up 
4 89813284 rs6815970 GWAS Follow-Up 
4 89819423 rs1246629 GWAS Follow-Up 
4 89827071 rs6813090 GWAS Follow-Up 
4 89828544 rs79524934 Candidate 
4 89832532 rs10019681 GWAS Follow-Up 
4 89835762 rs56221166 Candidate 
4 89836819 rs2609260 GWAS Follow-Up 
4 89839840 rs4693976 Candidate 
4 89847655 rs6835019 GWAS Follow-Up 
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4 89850005 rs2704587 Candidate 
4 89850263 rs2609282 GWAS Follow-Up 
4 89850542 rs2125409 Candidate 
4 89853598 rs1458562 Candidate 
4 89854079 rs4693977 Candidate 
4 89854167 rs4693978 Candidate 
4 89860819 rs7660385 Candidate 
4 89860843 rs2464522 Candidate 
4 89860847 rs2464523 Candidate 
4 89861309 rs2904256 Candidate 
4 89862169 rs987314 Candidate 
4 89864998 rs59489826 Candidate 
4 89866713 rs4416442 Candidate 
4 89869078 rs2869966 Candidate 
4 89869332 rs2869967 Candidate 
4 89873092 rs6837671 Candidate 
4 89875694 rs56162738 Candidate 
4 89879488 rs34749134 Candidate 
4 89879663 rs2464526 Candidate 
4 89883818 rs7671261 GWAS Follow-Up 
4 89883979 rs7671167 GWAS Follow-Up 
4 89885086 rs2013701 GWAS Follow-Up 
4 89885714 rs2904259 GWAS Follow-Up 
4 89886297 rs1903003 GWAS Follow-Up 
4 89886358 rs1903004 Candidate 
4 89891597 rs1458560 Candidate 
4 89895944 rs2085601 Candidate 
4 89896036 rs6838424 GWAS Follow-Up 
4 89898476 rs11737182 Candidate 
4 89898681 rs11737260 Candidate 
4 89900452 rs10470936 GWAS Follow-Up 
4 89906598 rs78681184 GWAS Follow-Up 
4 89907604 rs7691363 GWAS Follow-Up 
4 89908727 rs11737016 GWAS Follow-Up 
4 89917563 rs4693981 GWAS Follow-Up 
4 89918312 rs7659904 GWAS Follow-Up 
4 89921288 rs12508371 GWAS Follow-Up 
4 89925320 rs2178586 GWAS Follow-Up 
4 89925969 rs6852373 GWAS Follow-Up 
4 89926193 rs6852928 Candidate 
4 89927612 rs13129885 Candidate 
4 89928203 rs10015415 Candidate 
4 89928489 rs6849143 Candidate 
4 89928532 rs6823536 GWAS Follow-Up 
4 89929610 rs1708667 GWAS Follow-Up 
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4 89930392 rs1398942 GWAS Follow-Up 
4 89930434 rs1795738 GWAS Follow-Up 
4 89931070 rs12505696 Candidate 
4 89933630 rs1795734 Candidate 
4 89934550 rs1849597 GWAS Follow-Up 
4 89935386 rs12509305 Candidate 
4 89937184 rs1398940 Candidate 
4 89938362 rs12508524 Candidate 
4 89947352 rs1708669 GWAS Follow-Up 
4 89948639 rs2464514 GWAS Follow-Up 
4 89948897 rs34624010 GWAS Follow-Up 
4 89951561 rs1708668 Candidate 
4 89955623 rs1588730 Candidate 
4 89960285 rs2704571 GWAS Follow-Up 
4 89973621 rs28379646 Candidate 
4 89973910 rs2670623 GWAS Follow-Up 
4 90000860 rs10004795 GWAS Follow-Up 
4 90003669 rs35652620 GWAS Follow-Up 
4 90010941 rs12649385 GWAS Follow-Up 
4 90011642 rs6825998 Candidate 
4 90019365 rs6843986 GWAS Follow-Up 
4 90020087 rs6846010 GWAS Follow-Up 
4 90024204 rs62306363 Candidate 
4 90024321 rs4325981 GWAS Follow-Up 
4 90024793 rs62306364 GWAS Follow-Up 
4 90024960 rs10009665 Candidate 
4 90025750 rs13113298 GWAS Follow-Up 
4 90028412 rs7440590 Candidate 
4 90028653 rs4285052 GWAS Follow-Up 
4 90031328 rs62306390 GWAS Follow-Up 
4 90034686 rs17015027 Candidate 
4 90035549 rs2280099 GWAS Follow-Up 
4 90045646 rs35624987 Candidate 
4 90049404 rs6844490 Candidate 
4 90052321 rs58377799 Candidate 
4 90053943 rs5029557 Candidate 
4 90055959 rs7692291 GWAS Follow-Up 
4 90056378 rs12647781 Candidate 
4 90057814 rs1398944 Candidate 
4 90057983 rs7658455 Candidate 
4 90058856 rs6821678 Candidate 
4 90059434 rs6828137 Candidate 
4 90062409 rs7690336 GWAS Follow-Up 
4 90062555 rs75140020 Candidate 
4 90073214 rs756345 GWAS Follow-Up 
Page 62 of 133 AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
4 90075384 rs7684332 GWAS Follow-Up 
4 90076233 rs62306424 GWAS Follow-Up 
4 90077090 rs4491985 Candidate 
4 90077367 rs7672716 GWAS Follow-Up 
4 90077431 rs7672894 GWAS Follow-Up 
4 90077986 rs79013678 GWAS Follow-Up 
4 90113524 rs78122929 GWAS Follow-Up 
4 90117271 rs79757761 GWAS Follow-Up 
4 90124852 rs80007183 GWAS Follow-Up 
4 104156174 rs6855414 GWAS Follow-Up 
4 106395144 rs35571699 GWAS Follow-Up 
4 106448900 rs4082504 GWAS Follow-Up 
4 106457330 rs7669317 GWAS Follow-Up 
4 106510470 rs2276970 GWAS Follow-Up 
4 106511488 rs17324954 Candidate 
4 106520742 rs17035917 Candidate 
4 106523319 rs73837046 Candidate 
4 106523932 rs1374531 Candidate 
4 106526544 rs17035939 Candidate 
4 106527508 rs11735213 Candidate 
4 106531846 rs17035960 Candidate 
4 106556518 rs17036027 Candidate 
4 106592617 rs12512339 Candidate 
4 106593574 rs17036090 Candidate 
4 106593850 rs4235415 Candidate 
4 106624529 rs17036129 GWAS Follow-Up 
4 106625263 rs10516523 GWAS Follow-Up 
4 106631870 rs11727735 Candidate 
4 106684022 rs62317671 Candidate 
4 106688904 rs10516526 Candidate 
4 106698892 rs2553449 Candidate 
4 106718253 rs72673821 Candidate 
4 106729933 rs11097901 Candidate 
4 106741163 rs11723639 Candidate 
4 106746012 rs11731417 Candidate 
4 106755996 rs11728716 Candidate 
4 106766430 rs11722225 Candidate 
4 106767741 rs17036337 Candidate 
4 106768598 rs72673865 Candidate 
4 106792380 rs2553440 Candidate 
4 106808107 rs17331332 Candidate 
4 106808181 rs72673888 Candidate 
4 106812732 rs11933466 Candidate 
4 106814302 rs72673891 Candidate 
4 106843958 rs7664805 Candidate 
Page 63 of 133  AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
4 106861730 rs4340795 GWAS Follow-Up 
4 106922960 rs11730681 GWAS Follow-Up 
4 107232695 rs114723682 GWAS Follow-Up 
4 108009235 rs72666083 GWAS Follow-Up 
4 109757451 rs10015699 GWAS Follow-Up 
4 109760367 rs28675901 GWAS Follow-Up 
4 119412100 rs17642633 Candidate 
4 119454437 rs56203850 Candidate 
4 119454442 rs34983100 Candidate 
4 119462685 rs2200517 Candidate 
4 119605009 rs298982 Candidate 
4 119641941 rs298992 Candidate 
4 119646000 rs298991 Candidate 
4 119648689 rs6820588 Candidate 
4 119657920 rs17323606 Candidate 
4 119686551 rs2288306 Candidate 
4 119886214 rs78300132 GWAS Follow-Up 
4 132496237 rs9997012 GWAS Follow-Up 
4 132501395 rs36124350 GWAS Follow-Up 
4 132507123 rs28679731 GWAS Follow-Up 
4 132509731 rs28714103 GWAS Follow-Up 
4 145227600 rs13118083 Candidate 
4 145229710 rs13106167 GWAS Follow-Up 
4 145234515 rs6828489 GWAS Follow-Up 
4 145240011 rs4256191 Candidate 
4 145240152 rs4321584 GWAS Follow-Up 
4 145242662 rs6537275 GWAS Follow-Up 
4 145249275 rs12512788 Candidate 
4 145250306 rs6843104 GWAS Follow-Up 
4 145254685 rs7377575 Candidate 
4 145257681 rs2202507 Candidate 
4 145258754 rs9995482 Candidate 
4 145259126 rs13118748 GWAS Follow-Up 
4 145260495 rs7661046 GWAS Follow-Up 
4 145262927 rs13105210 GWAS Follow-Up 
4 145263756 rs6822064 Candidate 
4 145264014 rs6840871 Candidate 
4 145270867 rs987246 GWAS Follow-Up 
4 145272119 rs34991888 Candidate 
4 145272692 rs17766168 Candidate 
4 145273928 rs4835177 GWAS Follow-Up 
4 145275039 rs6537279 Candidate 
4 145278837 rs17766287 Candidate 
4 145302155 rs1394998 Candidate 
4 145310689 rs72731541 Candidate 
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4 145321006 rs7654571 Candidate 
4 145333609 rs17019336 Candidate 
4 145363247 rs1602238 Candidate 
4 145363781 rs11735249 Candidate 
4 145371436 rs13142439 GWAS Follow-Up 
4 145372248 rs12510916 GWAS Follow-Up 
4 145375299 rs71614507 Candidate 
4 145375405 rs17019368 GWAS Follow-Up 
4 145381766 rs17019370 GWAS Follow-Up 
4 145388834 rs2130499 GWAS Follow-Up 
4 145388954 rs62343635 GWAS Follow-Up 
4 145417318 rs17019390 Candidate 
4 145418294 rs11736238 Candidate 
4 145418803 rs72731582 GWAS Follow-Up 
4 145425040 rs12639777 Candidate 
4 145425849 rs35937742 Candidate 
4 145425936 rs34265962 Candidate 
4 145428569 rs12500946 Candidate 
4 145429056 rs11935246 Candidate 
4 145431497 rs1512282 GWAS Follow-Up 
4 145432894 rs7654793 Candidate 
4 145434584 rs1032295 Candidate 
4 145434688 rs1032296 Candidate 
4 145434744 rs1032297 Candidate 
4 145434901 rs1512281 Candidate 
4 145436324 rs12504628 Candidate 
4 145436894 rs7697189 GWAS Follow-Up 
4 145437014 rs7681384 GWAS Follow-Up 
4 145437081 rs7698984 Candidate 
4 145437319 rs7677035 GWAS Follow-Up 
4 145444039 rs13107186 Candidate 
4 145450959 rs1512285 Candidate 
4 145452783 rs6845536 GWAS Follow-Up 
4 145460230 rs13147758 GWAS Follow-Up 
4 145469373 rs62346060 Candidate 
4 145469968 rs6537292 GWAS Follow-Up 
4 145474297 rs1489760 GWAS Follow-Up 
4 145478777 rs4834988 GWAS Follow-Up 
4 145479167 rs28758624 Candidate 
4 145480780 rs1828591 GWAS Follow-Up 
4 145482243 rs28626624 GWAS Follow-Up 
4 145484638 rs12510044 GWAS Follow-Up 
4 145485738 rs1980057 Candidate 
4 145485915 rs7655625 Candidate 
4 145486389 rs13118928 GWAS Follow-Up 
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4 145489098 rs13140176 GWAS Follow-Up 
4 145499389 rs34544231 GWAS Follow-Up 
4 145499473 rs78652667 GWAS Follow-Up 
4 145500596 rs13136959 GWAS Follow-Up 
4 145502121 rs71614512 GWAS Follow-Up 
4 145506456 rs13141641 GWAS Follow-Up 
4 145506558 rs6852830 Candidate 
4 145506871 rs6537298 Candidate 
4 145511040 rs11724319 Candidate 
4 145511875 rs7670758 Candidate 
4 145515769 rs1542726 GWAS Follow-Up 
4 145516378 rs1489765 GWAS Follow-Up 
4 145517578 rs2353397 Candidate 
4 145520608 rs4835180 Candidate 
4 145521189 rs10023833 Candidate 
4 145521867 rs2035901 Candidate 
4 145568352 rs7689420 GWAS Follow-Up 
4 145574844 rs1812175 GWAS Follow-Up 
4 145670871 rs11944404 Candidate 
4 145685411 rs7696840 Candidate 
4 145685639 rs7697420 Candidate 
4 145883142 rs62343136 GWAS Follow-Up 
4 145903346 rs10016839 Candidate 
4 145910286 rs6842499 GWAS Follow-Up 
4 145917557 rs2056279 GWAS Follow-Up 
4 145917680 rs2056278 GWAS Follow-Up 
4 145925105 rs12506689 GWAS Follow-Up 
4 145974688 rs11734845 Candidate 
4 145984839 rs17781702 GWAS Follow-Up 
4 146056320 rs1804528 GWAS Follow-Up 
4 146073103 rs4508909 GWAS Follow-Up 
4 147351628 rs10017463 GWAS Follow-Up 
4 147354570 rs11726588 GWAS Follow-Up 
4 147355224 rs10030464 GWAS Follow-Up 
4 147389169 rs10012310 GWAS Follow-Up 
4 147393001 rs6537424 GWAS Follow-Up 
4 147394565 rs3914627 GWAS Follow-Up 
4 147425114 rs7439061 GWAS Follow-Up 
4 147442492 rs12500663 GWAS Follow-Up 
4 147446692 rs2357087 GWAS Follow-Up 
4 147466990 rs2102252 GWAS Follow-Up 
4 147467353 rs6840503 GWAS Follow-Up 
4 147469133 rs1504355 GWAS Follow-Up 
4 169644989 rs17542430 GWAS Follow-Up 
4 169670530 rs6817535 GWAS Follow-Up 
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4 180192751 rs28502482 Candidate 
4 180193431 rs6848106 Candidate 
4 180193914 rs6828433 Candidate 
4 185935259 rs13119549 GWAS Follow-Up 
5 1107828 rs4975642 GWAS Follow-Up 
5 1108250 rs4975639 GWAS Follow-Up 
5 7427289 rs7710510 Candidate 
5 7434617 rs6555465 Candidate 
5 7438910 rs6878468 Candidate 
5 7442910 rs6881726 Candidate 
5 7520881 rs13166360 GWAS Follow-Up 
5 7527521 rs2055388 GWAS Follow-Up 
5 7564015 rs11134242 Candidate 
5 7757647 rs52827085 GWAS Follow-Up 
5 7900833 rs8659 GWAS Follow-Up 
5 13741163 rs6881967 Candidate 
5 13742825 rs4701981 Candidate 
5 13742858 rs6554811 Candidate 
5 13745719 rs1502045 Candidate 
5 13750975 rs6889428 Candidate 
5 13753984 rs3734108 Candidate 
5 13755951 rs2134259 Candidate 
5 13755975 rs2134258 Candidate 
5 13756129 rs2134257 Candidate 
5 13761321 rs61016840 Candidate 
5 35141661 rs75433606 GWAS Follow-Up 
5 35145815 rs79642114 GWAS Follow-Up 
5 35149100 rs78493119 GWAS Follow-Up 
5 36656718 rs4869682 GWAS Follow-Up 
5 38895199 rs10042088 GWAS Follow-Up 
5 38905288 rs10040172 Candidate 
5 38910764 rs72732729 GWAS Follow-Up 
5 38921198 rs10075572 GWAS Follow-Up 
5 38922398 rs2278330 GWAS Follow-Up 
5 38923732 rs357292 GWAS Follow-Up 
5 38935244 rs1051942 Candidate 
5 38964026 rs28684455 Candidate 
5 39004105 rs62359819 GWAS Follow-Up 
5 39009131 rs10060696 GWAS Follow-Up 
5 39018114 rs62359835 GWAS Follow-Up 
5 39019612 rs61343691 GWAS Follow-Up 
5 39051341 rs10037713 Candidate 
5 39062977 rs9292730 GWAS Follow-Up 
5 39063119 rs9292731 GWAS Follow-Up 
5 40704090 rs6872282 GWAS Follow-Up 
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5 43477344 rs74826072 GWAS Follow-Up 
5 49860118 rs12657678 GWAS Follow-Up 
5 49870703 rs4605740 GWAS Follow-Up 
5 49872016 rs7721806 GWAS Follow-Up 
5 49872572 rs7704183 GWAS Follow-Up 
5 49917122 rs11951835 GWAS Follow-Up 
5 50068245 rs154140 GWAS Follow-Up 
5 50089919 rs27466 GWAS Follow-Up 
5 50095914 rs32376 GWAS Follow-Up 
5 50140456 rs27389 GWAS Follow-Up 
5 50584237 rs4141541 GWAS Follow-Up 
5 50595433 rs1501985 GWAS Follow-Up 
5 50600177 rs10066412 GWAS Follow-Up 
5 53502468 rs13358454 GWAS Follow-Up 
5 53502836 rs445953 GWAS Follow-Up 
5 54398049 rs2069187 GWAS Follow-Up 
5 54398065 rs2069186 GWAS Follow-Up 
5 58267976 rs829259 GWAS Follow-Up 
5 58268853 rs10075508 GWAS Follow-Up 
5 58333771 rs4699934 Candidate 
5 58333808 rs4700319 Candidate 
5 58337549 rs1498606 Candidate 
5 58561066 rs10061786 GWAS Follow-Up 
5 58564232 rs27723 GWAS Follow-Up 
5 58579495 rs545611 GWAS Follow-Up 
5 58589499 rs12655617 GWAS Follow-Up 
5 59065430 rs10940648 GWAS Follow-Up 
5 59065790 rs1504982 GWAS Follow-Up 
5 59369794 rs1588265 GWAS Follow-Up 
5 59439082 rs1544791 GWAS Follow-Up 
5 62703874 rs10058963 GWAS Follow-Up 
5 62709953 rs10038844 GWAS Follow-Up 
5 62717532 rs10073868 GWAS Follow-Up 
5 62720889 rs56356819 GWAS Follow-Up 
5 70969032 rs281143 Candidate 
5 77136120 rs354595 Candidate 
5 78944371 rs72768817 Candidate 
5 78946215 rs55687040 Candidate 
5 78963323 rs12657392 Candidate 
5 83765815 rs62360156 GWAS Follow-Up 
5 89830456 rs679568 GWAS Follow-Up 
5 89844438 rs27201 GWAS Follow-Up 
5 89853069 rs42467 GWAS Follow-Up 
5 89854448 rs154568 GWAS Follow-Up 
5 94246553 rs469843 GWAS Follow-Up 
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5 94252861 rs159349 GWAS Follow-Up 
5 94861118 rs17084873 GWAS Follow-Up 
5 94939193 rs17084927 GWAS Follow-Up 
5 94994467 rs34297786 GWAS Follow-Up 
5 95036700 rs153916 Candidate 
5 95091201 rs34899 GWAS Follow-Up 
5 95115959 rs41276257 GWAS Follow-Up 
5 95234350 rs3777204 GWAS Follow-Up 
5 95236459 rs3815768 GWAS Follow-Up 
5 95236474 rs113894818 GWAS Follow-Up 
5 108107311 rs114508915 GWAS Follow-Up 
5 108581219 rs61701247 GWAS Follow-Up 
5 108581474 rs17161655 GWAS Follow-Up 
5 111083884 rs3797734 GWAS Follow-Up 
5 111084118 rs17133711 GWAS Follow-Up 
5 111479750 rs62372418 GWAS Follow-Up 
5 111501334 rs1020951 GWAS Follow-Up 
5 111501729 rs6594566 GWAS Follow-Up 
5 111503142 rs6594567 GWAS Follow-Up 
5 111503308 rs2114991 GWAS Follow-Up 
5 111503618 rs10070995 GWAS Follow-Up 
5 111590409 rs34819608 GWAS Follow-Up 
5 111595745 rs28620667 GWAS Follow-Up 
5 111602713 rs13358904 GWAS Follow-Up 
5 111603683 rs10478074 GWAS Follow-Up 
5 111669737 rs10037235 GWAS Follow-Up 
5 111675130 rs13190229 GWAS Follow-Up 
5 120141352 rs9327168 Candidate 
5 120144768 rs7715474 Candidate 
5 120755648 rs11951505 Candidate 
5 120849829 rs17521807 GWAS Follow-Up 
5 120889325 rs1896740 GWAS Follow-Up 
5 120897889 rs2217319 GWAS Follow-Up 
5 120899371 rs7723363 GWAS Follow-Up 
5 122087617 rs79177619 GWAS Follow-Up 
5 122116803 rs56364502 GWAS Follow-Up 
5 122131511 rs17149627 GWAS Follow-Up 
5 122225480 rs246283 GWAS Follow-Up 
5 122259553 rs451897 GWAS Follow-Up 
5 122321622 rs882143 GWAS Follow-Up 
5 122328421 rs1551937 GWAS Follow-Up 
5 122354298 rs3813313 GWAS Follow-Up 
5 122405090 rs7700388 GWAS Follow-Up 
5 122405957 rs6860095 GWAS Follow-Up 
5 122411771 rs4836423 GWAS Follow-Up 
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5 122412709 rs6595430 GWAS Follow-Up 
5 122413016 rs7704775 GWAS Follow-Up 
5 122418041 rs4469193 GWAS Follow-Up 
5 124504333 rs10463784 GWAS Follow-Up 
5 126569039 rs10065046 Candidate 
5 126610750 rs60477974 Candidate 
5 126617469 rs17604239 Candidate 
5 131801726 rs2522056 GWAS Follow-Up 
5 131839618 rs4705952 GWAS Follow-Up 
5 131862977 rs4143832 GWAS Follow-Up 
5 131867702 rs2706399 GWAS Follow-Up 
5 131870689 rs11242120 GWAS Follow-Up 
5 131901225 rs2244012 GWAS Follow-Up 
5 131973177 rs2040704 GWAS Follow-Up 
5 131995843 rs1295686 GWAS Follow-Up 
5 131995964 rs20541 Candidate 
5 132030284 rs17690923 Candidate 
5 132074695 rs57586624 GWAS Follow-Up 
5 132132647 rs803137 GWAS Follow-Up 
5 132759324 rs29545 Candidate 
5 146714174 rs75404872 GWAS Follow-Up 
5 147685952 rs7734458 Candidate 
5 147705474 rs7727886 Candidate 
5 147715820 rs6894032 Candidate 
5 147779935 rs17720155 Candidate 
5 147790860 rs7730971 Candidate 
5 147805120 rs10043775 GWAS Follow-Up 
5 147815415 rs62387740 GWAS Follow-Up 
5 147832486 rs7727161 Candidate 
5 147842353 rs11168048 Candidate 
5 147844392 rs7735184 Candidate 
5 147845815 rs3995090 Candidate 
5 147846403 rs11742110 Candidate 
5 147846707 rs6889822 Candidate 
5 147847273 rs4597955 Candidate 
5 147849759 rs3995091 Candidate 
5 147854970 rs10037493 Candidate 
5 147876489 rs78924106 Candidate 
5 147877724 rs7723153 GWAS Follow-Up 
5 147910860 rs6882417 Candidate 
5 147924255 rs17706683 Candidate 
5 147936863 rs10477385 Candidate 
5 147949611 rs56101651 Candidate 
5 147964658 rs10040819 Candidate 
5 147987866 rs79721457 Candidate 
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5 148191398 rs2116714 GWAS Follow-Up 
5 148206440 rs1042713 GWAS Follow-Up 
5 148206473 rs1042714 GWAS Follow-Up 
5 148215902 rs17108817 Candidate 
5 148310587 rs10054497 Candidate 
5 148388420 rs55853803 GWAS Follow-Up 
5 148407893 rs6875902 GWAS Follow-Up 
5 155450424 rs2116737 GWAS Follow-Up 
5 156664205 rs13158276 Candidate 
5 156682890 rs25777 Candidate 
5 156684911 rs246750 Candidate 
5 156687631 rs511133 Candidate 
5 156766708 rs10037858 GWAS Follow-Up 
5 156770133 rs10037485 GWAS Follow-Up 
5 156807779 rs11738586 Candidate 
5 156816895 rs80320835 Candidate 
5 156817376 rs7724666 Candidate 
5 156859914 rs6887572 GWAS Follow-Up 
5 156872805 rs75326191 Candidate 
5 156890399 rs76634949 Candidate 
5 156898690 rs6860507 GWAS Follow-Up 
5 156899925 rs61743233 GWAS Follow-Up 
5 156901701 rs11739062 Candidate 
5 156916611 rs10058865 Candidate 
5 156917340 rs10067096 GWAS Follow-Up 
5 156918147 rs35413759 Candidate 
5 156918850 rs2287749 GWAS Follow-Up 
5 156920756 rs1990950 Candidate 
5 156926442 rs13361953 Candidate 
5 156926777 rs12522418 Candidate 
5 156928008 rs56168343 Candidate 
5 156932376 rs2277027 Candidate 
5 156936364 rs1422795 Candidate 
5 156942285 rs11740562 Candidate 
5 156944895 rs59327154 Candidate 
5 156945148 rs58873874 Candidate 
5 156948047 rs72811307 Candidate 
5 156948318 rs72811310 Candidate 
5 156970878 rs11739504 Candidate 
5 156971760 rs6874116 Candidate 
5 156972294 rs10056240 Candidate 
5 156977853 rs12189024 Candidate 
5 156988798 rs7705444 Candidate 
5 156989957 rs7724199 Candidate 
5 156991508 rs11134819 Candidate 
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5 156999098 rs11738723 GWAS Follow-Up 
5 157001302 rs11134822 Candidate 
5 157020761 rs6873008 Candidate 
5 157029138 rs62390768 Candidate 
5 157030395 rs10035961 Candidate 
5 157031112 rs11134828 Candidate 
5 157032982 rs78827776 GWAS Follow-Up 
5 157036921 rs17054764 GWAS Follow-Up 
5 157036971 rs62390771 Candidate 
5 157045629 rs6872995 Candidate 
5 157055047 rs6895071 Candidate 
5 157057117 rs11949014 Candidate 
5 157060342 rs10452508 Candidate 
5 157073747 rs12188040 GWAS Follow-Up 
5 157084408 rs9686901 Candidate 
5 157095798 rs6880381 GWAS Follow-Up 
5 157098756 rs11740603 Candidate 
5 157102063 rs10051782 Candidate 
5 157102159 rs10051838 GWAS Follow-Up 
5 157102185 rs6884959 GWAS Follow-Up 
5 157108495 rs10476134 Candidate 
5 157109069 rs11948668 Candidate 
5 158473367 rs17717876 Candidate 
5 161508728 rs209348 Candidate 
6 625549 rs2294668 Candidate 
6 938900 rs1764109 GWAS Follow-Up 
6 944907 rs17141671 GWAS Follow-Up 
6 946027 rs1161903 GWAS Follow-Up 
6 3496394 rs115650241 GWAS Follow-Up 
6 6825783 rs1892456 GWAS Follow-Up 
6 6827155 rs1286057 GWAS Follow-Up 
6 6959638 rs7752610 Candidate 
6 6959748 rs7770144 Candidate 
6 6964649 rs4142382 Candidate 
6 6969310 rs7768191 Candidate 
6 7563232 rs2076295 Candidate 
6 14856357 rs12189594 GWAS Follow-Up 
6 17630306 rs75516911 GWAS Follow-Up 
6 17644195 rs74599670 GWAS Follow-Up 
6 19920904 rs7768737 GWAS Follow-Up 
6 19926974 rs78248154 GWAS Follow-Up 
6 19929575 rs75051506 GWAS Follow-Up 
6 23381935 rs9393408 GWAS Follow-Up 
6 24971983 rs654285 GWAS Follow-Up 
6 28130359 rs1150669 GWAS Follow-Up 
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6 28134368 rs1150674 GWAS Follow-Up 
6 28142276 rs1150678 GWAS Follow-Up 
6 28219661 rs9986596 GWAS Follow-Up 
6 28227217 rs61737338 GWAS Follow-Up 
6 28227436 rs12000 GWAS Follow-Up 
6 28227604 rs1635 GWAS Follow-Up 
6 28227633 rs9461446 GWAS Follow-Up 
6 28228342 rs1679709 GWAS Follow-Up 
6 28239873 rs16893892 GWAS Follow-Up 
6 28239915 rs11965538 GWAS Follow-Up 
6 28254862 rs41269293 GWAS Follow-Up 
6 28264681 rs3800324 GWAS Follow-Up 
6 28264692 rs3800325 GWAS Follow-Up 
6 28264717 rs3800326 GWAS Follow-Up 
6 28268824 rs33932084 GWAS Follow-Up 
6 28269407 rs16893917 GWAS Follow-Up 
6 28269663 rs1997660 GWAS Follow-Up 
6 28270047 rs6456811 GWAS Follow-Up 
6 28294499 rs34223404 GWAS Follow-Up 
6 28294550 rs853684 GWAS Follow-Up 
6 28297313 rs853678 GWAS Follow-Up 
6 28309569 rs9468344 GWAS Follow-Up 
6 28322296 rs6903823 Candidate 
6 28327371 rs733743 GWAS Follow-Up 
6 28331094 rs17856167 GWAS Follow-Up 
6 28331128 rs13201753 GWAS Follow-Up 
6 28331573 rs213227 GWAS Follow-Up 
6 28358320 rs1361385 GWAS Follow-Up 
6 28358335 rs1416918 GWAS Follow-Up 
6 28358893 rs2232434 GWAS Follow-Up 
6 28359073 rs2232432 GWAS Follow-Up 
6 28359186 rs2232430 GWAS Follow-Up 
6 28366151 rs2232423 GWAS Follow-Up 
6 28472253 rs34955392 GWAS Follow-Up 
6 28483482 rs116131800 GWAS Follow-Up 
6 28497339 rs115051243 GWAS Follow-Up 
6 31379109 rs1051794 GWAS Follow-Up 
6 31384479 rs2848713 GWAS Follow-Up 
6 31407643 rs7772549 GWAS Follow-Up 
6 31417191 rs3128982 GWAS Follow-Up 
6 31425985 rs2596480 GWAS Follow-Up 
6 31432125 rs2284178 GWAS Follow-Up 
6 31437305 rs2395031 GWAS Follow-Up 
6 31438368 rs2244839 GWAS Follow-Up 
6 31442137 rs6940467 GWAS Follow-Up 
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6 31443323 rs12660382 GWAS Follow-Up 
6 31446796 rs2248462 GWAS Follow-Up 
6 31448976 rs3099844 GWAS Follow-Up 
6 31461089 rs3130922 GWAS Follow-Up 
6 31463491 rs2516408 GWAS Follow-Up 
6 31464050 rs6916394 GWAS Follow-Up 
6 31470875 rs4713468 GWAS Follow-Up 
6 31472720 rs2855812 GWAS Follow-Up 
6 31474820 rs41293883 GWAS Follow-Up 
6 31475486 rs3132468 GWAS Follow-Up 
6 31476134 rs3131635 GWAS Follow-Up 
6 31476854 rs2844498 GWAS Follow-Up 
6 31478986 rs2246618 GWAS Follow-Up 
6 31480398 rs2844496 GWAS Follow-Up 
6 31483415 rs2844494 GWAS Follow-Up 
6 31488145 rs3130637 GWAS Follow-Up 
6 31489644 rs3132454 GWAS Follow-Up 
6 31496921 rs114009639 GWAS Follow-Up 
6 31496925 rs3093983 GWAS Follow-Up 
6 31497399 rs3130055 GWAS Follow-Up 
6 31498497 rs3093978 GWAS Follow-Up 
6 31506691 rs2071596 GWAS Follow-Up 
6 31510105 rs2239528 GWAS Follow-Up 
6 31511857 rs2251824 GWAS Follow-Up 
6 31512720 rs2071594 GWAS Follow-Up 
6 31512799 rs2071593 GWAS Follow-Up 
6 31513402 rs2239705 GWAS Follow-Up 
6 31515340 rs2071592 GWAS Follow-Up 
6 31520426 rs6916921 GWAS Follow-Up 
6 31524851 rs2857605 GWAS Follow-Up 
6 31525319 rs2239707 GWAS Follow-Up 
6 31526080 rs184070214 GWAS Follow-Up 
6 31528130 rs4947324 GWAS Follow-Up 
6 31540313 rs909253 GWAS Follow-Up 
6 31540556 rs2229094 GWAS Follow-Up 
6 31540784 rs1041981 GWAS Follow-Up 
6 31542308 rs1799964 GWAS Follow-Up 
6 31542476 rs1800630 GWAS Follow-Up 
6 31543031 rs1800629 GWAS Follow-Up 
6 31544189 rs3093662 GWAS Follow-Up 
6 31561747 rs4947328 GWAS Follow-Up 
6 31562615 rs2515920 GWAS Follow-Up 
6 31564821 rs2844480 GWAS Follow-Up 
6 31567422 rs2857596 GWAS Follow-Up 
6 31568469 rs2857595 Candidate 
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6 31572956 rs2844479 Candidate 
6 31575276 rs9348876 GWAS Follow-Up 
6 31583931 rs2269475 GWAS Follow-Up 
6 31590898 rs2736172 Candidate 
6 31601735 rs114867649 GWAS Follow-Up 
6 31603591 rs2261033 GWAS Follow-Up 
6 31604044 rs3132453 GWAS Follow-Up 
6 31615167 rs2844463 GWAS Follow-Up 
6 31618761 rs3130050 GWAS Follow-Up 
6 31619576 rs3117583 GWAS Follow-Up 
6 31627523 rs3130617 GWAS Follow-Up 
6 31628733 rs805262 GWAS Follow-Up 
6 31632134 rs3130618 GWAS Follow-Up 
6 31639757 rs805267 GWAS Follow-Up 
6 31639979 rs9267532 GWAS Follow-Up 
6 31646398 rs2280800 GWAS Follow-Up 
6 31673436 rs9267546 GWAS Follow-Up 
6 31675765 rs2242653 GWAS Follow-Up 
6 31683157 rs3749952 GWAS Follow-Up 
6 31707730 rs3131382 GWAS Follow-Up 
6 31708147 rs409558 GWAS Follow-Up 
6 31710968 rs707915 GWAS Follow-Up 
6 31713124 rs3749953 GWAS Follow-Up 
6 31713454 rs3828922 GWAS Follow-Up 
6 31717692 rs3117572 GWAS Follow-Up 
6 31718602 rs2299851 GWAS Follow-Up 
6 31722262 rs9296001 GWAS Follow-Up 
6 31726688 rs707939 GWAS Follow-Up 
6 31728267 rs2075801 GWAS Follow-Up 
6 31729359 rs707938 GWAS Follow-Up 
6 31731881 rs6905572 GWAS Follow-Up 
6 31733466 rs114810088 GWAS Follow-Up 
6 31750509 rs114514104 GWAS Follow-Up 
6 31750517 rs117497713 GWAS Follow-Up 
6 31764899 rs480092 GWAS Follow-Up 
6 31773821 rs115103462 GWAS Follow-Up 
6 31777946 rs2075800 GWAS Follow-Up 
6 31778077 rs2227955 GWAS Follow-Up 
6 31778272 rs2227956 GWAS Follow-Up 
6 31778529 rs2075799 GWAS Follow-Up 
6 31783507 rs1043618 GWAS Follow-Up 
6 31786963 rs2763977 Candidate 
6 31914179 rs12614 GWAS Follow-Up 
6 31916400 rs537160 GWAS Follow-Up 
6 31916951 rs541862 GWAS Follow-Up 
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6 31917540 rs4151657 GWAS Follow-Up 
6 31919578 rs2072633 GWAS Follow-Up 
6 31920873 rs4151664 GWAS Follow-Up 
6 31922254 rs630379 GWAS Follow-Up 
6 31928306 rs438999 GWAS Follow-Up 
6 31929014 rs437179 GWAS Follow-Up 
6 31930462 rs429608 GWAS Follow-Up 
6 31938120 rs116035606 GWAS Follow-Up 
6 31946614 rs6941112 Candidate 
6 31947460 rs389883 GWAS Follow-Up 
6 31947594 rs389512 GWAS Follow-Up 
6 32017521 rs10046127 GWAS Follow-Up 
6 32019769 rs12333245 GWAS Follow-Up 
6 32026808 rs12198173 GWAS Follow-Up 
6 32029183 rs2269429 GWAS Follow-Up 
6 32032743 rs204883 Candidate 
6 32033007 rs7766862 Candidate 
6 32038700 rs2071295 GWAS Follow-Up 
6 32044834 rs9267798 GWAS Follow-Up 
6 32046275 rs7774197 GWAS Follow-Up 
6 32049423 rs12211410 GWAS Follow-Up 
6 32050067 rs185819 GWAS Follow-Up 
6 32052216 rs149995364 GWAS Follow-Up 
6 32052983 rs169496 GWAS Follow-Up 
6 32056580 rs204900 GWAS Follow-Up 
6 32057972 rs17201588 Candidate 
6 32062687 rs2071293 GWAS Follow-Up 
6 32063681 rs17201602 GWAS Follow-Up 
6 32064098 rs204896 GWAS Follow-Up 
6 32065113 rs61746206 GWAS Follow-Up 
6 32066177 rs17421624 Candidate 
6 32070069 rs41268896 Candidate 
6 32070074 rs41268899 Candidate 
6 32071893 rs3134954 GWAS Follow-Up 
6 32072940 rs439844 GWAS Follow-Up 
6 32074804 rs12153855 GWAS Follow-Up 
6 32077380 rs411337 GWAS Follow-Up 
6 32078373 rs3807039 GWAS Follow-Up 
6 32080146 rs3130342 GWAS Follow-Up 
6 32083175 rs8111 Candidate 
6 32101762 rs9267803 Candidate 
6 32105001 rs4713505 Candidate 
6 32120715 rs1053924 GWAS Follow-Up 
6 32122472 rs116326274 GWAS Follow-Up 
6 32134510 rs3096697 GWAS Follow-Up 
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6 32145205 rs3134947 GWAS Follow-Up 
6 32145707 rs2269423 GWAS Follow-Up 
6 32147696 rs3130349 GWAS Follow-Up 
6 32147761 rs3134943 GWAS Follow-Up 
6 32151443 rs2070600 GWAS Follow-Up 
6 32154285 rs204995 GWAS Follow-Up 
6 32155581 rs204993 Candidate 
6 32157364 rs2856437 Candidate 
6 32161366 rs204991 GWAS Follow-Up 
6 32179896 rs2071286 GWAS Follow-Up 
6 32186264 rs436388 Candidate 
6 32187023 rs394657 GWAS Follow-Up 
6 32188823 rs8192585 GWAS Follow-Up 
6 32189032 rs415929 GWAS Follow-Up 
6 32190028 rs3132946 GWAS Follow-Up 
6 32190217 rs915895 Candidate 
6 32190390 rs915894 Candidate 
6 32192560 rs2267644 GWAS Follow-Up 
6 32194339 rs499691 GWAS Follow-Up 
6 32199352 rs9267873 GWAS Follow-Up 
6 32218843 rs3115573 GWAS Follow-Up 
6 32218989 rs9296015 GWAS Follow-Up 
6 32219725 rs4959089 GWAS Follow-Up 
6 32244627 rs3130340 GWAS Follow-Up 
6 32245827 rs3115553 GWAS Follow-Up 
6 32257566 rs926070 GWAS Follow-Up 
6 32260350 rs6935269 GWAS Follow-Up 
6 32261252 rs7775397 GWAS Follow-Up 
6 32273765 rs6457536 GWAS Follow-Up 
6 32282033 rs547261 GWAS Follow-Up 
6 32282854 rs6910071 GWAS Follow-Up 
6 32289318 rs547077 GWAS Follow-Up 
6 32298372 rs9405090 GWAS Follow-Up 
6 32321554 rs2395148 GWAS Follow-Up 
6 32333955 rs9268368 GWAS Follow-Up 
6 32334754 rs7770048 GWAS Follow-Up 
6 32336187 rs3129934 GWAS Follow-Up 
6 32336586 rs9268384 GWAS Follow-Up 
6 32337686 rs3129941 GWAS Follow-Up 
6 32338695 rs3129943 GWAS Follow-Up 
6 32383108 rs9268528 GWAS Follow-Up 
6 32395568 rs2187818 GWAS Follow-Up 
6 32397403 rs9268585 GWAS Follow-Up 
6 32400070 rs9268606 GWAS Follow-Up 
6 32577380 rs660895 GWAS Follow-Up 
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6 32586854 rs9271366 GWAS Follow-Up 
6 32605884 rs2187668 GWAS Follow-Up 
6 32650809 rs17212090 Candidate 
6 32651117 rs9275141 GWAS Follow-Up 
6 32657578 rs7774434 GWAS Follow-Up 
6 32663851 rs6457617 GWAS Follow-Up 
6 32664458 rs2647012 GWAS Follow-Up 
6 32664960 rs9357152 Candidate 
6 32667230 rs2858312 Candidate 
6 32669156 rs9275390 GWAS Follow-Up 
6 32669767 rs2647050 GWAS Follow-Up 
6 32670255 rs2856718 Candidate 
6 32670308 rs2856717 GWAS Follow-Up 
6 32671103 rs13192471 GWAS Follow-Up 
6 32678999 rs9275572 GWAS Follow-Up 
6 32680928 rs7765379 GWAS Follow-Up 
6 32681631 rs9275596 GWAS Follow-Up 
6 32682724 rs3873444 GWAS Follow-Up 
6 32682862 rs3892710 GWAS Follow-Up 
6 32689529 rs9461799 GWAS Follow-Up 
6 32713267 rs2239800 GWAS Follow-Up 
6 32714143 rs2071800 GWAS Follow-Up 
6 32730940 rs2071550 GWAS Follow-Up 
6 32739888 rs1383265 GWAS Follow-Up 
6 32752139 rs719654 GWAS Follow-Up 
6 32757297 rs9276711 GWAS Follow-Up 
6 32758394 rs7758736 GWAS Follow-Up 
6 32759448 rs3948793 GWAS Follow-Up 
6 32763110 rs2621377 GWAS Follow-Up 
6 32779996 rs2857114 GWAS Follow-Up 
6 32781776 rs2856997 GWAS Follow-Up 
6 32782112 rs11575907 GWAS Follow-Up 
6 32782387 rs2071475 GWAS Follow-Up 
6 32782582 rs2071474 GWAS Follow-Up 
6 32783086 rs7383287 GWAS Follow-Up 
6 32783387 rs60601161 Candidate 
6 32783896 rs2621326 GWAS Follow-Up 
6 32784676 rs2071554 GWAS Follow-Up 
6 32785515 rs2857107 GWAS Follow-Up 
6 32787570 rs2857106 GWAS Follow-Up 
6 32788707 rs2621323 GWAS Follow-Up 
6 32789480 rs2621321 GWAS Follow-Up 
6 32790059 rs2857105 GWAS Follow-Up 
6 32790089 rs16870908 GWAS Follow-Up 
6 32791299 rs2857103 GWAS Follow-Up 
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6 32792973 rs1894411 GWAS Follow-Up 
6 32794676 rs2857101 GWAS Follow-Up 
6 32795032 rs10484565 GWAS Follow-Up 
6 32796019 rs241455 GWAS Follow-Up 
6 32796653 rs241449 GWAS Follow-Up 
6 32796685 rs241448 GWAS Follow-Up 
6 32796751 rs241447 GWAS Follow-Up 
6 32797537 rs241439 GWAS Follow-Up 
6 32797620 rs241438 GWAS Follow-Up 
6 32797684 rs241437 GWAS Follow-Up 
6 32800412 rs1800454 Candidate 
6 32802938 rs140654840 GWAS Follow-Up 
6 32803316 rs4148871 GWAS Follow-Up 
6 32803840 rs241429 GWAS Follow-Up 
6 32804070 rs241428 GWAS Follow-Up 
6 32804798 rs3819721 GWAS Follow-Up 
6 32804934 rs241424 GWAS Follow-Up 
6 32805049 rs2239701 GWAS Follow-Up 
6 32805470 rs2071465 GWAS Follow-Up 
6 32806121 rs2071544 GWAS Follow-Up 
6 32806461 rs2071552 GWAS Follow-Up 
6 32806786 rs4713598 GWAS Follow-Up 
6 32808232 rs3763349 GWAS Follow-Up 
6 32809848 rs9357155 GWAS Follow-Up 
6 32810443 rs9276810 GWAS Follow-Up 
6 32811629 rs2071543 GWAS Follow-Up 
6 32812858 rs2071541 GWAS Follow-Up 
6 32813279 rs1057373 GWAS Follow-Up 
6 32814659 rs4711312 GWAS Follow-Up 
6 32814942 rs1057149 GWAS Follow-Up 
6 32814975 rs1135216 GWAS Follow-Up 
6 32816700 rs2071482 GWAS Follow-Up 
6 32816772 rs41550019 GWAS Follow-Up 
6 32818678 rs2071538 GWAS Follow-Up 
6 32818774 rs1057141 GWAS Follow-Up 
6 32819517 rs2284190 GWAS Follow-Up 
6 32819865 rs2071481 GWAS Follow-Up 
6 32822858 rs4713600 GWAS Follow-Up 
6 32823567 rs991760 GWAS Follow-Up 
6 32823948 rs241419 GWAS Follow-Up 
6 32825090 rs17587 GWAS Follow-Up 
6 32825379 rs2071476 GWAS Follow-Up 
6 32849639 rs2170185 Candidate 
6 32875323 rs1585894 GWAS Follow-Up 
6 32879233 rs154986 GWAS Follow-Up 
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6 34423845 rs9380439 GWAS Follow-Up 
6 34424109 rs2395562 GWAS Follow-Up 
6 34427026 rs4713793 GWAS Follow-Up 
6 36912256 rs12199301 GWAS Follow-Up 
6 36912558 rs1543274 GWAS Follow-Up 
6 36912826 rs1543273 GWAS Follow-Up 
6 36913073 rs6926781 GWAS Follow-Up 
6 36914173 rs1023036 GWAS Follow-Up 
6 36922684 rs1405069 GWAS Follow-Up 
6 36924102 rs707542 GWAS Follow-Up 
6 36939363 rs3778025 GWAS Follow-Up 
6 39588118 rs2446649 Candidate 
6 39596972 rs2446651 Candidate 
6 39659744 rs160020 Candidate 
6 39699399 rs303648 GWAS Follow-Up 
6 39748040 rs12206691 Candidate 
6 39784365 rs2395730 Candidate 
6 39788496 rs9349128 GWAS Follow-Up 
6 39814409 rs9471190 GWAS Follow-Up 
6 39881102 rs7762875 GWAS Follow-Up 
6 39881120 rs35825585 GWAS Follow-Up 
6 40125087 rs35505357 Candidate 
6 40125459 rs7751650 Candidate 
6 46606328 rs639434 GWAS Follow-Up 
6 46608766 rs681513 GWAS Follow-Up 
6 46613083 rs952884 GWAS Follow-Up 
6 48012271 rs332583 GWAS Follow-Up 
6 48013978 rs332580 GWAS Follow-Up 
6 48037486 rs954807 GWAS Follow-Up 
6 67331290 rs273919 GWAS Follow-Up 
6 67333516 rs571501 GWAS Follow-Up 
6 67369628 rs1455088 GWAS Follow-Up 
6 80038691 rs34339079 GWAS Follow-Up 
6 80039113 rs13198377 GWAS Follow-Up 
6 80040471 rs13210827 GWAS Follow-Up 
6 80047861 rs10484944 GWAS Follow-Up 
6 80557880 rs9448838 GWAS Follow-Up 
6 88518960 rs6454650 GWAS Follow-Up 
6 88520263 rs6922280 GWAS Follow-Up 
6 88534879 rs9294391 GWAS Follow-Up 
6 89728922 rs17277859 GWAS Follow-Up 
6 93345551 rs17575208 GWAS Follow-Up 
6 109074947 rs565050 Candidate 
6 109078539 rs523632 Candidate 
6 109082625 rs507189 Candidate 
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6 109087078 rs574217 Candidate 
6 109088972 rs58362680 Candidate 
6 109105309 rs7760445 Candidate 
6 109106656 rs529022 Candidate 
6 109110268 rs569867 Candidate 
6 109158405 rs2848598 Candidate 
6 109182944 rs1268055 Candidate 
6 109193484 rs1327472 Candidate 
6 109197379 rs9386758 GWAS Follow-Up 
6 109244232 rs1475055 Candidate 
6 109266255 rs2806356 Candidate 
6 109268050 rs2798641 Candidate 
6 109270551 rs2768552 Candidate 
6 109276552 rs72935149 Candidate 
6 109323519 rs2273668 GWAS Follow-Up 
6 109383576 rs35740192 Candidate 
6 109410569 rs6929104 Candidate 
6 112609597 rs7742249 GWAS Follow-Up 
6 112615438 rs9374315 GWAS Follow-Up 
6 116325108 rs34064900 GWAS Follow-Up 
6 116325142 rs3756772 GWAS Follow-Up 
6 116387134 rs1999930 GWAS Follow-Up 
6 116441646 rs2228547 GWAS Follow-Up 
6 116446576 rs1064583 GWAS Follow-Up 
6 116478187 rs6910311 GWAS Follow-Up 
6 116520348 rs1204842 GWAS Follow-Up 
6 116568773 rs1052443 Candidate 
6 116571695 rs3749893 Candidate 
6 116575083 rs2232470 GWAS Follow-Up 
6 116575116 rs17524614 GWAS Follow-Up 
6 116600453 rs3749894 GWAS Follow-Up 
6 116600616 rs61746508 GWAS Follow-Up 
6 116720487 rs10485183 GWAS Follow-Up 
6 116720514 rs35548455 GWAS Follow-Up 
6 116721656 rs2227125 GWAS Follow-Up 
6 123702499 rs3813328 Candidate 
6 123703983 rs2043148 Candidate 
6 123715748 rs9385299 Candidate 
6 123715968 rs9401668 Candidate 
6 123731285 rs9388238 Candidate 
6 142548099 rs225717 GWAS Follow-Up 
6 142565531 rs1931983 GWAS Follow-Up 
6 142655490 rs2039987 Candidate 
6 142663177 rs1342060 Candidate 
6 142668901 rs9399401 Candidate 
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6 142679572 rs6570507 GWAS Follow-Up 
6 142688969 rs17280293 Candidate 
6 142691549 rs11155242 Candidate 
6 142703877 rs4896582 GWAS Follow-Up 
6 142707133 rs6937121 Candidate 
6 142725182 rs73780221 Candidate 
6 142750516 rs3817928 Candidate 
6 142764073 rs9403386 Candidate 
6 142767633 rs3748069 GWAS Follow-Up 
6 142777064 rs7776375 Candidate 
6 142797289 rs7763064 GWAS Follow-Up 
6 145275656 rs73613930 GWAS Follow-Up 
6 145276870 rs9484931 GWAS Follow-Up 
6 145281094 rs9322011 GWAS Follow-Up 
6 145282579 rs73613983 GWAS Follow-Up 
6 145283387 rs9497155 GWAS Follow-Up 
6 145311901 rs1416295 GWAS Follow-Up 
6 151427385 rs6934983 GWAS Follow-Up 
6 151641001 rs12205375 GWAS Follow-Up 
6 161937977 rs78008396 GWAS Follow-Up 
6 162056646 rs79403850 GWAS Follow-Up 
6 163543699 rs536980 GWAS Follow-Up 
6 163546352 rs547539 GWAS Follow-Up 
6 163551992 rs498657 GWAS Follow-Up 
6 163571901 rs6455866 GWAS Follow-Up 
6 163572250 rs6921357 GWAS Follow-Up 
6 163578666 rs10945875 GWAS Follow-Up 
6 163580885 rs12190368 GWAS Follow-Up 
6 163581656 rs12190791 GWAS Follow-Up 
6 163583121 rs12197200 GWAS Follow-Up 
6 163605701 rs2763999 GWAS Follow-Up 
6 169416679 rs12194918 GWAS Follow-Up 
6 169418823 rs1322638 GWAS Follow-Up 
6 169421120 rs11752531 GWAS Follow-Up 
6 169421443 rs11755456 GWAS Follow-Up 
6 169425778 rs12203323 GWAS Follow-Up 
6 169429003 rs910690 GWAS Follow-Up 
6 169440902 rs7741593 GWAS Follow-Up 
6 169442689 rs959687 GWAS Follow-Up 
7 4246412 rs7812170 GWAS Follow-Up 
7 14540895 rs62443479 GWAS Follow-Up 
7 14586855 rs62443522 GWAS Follow-Up 
7 39409900 rs12672997 GWAS Follow-Up 
7 39419781 rs6462913 GWAS Follow-Up 
7 43413384 rs10282127 GWAS Follow-Up 
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7 43413421 rs10281930 GWAS Follow-Up 
7 43414004 rs9639873 GWAS Follow-Up 
7 46435992 rs62452690 GWAS Follow-Up 
7 46437330 rs6980173 GWAS Follow-Up 
7 50419792 rs28733769 Candidate 
7 78127027 rs4421288 GWAS Follow-Up 
7 78138542 rs4730345 GWAS Follow-Up 
7 78151125 rs724914 GWAS Follow-Up 
7 78158840 rs10447824 GWAS Follow-Up 
7 78234493 rs416102 GWAS Follow-Up 
7 79804665 rs13227898 Candidate 
7 79812826 rs67077197 Candidate 
7 81359051 rs5745687 GWAS Follow-Up 
7 96795041 rs10229181 GWAS Follow-Up 
7 99872675 rs73161741 GWAS Follow-Up 
7 99956290 rs2906644 GWAS Follow-Up 
7 99971313 rs2405442 GWAS Follow-Up 
7 100012334 rs34919929 GWAS Follow-Up 
7 100013457 rs5015756 Candidate 
7 100042413 rs55773945 GWAS Follow-Up 
7 100079857 rs6971558 GWAS Follow-Up 
7 100091795 rs12539172 GWAS Follow-Up 
7 100092311 rs11971846 GWAS Follow-Up 
7 104084209 rs62485096 Candidate 
7 125521995 rs721118 Candidate 
7 129617727 rs10808241 GWAS Follow-Up 
7 136630812 rs10225215 GWAS Follow-Up 
7 136642634 rs2350782 GWAS Follow-Up 
7 139172868 rs67345907 GWAS Follow-Up 
7 139172887 rs9642124 GWAS Follow-Up 
7 140217670 rs3748088 GWAS Follow-Up 
7 154460660 rs118189482 Candidate 
7 156250444 rs7778219 GWAS Follow-Up 
7 156259409 rs1881008 GWAS Follow-Up 
7 156259583 rs1534008 GWAS Follow-Up 
7 157788880 rs10258167 GWAS Follow-Up 
7 157788972 rs10258292 GWAS Follow-Up 
7 157791029 rs11984274 GWAS Follow-Up 
7 157791818 rs12665894 GWAS Follow-Up 
8 3600189 rs9650510 Candidate 
8 3604955 rs10503216 Candidate 
8 4483141 rs2616984 GWAS Follow-Up 
8 4489315 rs62486712 GWAS Follow-Up 
8 8630269 rs506960 GWAS Follow-Up 
8 8632957 rs565203 GWAS Follow-Up 
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8 8633928 rs535094 GWAS Follow-Up 
8 8635888 rs617813 Candidate 
8 9740358 rs10104353 GWAS Follow-Up 
8 9740636 rs6601389 GWAS Follow-Up 
8 9740657 rs6601390 GWAS Follow-Up 
8 9741171 rs6990268 GWAS Follow-Up 
8 9741478 rs10098618 GWAS Follow-Up 
8 9742525 rs12056944 GWAS Follow-Up 
8 9742841 rs7828229 GWAS Follow-Up 
8 9744650 rs6989793 GWAS Follow-Up 
8 9973371 rs963593 GWAS Follow-Up 
8 9976540 rs7843924 GWAS Follow-Up 
8 9977918 rs6983332 GWAS Follow-Up 
8 9978471 rs6986885 GWAS Follow-Up 
8 9978940 rs12678800 GWAS Follow-Up 
8 9979992 rs2062331 GWAS Follow-Up 
8 9981149 rs2062333 GWAS Follow-Up 
8 9981854 rs17689674 GWAS Follow-Up 
8 9983369 rs17151147 GWAS Follow-Up 
8 9995853 rs17151188 GWAS Follow-Up 
8 9997980 rs62488714 GWAS Follow-Up 
8 10005883 rs58764043 GWAS Follow-Up 
8 10006664 rs4840464 GWAS Follow-Up 
8 10009952 rs11993089 GWAS Follow-Up 
8 10012232 rs62488738 GWAS Follow-Up 
8 10077806 rs10110380 GWAS Follow-Up 
8 10082746 rs11249978 GWAS Follow-Up 
8 10083040 rs10089666 GWAS Follow-Up 
8 10083515 rs4265190 GWAS Follow-Up 
8 10084886 rs13256234 GWAS Follow-Up 
8 10099624 rs12550483 GWAS Follow-Up 
8 10115960 rs4258008 GWAS Follow-Up 
8 10117279 rs35226696 GWAS Follow-Up 
8 10117759 rs11782000 GWAS Follow-Up 
8 10445702 rs12543042 GWAS Follow-Up 
8 10448142 rs12681639 GWAS Follow-Up 
8 10458377 rs12680137 Candidate 
8 10573698 rs75731123 GWAS Follow-Up 
8 11562513 rs62489319 GWAS Follow-Up 
8 11567140 rs4489290 GWAS Follow-Up 
8 11567376 rs7817412 GWAS Follow-Up 
8 11611353 rs17153747 GWAS Follow-Up 
8 11611366 rs17153752 GWAS Follow-Up 
8 14660581 rs35770515 GWAS Follow-Up 
8 14668859 rs7002469 GWAS Follow-Up 
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8 18163452 rs73584323 GWAS Follow-Up 
8 18164315 rs73666603 GWAS Follow-Up 
8 27146595 rs148666973 GWAS Follow-Up 
8 32303612 rs6468104 Candidate 
8 32306984 rs6996957 Candidate 
8 32365695 rs68189791 Candidate 
8 32403573 rs7823498 Candidate 
8 32410110 rs4236709 Candidate 
8 32412359 rs2439312 Candidate 
8 41653471 rs79432940 GWAS Follow-Up 
8 41663090 rs77788808 GWAS Follow-Up 
8 54453130 rs9693226 Candidate 
8 54529344 rs28414831 Candidate 
8 74335766 rs144404773 GWAS Follow-Up 
8 76202315 rs11998486 GWAS Follow-Up 
8 76216868 rs57747815 GWAS Follow-Up 
8 83534705 rs16910688 Candidate 
8 83538521 rs72677531 Candidate 
8 96226228 rs2514560 Candidate 
8 96230017 rs74956051 Candidate 
8 100803907 rs62534610 GWAS Follow-Up 
8 103208028 rs1265143 GWAS Follow-Up 
8 103215928 rs1265154 GWAS Follow-Up 
8 103265132 rs2853235 GWAS Follow-Up 
8 103282518 rs2978431 GWAS Follow-Up 
8 103313114 rs76081441 GWAS Follow-Up 
8 108868731 rs13274153 GWAS Follow-Up 
8 108894697 rs34503613 GWAS Follow-Up 
8 108899439 rs72680424 GWAS Follow-Up 
8 108950190 rs72680448 GWAS Follow-Up 
8 121377702 rs6990426 GWAS Follow-Up 
8 121465262 rs6989609 GWAS Follow-Up 
8 121475611 rs77269571 GWAS Follow-Up 
8 121479247 rs75201989 GWAS Follow-Up 
8 124078472 rs80042305 GWAS Follow-Up 
8 124264927 rs1044714 GWAS Follow-Up 
8 124300658 rs11782961 GWAS Follow-Up 
8 124379755 rs13248086 GWAS Follow-Up 
8 125961813 rs9297704 GWAS Follow-Up 
8 125962981 rs75785682 GWAS Follow-Up 
8 125963969 rs78809767 GWAS Follow-Up 
8 132883079 rs7006137 GWAS Follow-Up 
8 140949469 rs2614717 GWAS Follow-Up 
8 140954213 rs2665945 GWAS Follow-Up 
8 144973617 rs72693382 GWAS Follow-Up 
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8 144974142 rs10100277 GWAS Follow-Up 
8 144974963 rs7831595 Candidate 
8 144976572 rs4077669 Candidate 
8 144977279 rs4073900 Candidate 
8 144981498 rs7461753 Candidate 
8 144986793 rs3923387 Candidate 
8 144993324 rs6984820 Candidate 
8 144996029 rs7833924 Candidate 
8 145001031 rs55895668 Candidate 
8 145006790 rs10866916 Candidate 
8 145011204 rs6993938 Candidate 
8 145020477 rs12543539 Candidate 
8 145031265 rs11777239 Candidate 
8 145034852 rs11780978 Candidate 
8 145035342 rs7357417 Candidate 
8 145039400 rs72695409 Candidate 
9 286491 rs3209441 Candidate 
9 306277 rs35381637 Candidate 
9 306734 rs62533402 Candidate 
9 660970 rs10815439 GWAS Follow-Up 
9 668887 rs7035770 GWAS Follow-Up 
9 669125 rs9408665 GWAS Follow-Up 
9 669259 rs10815451 GWAS Follow-Up 
9 671053 rs4584192 GWAS Follow-Up 
9 674428 rs4742217 GWAS Follow-Up 
9 675377 rs4742219 GWAS Follow-Up 
9 675419 rs4742220 GWAS Follow-Up 
9 682330 rs9299037 GWAS Follow-Up 
9 682646 rs9407359 GWAS Follow-Up 
9 684096 rs1323262 GWAS Follow-Up 
9 685819 rs9408677 GWAS Follow-Up 
9 2808536 rs12353495 GWAS Follow-Up 
9 2811731 rs12340161 GWAS Follow-Up 
9 2815440 rs73394639 GWAS Follow-Up 
9 2815601 rs12340564 GWAS Follow-Up 
9 2839934 rs3824352 GWAS Follow-Up 
9 2842672 rs12345518 GWAS Follow-Up 
9 2843201 rs12343488 GWAS Follow-Up 
9 3833771 rs116892582 GWAS Follow-Up 
9 3968385 rs117377928 GWAS Follow-Up 
9 4149475 rs982820 GWAS Follow-Up 
9 4150202 rs10125159 GWAS Follow-Up 
9 4150733 rs1998271 GWAS Follow-Up 
9 4151202 rs12353487 GWAS Follow-Up 
9 4151884 rs12344449 GWAS Follow-Up 
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9 4152555 rs927322 GWAS Follow-Up 
9 4153183 rs62524070 GWAS Follow-Up 
9 4154267 rs12553203 GWAS Follow-Up 
9 6266440 rs2026991 GWAS Follow-Up 
9 6268204 rs2039386 GWAS Follow-Up 
9 6268893 rs2000199 GWAS Follow-Up 
9 6271238 rs1041537 GWAS Follow-Up 
9 7007063 rs7025832 GWAS Follow-Up 
9 7019562 rs147029433 GWAS Follow-Up 
9 7641251 rs10976470 Candidate 
9 7646850 rs10976473 Candidate 
9 7650677 rs55833066 GWAS Follow-Up 
9 7654872 rs75241563 GWAS Follow-Up 
9 7655095 rs79280735 Candidate 
9 7657370 rs16926508 GWAS Follow-Up 
9 7657636 rs17544446 GWAS Follow-Up 
9 7658421 rs78645567 GWAS Follow-Up 
9 7660751 rs11790748 GWAS Follow-Up 
9 7661068 rs17627322 GWAS Follow-Up 
9 7662198 rs10976481 GWAS Follow-Up 
9 7662660 rs10976483 Candidate 
9 7665194 rs10976486 GWAS Follow-Up 
9 7669918 rs74822503 Candidate 
9 7670008 rs78491788 GWAS Follow-Up 
9 7671218 rs77014806 Candidate 
9 7681732 rs78467782 GWAS Follow-Up 
9 7682063 rs10976498 GWAS Follow-Up 
9 7682480 rs10815656 GWAS Follow-Up 
9 7682860 rs4740904 GWAS Follow-Up 
9 7700884 rs72695191 GWAS Follow-Up 
9 8353593 rs75885112 GWAS Follow-Up 
9 9070768 rs324513 GWAS Follow-Up 
9 9072442 rs634098 GWAS Follow-Up 
9 9072447 rs580780 GWAS Follow-Up 
9 9073311 rs324483 GWAS Follow-Up 
9 9074622 rs182720 GWAS Follow-Up 
9 9076554 rs324487 GWAS Follow-Up 
9 9077555 rs324474 GWAS Follow-Up 
9 9077607 rs324475 GWAS Follow-Up 
9 9079771 rs324479 GWAS Follow-Up 
9 9080896 rs324473 GWAS Follow-Up 
9 9086923 rs369166 GWAS Follow-Up 
9 9088309 rs3004230 GWAS Follow-Up 
9 9089810 rs324465 GWAS Follow-Up 
9 9090197 rs172863 GWAS Follow-Up 
Page 87 of 133  AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
9 9090876 rs324466 Candidate 
9 9102409 rs324542 Candidate 
9 9102650 rs10759040 GWAS Follow-Up 
9 14074022 rs516325 GWAS Follow-Up 
9 14074266 rs1689280 GWAS Follow-Up 
9 14079067 rs480700 GWAS Follow-Up 
9 14080129 rs1689282 GWAS Follow-Up 
9 14089242 rs574460 GWAS Follow-Up 
9 14099484 rs516090 GWAS Follow-Up 
9 14117221 rs580501 GWAS Follow-Up 
9 16267194 rs9298753 GWAS Follow-Up 
9 16287889 rs9406608 Candidate 
9 16288267 rs7874755 Candidate 
9 16288424 rs7875024 Candidate 
9 16289428 rs6475025 Candidate 
9 16291556 rs9407736 Candidate 
9 19910154 rs1887392 GWAS Follow-Up 
9 19913350 rs72692011 GWAS Follow-Up 
9 19916322 rs72692016 GWAS Follow-Up 
9 29824057 rs10738827 GWAS Follow-Up 
9 29824209 rs7023887 GWAS Follow-Up 
9 29824222 rs6476159 GWAS Follow-Up 
9 29827670 rs4878419 GWAS Follow-Up 
9 37684753 rs7469365 GWAS Follow-Up 
9 38453822 rs80045011 GWAS Follow-Up 
9 72559567 rs10868299 GWAS Follow-Up 
9 72562015 rs7033495 Candidate 
9 72565890 rs34131182 Candidate 
9 72566736 rs1389119 Candidate 
9 72572045 rs10868327 GWAS Follow-Up 
9 72574727 rs7863165 GWAS Follow-Up 
9 72611680 rs10868358 GWAS Follow-Up 
9 72614812 rs870011 GWAS Follow-Up 
9 72617499 rs4490905 GWAS Follow-Up 
9 72648997 rs2975926 GWAS Follow-Up 
9 72650127 rs4430153 GWAS Follow-Up 
9 91397958 rs73652622 GWAS Follow-Up 
9 93887773 rs13284085 GWAS Follow-Up 
9 96903388 rs75373744 GWAS Follow-Up 
9 96905548 rs10993067 GWAS Follow-Up 
9 96910808 rs2398937 GWAS Follow-Up 
9 96977650 rs10739973 GWAS Follow-Up 
9 96978588 rs2768637 GWAS Follow-Up 
9 96978917 rs2717488 GWAS Follow-Up 
9 96993598 rs2080658 GWAS Follow-Up 
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9 96997137 rs9409707 GWAS Follow-Up 
9 97000398 rs2675278 GWAS Follow-Up 
9 97008212 rs2675275 GWAS Follow-Up 
9 97008227 rs2263455 GWAS Follow-Up 
9 98153197 rs357535 Candidate 
9 98167811 rs357527 Candidate 
9 98177173 rs357561 Candidate 
9 98189165 rs357524 Candidate 
9 98189335 rs357523 Candidate 
9 98191723 rs58831996 Candidate 
9 98209594 rs357564 GWAS Follow-Up 
9 98231008 rs16909898 Candidate 
9 98256309 rs10512249 Candidate 
9 98259703 rs10512248 GWAS Follow-Up 
9 98319969 rs17370391 GWAS Follow-Up 
9 98340320 rs7025117 GWAS Follow-Up 
9 98367717 rs10818991 GWAS Follow-Up 
9 98410405 rs10990303 GWAS Follow-Up 
9 109495224 rs10739227 Candidate 
9 109506245 rs7036275 Candidate 
9 109507432 rs6477542 Candidate 
9 113636793 rs551517 Candidate 
9 119516230 rs13297442 GWAS Follow-Up 
9 119523436 rs13291355 GWAS Follow-Up 
9 119525648 rs13283406 GWAS Follow-Up 
9 119529014 rs13300728 GWAS Follow-Up 
9 120969775 rs10818121 GWAS Follow-Up 
9 120973280 rs1327799 GWAS Follow-Up 
9 120974390 rs4836712 GWAS Follow-Up 
9 120981143 rs1410200 GWAS Follow-Up 
9 130336321 rs4836568 Candidate 
9 134258779 rs542305 GWAS Follow-Up 
9 135965662 rs686246 Candidate 
9 135974100 rs886017 Candidate 
9 135977366 rs34170541 GWAS Follow-Up 
9 136029645 rs35898523 GWAS Follow-Up 
9 136037742 rs2073924 GWAS Follow-Up 
9 136047393 rs2039184 GWAS Follow-Up 
9 136131188 rs8176749 GWAS Follow-Up 
9 136131322 rs8176746 GWAS Follow-Up 
9 136131347 rs8176745 GWAS Follow-Up 
9 136131350 rs8176744 GWAS Follow-Up 
9 136131437 rs8176742 GWAS Follow-Up 
9 136131461 rs8176741 GWAS Follow-Up 
9 136131472 rs8176740 GWAS Follow-Up 
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9 136131576 rs55727303 GWAS Follow-Up 
9 136131592 rs7853989 GWAS Follow-Up 
9 136131651 rs1053878 GWAS Follow-Up 
9 136132873 rs8176720 GWAS Follow-Up 
9 136133506 rs512770 GWAS Follow-Up 
9 136135108 rs8176707 Candidate 
9 136135238 rs549446 GWAS Follow-Up 
9 136136770 rs688976 GWAS Follow-Up 
9 136137065 rs687621 GWAS Follow-Up 
9 136139265 rs657152 GWAS Follow-Up 
9 136142203 rs514659 GWAS Follow-Up 
9 136149229 rs505922 GWAS Follow-Up 
9 136149399 rs507666 GWAS Follow-Up 
9 136153875 rs651007 GWAS Follow-Up 
9 136154168 rs579459 GWAS Follow-Up 
9 136155000 rs635634 GWAS Follow-Up 
9 136199466 rs886089 GWAS Follow-Up 
9 136199503 rs886090 GWAS Follow-Up 
9 136223541 rs143037947 GWAS Follow-Up 
9 136227260 rs12763 GWAS Follow-Up 
9 136268952 rs33919837 GWAS Follow-Up 
9 136269143 rs17150554 GWAS Follow-Up 
9 136277482 rs2285487 GWAS Follow-Up 
9 136277854 rs2285488 Candidate 
9 136279935 rs6597630 GWAS Follow-Up 
9 136287582 rs34024143 GWAS Follow-Up 
9 136291594 rs28515121 GWAS Follow-Up 
9 136301982 rs2301612 GWAS Follow-Up 
9 136305530 rs28647808 GWAS Follow-Up 
9 136310908 rs685523 GWAS Follow-Up 
9 136319589 rs28503257 GWAS Follow-Up 
9 136322529 rs3094327 Candidate 
9 136323754 rs4962153 GWAS Follow-Up 
9 136326554 rs739467 Candidate 
9 136333487 rs3094381 Candidate 
9 136502369 rs3025383 Candidate 
9 136502572 rs13284520 Candidate 
9 136502987 rs3025387 GWAS Follow-Up 
9 136505241 rs1108581 Candidate 
10 2628101 rs10047370 GWAS Follow-Up 
10 2629002 rs4565802 GWAS Follow-Up 
10 2630239 rs10794928 GWAS Follow-Up 
10 2631518 rs7085508 GWAS Follow-Up 
10 2635863 rs11251392 GWAS Follow-Up 
10 2637008 rs7084825 GWAS Follow-Up 
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10 3075076 rs17135074 Candidate 
10 5996751 rs41294041 GWAS Follow-Up 
10 6002697 rs41294153 GWAS Follow-Up 
10 12131081 rs3740015 GWAS Follow-Up 
10 12143105 rs2062988 GWAS Follow-Up 
10 12179270 rs10906083 Candidate 
10 12215180 rs2399786 GWAS Follow-Up 
10 12277992 rs7068966 Candidate 
10 12314997 rs10906115 GWAS Follow-Up 
10 12546743 rs2815660 GWAS Follow-Up 
10 12547135 rs7920446 GWAS Follow-Up 
10 12644970 rs73572263 GWAS Follow-Up 
10 12646813 rs17151970 GWAS Follow-Up 
10 19093747 rs4447064 GWAS Follow-Up 
10 19116011 rs12572254 GWAS Follow-Up 
10 19116610 rs1329241 GWAS Follow-Up 
10 19118287 rs11007193 GWAS Follow-Up 
10 19120169 rs7073789 GWAS Follow-Up 
10 19121271 rs7095160 GWAS Follow-Up 
10 19125235 rs1410922 GWAS Follow-Up 
10 19137100 rs7080850 GWAS Follow-Up 
10 19151542 rs1329218 GWAS Follow-Up 
10 19160986 rs4748537 GWAS Follow-Up 
10 19169676 rs7917968 GWAS Follow-Up 
10 19169862 rs7921382 GWAS Follow-Up 
10 19172869 rs4747363 GWAS Follow-Up 
10 19176810 rs928058 GWAS Follow-Up 
10 21393804 rs478559 GWAS Follow-Up 
10 21416245 rs658096 GWAS Follow-Up 
10 21417606 rs12573237 GWAS Follow-Up 
10 21444603 rs1751915 GWAS Follow-Up 
10 21453457 rs11012552 GWAS Follow-Up 
10 21454915 rs72798503 GWAS Follow-Up 
10 21469847 rs11594335 GWAS Follow-Up 
10 45463220 rs10793573 Candidate 
10 45464035 rs3814566 Candidate 
10 61645590 rs1184089 GWAS Follow-Up 
10 61655297 rs1171812 GWAS Follow-Up 
10 61656044 rs2456712 GWAS Follow-Up 
10 61664610 rs1171828 GWAS Follow-Up 
10 61665886 rs1171830 GWAS Follow-Up 
10 71525084 rs2255667 GWAS Follow-Up 
10 73390724 rs56235440 Candidate 
10 73393901 rs12218474 Candidate 
10 73406697 rs4747179 Candidate 
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10 73407384 rs10999928 GWAS Follow-Up 
10 73407465 rs10999929 Candidate 
10 73408918 rs12414776 Candidate 
10 73409978 rs4746093 Candidate 
10 73416480 rs1665684 GWAS Follow-Up 
10 73416753 rs1665686 GWAS Follow-Up 
10 73420289 rs1665620 GWAS Follow-Up 
10 73437036 rs1227039 Candidate 
10 78117651 rs10430475 Candidate 
10 78122729 rs12766217 GWAS Follow-Up 
10 78140834 rs7904646 Candidate 
10 78149043 rs7909650 Candidate 
10 78151195 rs1873462 Candidate 
10 78155282 rs1873463 Candidate 
10 78159948 rs1907339 Candidate 
10 78160976 rs1907340 Candidate 
10 78315224 rs11001819 Candidate 
10 78444456 rs241 GWAS Follow-Up 
10 82072310 rs10788562 Candidate 
10 82191255 rs4934153 Candidate 
10 82203663 rs4934169 Candidate 
10 82218964 rs12220642 Candidate 
10 82219066 rs12220655 Candidate 
10 82222178 rs7100689 Candidate 
10 82222698 rs1993484 Candidate 
10 82250831 rs7097656 Candidate 
10 82263683 rs1902660 Candidate 
10 82265271 rs9633740 Candidate 
10 82280137 rs1878036 Candidate 
10 82284512 rs7096909 Candidate 
10 82301536 rs11185951 Candidate 
10 82304297 rs7084416 Candidate 
10 89889086 rs192758397 GWAS Follow-Up 
10 94782567 rs10786066 GWAS Follow-Up 
10 94783777 rs7895716 GWAS Follow-Up 
10 97057643 rs7900898 GWAS Follow-Up 
10 102056508 rs2278843 GWAS Follow-Up 
10 102072092 rs3844556 GWAS Follow-Up 
10 119225035 rs11198003 GWAS Follow-Up 
10 119225982 rs171444 GWAS Follow-Up 
10 119226791 rs4752065 GWAS Follow-Up 
10 119229740 rs74162318 GWAS Follow-Up 
10 119234786 rs242966 GWAS Follow-Up 
10 120422764 rs10736269 GWAS Follow-Up 
10 120424177 rs10886280 GWAS Follow-Up 
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10 120425908 rs11198553 GWAS Follow-Up 
10 120426758 rs10886282 GWAS Follow-Up 
10 120428781 rs17097926 GWAS Follow-Up 
10 122693564 rs1659592 Candidate 
10 122697162 rs35361560 Candidate 
10 129649177 rs10830186 GWAS Follow-Up 
10 129649561 rs11018347 GWAS Follow-Up 
10 129649832 rs74570725 GWAS Follow-Up 
10 129652382 rs4751539 GWAS Follow-Up 
10 129652386 rs4751540 GWAS Follow-Up 
10 129653425 rs4750921 GWAS Follow-Up 
10 129660060 rs4590782 GWAS Follow-Up 
10 129661686 rs11018367 GWAS Follow-Up 
10 130675517 rs942528 Candidate 
10 130679321 rs11016534 Candidate 
10 130688400 rs10764827 Candidate 
10 132384224 rs2397388 GWAS Follow-Up 
10 133001451 rs10829946 GWAS Follow-Up 
10 133002014 rs2918129 GWAS Follow-Up 
11 840034 rs11246327 GWAS Follow-Up 
11 5258162 rs4320977 GWAS Follow-Up 
11 20293580 rs72927136 GWAS Follow-Up 
11 31186536 rs61878246 GWAS Follow-Up 
11 35161670 rs353558 GWAS Follow-Up 
11 35163486 rs2553809 GWAS Follow-Up 
11 35164108 rs2553808 GWAS Follow-Up 
11 44800633 rs12577173 Candidate 
11 44802602 rs1377330 GWAS Follow-Up 
11 44807313 rs1670308 GWAS Follow-Up 
11 44869167 rs835795 Candidate 
11 44871323 rs755767 GWAS Follow-Up 
11 46762142 rs6485688 GWAS Follow-Up 
11 56575092 rs77235188 GWAS Follow-Up 
11 62001414 rs12806663 Candidate 
11 67186271 rs868167 GWAS Follow-Up 
11 67200812 rs55987642 GWAS Follow-Up 
11 67203442 rs60969594 GWAS Follow-Up 
11 67235051 rs143199541 GWAS Follow-Up 
11 67262411 rs144939807 GWAS Follow-Up 
11 67266164 rs61755426 GWAS Follow-Up 
11 67288594 rs2276118 GWAS Follow-Up 
11 67291914 rs55657661 Candidate 
11 67299586 rs118043292 Candidate 
11 67339536 rs676653 Candidate 
11 67344150 rs76835094 Candidate 
Page 93 of 133  AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
11 67352689 rs1695 GWAS Follow-Up 
11 67355797 rs79512139 Candidate 
11 67385062 rs72934504 Candidate 
11 67402362 rs3758938 GWAS Follow-Up 
11 67405967 rs11820792 Candidate 
11 67406829 rs1993839 Candidate 
11 67414492 rs948445 GWAS Follow-Up 
11 67430762 rs1551886 GWAS Follow-Up 
11 67433869 rs1551888 GWAS Follow-Up 
11 67453420 rs1824716 Candidate 
11 67456775 rs72936320 Candidate 
11 67461330 rs2514047 Candidate 
11 67462549 rs11227881 Candidate 
11 86165187 rs7108055 GWAS Follow-Up 
11 86165814 rs6592296 GWAS Follow-Up 
11 86165942 rs1563682 GWAS Follow-Up 
11 96606436 rs72974940 GWAS Follow-Up 
11 96617545 rs11214325 GWAS Follow-Up 
11 96624349 rs56338927 GWAS Follow-Up 
11 96653321 rs11215881 GWAS Follow-Up 
11 100036291 rs12802629 GWAS Follow-Up 
11 100051690 rs34562026 GWAS Follow-Up 
11 100060325 rs34029128 GWAS Follow-Up 
11 100406645 rs1216473 Candidate 
11 100407990 rs947950 Candidate 
11 101336544 rs12795728 GWAS Follow-Up 
11 101462942 rs1938828 Candidate 
11 101469434 rs2508736 Candidate 
11 102562700 rs2509010 GWAS Follow-Up 
11 102565820 rs35616217 GWAS Follow-Up 
11 102571892 rs2846365 GWAS Follow-Up 
11 102576358 rs2846707 GWAS Follow-Up 
11 102576375 rs1939015 GWAS Follow-Up 
11 102576382 rs12099177 GWAS Follow-Up 
11 102576468 rs11225389 GWAS Follow-Up 
11 102584104 rs35866072 GWAS Follow-Up 
11 102593248 rs1940475 GWAS Follow-Up 
11 102595492 rs3765620 GWAS Follow-Up 
11 102595579 rs17099450 GWAS Follow-Up 
11 102611332 rs117446737 Candidate 
11 102647536 rs2276108 Candidate 
11 102649482 rs17860955 GWAS Follow-Up 
11 102650389 rs17293607 GWAS Follow-Up 
11 102650424 rs486055 GWAS Follow-Up 
11 102651313 rs17435959 GWAS Follow-Up 
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11 102658807 rs11604098 Candidate 
11 102660097 rs11600510 Candidate 
11 102679052 rs1144396 GWAS Follow-Up 
11 102682285 rs1144397 GWAS Follow-Up 
11 102682503 rs502174 GWAS Follow-Up 
11 102691482 rs11225434 GWAS Follow-Up 
11 102695108 rs495366 GWAS Follow-Up 
11 102710707 rs476762 Candidate 
11 102711338 rs591058 GWAS Follow-Up 
11 102713620 rs679620 Candidate 
11 102714716 rs617819 GWAS Follow-Up 
11 102716321 rs645419 Candidate 
11 102717641 rs116187470 Candidate 
11 102719534 rs114176245 Candidate 
11 102720678 rs615098 Candidate 
11 102720945 rs626750 Candidate 
11 102721251 rs72981675 GWAS Follow-Up 
11 102721859 rs72981680 GWAS Follow-Up 
11 102724211 rs72981684 Candidate 
11 102724730 rs586701 GWAS Follow-Up 
11 102730033 rs72983521 Candidate 
11 102735103 rs476185 Candidate 
11 102736419 rs651159 Candidate 
11 102736642 rs652438 GWAS Follow-Up 
11 102738075 rs17368582 GWAS Follow-Up 
11 102742761 rs17368659 Candidate 
11 102748695 rs17368814 Candidate 
11 102752600 rs17368890 Candidate 
11 102754868 rs61493282 Candidate 
11 102760015 rs10791599 Candidate 
11 102760093 rs11225450 Candidate 
11 102760103 rs76380544 GWAS Follow-Up 
11 102761173 rs11607785 Candidate 
11 102763750 rs1940936 Candidate 
11 102764093 rs72983552 Candidate 
11 102773998 rs72983568 GWAS Follow-Up 
11 102785041 rs72983581 GWAS Follow-Up 
11 102785262 rs11225478 GWAS Follow-Up 
11 102791399 rs2096767 GWAS Follow-Up 
11 102791442 rs2096768 Candidate 
11 102795606 rs1892971 Candidate 
11 102800278 rs72985562 Candidate 
11 102804933 rs7115014 GWAS Follow-Up 
11 102806458 rs66740390 Candidate 
11 102814110 rs1042840 Candidate 
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11 102835040 rs72987535 Candidate 
11 102835942 rs575188 Candidate 
11 102836480 rs72987546 Candidate 
11 102837559 rs4572101 Candidate 
11 105921407 rs56351451 Candidate 
11 105921935 rs17093811 Candidate 
11 106272434 rs71486048 GWAS Follow-Up 
11 106285669 rs17552029 GWAS Follow-Up 
11 116334862 rs66899922 GWAS Follow-Up 
11 116339980 rs66633871 GWAS Follow-Up 
11 116347396 rs12295901 GWAS Follow-Up 
11 116347944 rs59414734 GWAS Follow-Up 
11 116348168 rs2102405 GWAS Follow-Up 
11 116362654 rs61906588 Candidate 
11 116362669 rs61904777 Candidate 
11 121239165 rs34266697 GWAS Follow-Up 
11 134019675 rs11223715 GWAS Follow-Up 
12 3473418 rs7132636 Candidate 
12 3474526 rs11062631 Candidate 
12 3474645 rs887357 Candidate 
12 3743248 rs73045289 Candidate 
12 3744449 rs56239173 Candidate 
12 5031590 rs4766312 GWAS Follow-Up 
12 5039830 rs4766313 GWAS Follow-Up 
12 13399602 rs77723079 GWAS Follow-Up 
12 13400296 rs12306669 GWAS Follow-Up 
12 13400843 rs4763331 GWAS Follow-Up 
12 13406688 rs10845727 GWAS Follow-Up 
12 13410141 rs879112 GWAS Follow-Up 
12 13410267 rs879111 GWAS Follow-Up 
12 13424324 rs11055327 GWAS Follow-Up 
12 13449078 rs10772647 GWAS Follow-Up 
12 13449850 rs7312507 GWAS Follow-Up 
12 28499875 rs11049546 GWAS Follow-Up 
12 28520621 rs10843161 GWAS Follow-Up 
12 28525437 rs11049560 GWAS Follow-Up 
12 28536817 rs1552760 GWAS Follow-Up 
12 28660345 rs10843190 GWAS Follow-Up 
12 28709700 rs2203088 GWAS Follow-Up 
12 28714095 rs11049714 GWAS Follow-Up 
12 28717991 rs7137119 GWAS Follow-Up 
12 28752354 rs1398377 GWAS Follow-Up 
12 28755517 rs1996042 GWAS Follow-Up 
12 28757415 rs117476787 GWAS Follow-Up 
12 28758275 rs1512568 GWAS Follow-Up 
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12 30424221 rs12833560 Candidate 
12 30451922 rs6487897 Candidate 
12 30521245 rs1267323 GWAS Follow-Up 
12 30526045 rs7974875 GWAS Follow-Up 
12 30536422 rs354111 GWAS Follow-Up 
12 48410517 rs6580649 GWAS Follow-Up 
12 48457385 rs3742074 GWAS Follow-Up 
12 48477086 rs7963934 GWAS Follow-Up 
12 48478664 rs4589362 GWAS Follow-Up 
12 48592792 rs11168455 GWAS Follow-Up 
12 48592872 rs4760698 GWAS Follow-Up 
12 48686741 rs2732487 GWAS Follow-Up 
12 48690177 rs2732446 GWAS Follow-Up 
12 48690363 rs2258342 GWAS Follow-Up 
12 48744897 rs2634674 GWAS Follow-Up 
12 52343480 rs61914028 Candidate 
12 52352745 rs813470 GWAS Follow-Up 
12 52356892 rs772222 GWAS Follow-Up 
12 52358168 rs771997 Candidate 
12 52358195 rs771998 GWAS Follow-Up 
12 52362479 rs10876222 GWAS Follow-Up 
12 52362786 rs10783486 Candidate 
12 52369300 rs2242106 GWAS Follow-Up 
12 52371341 rs11169971 GWAS Follow-Up 
12 52381026 rs2252518 GWAS Follow-Up 
12 52381230 rs2252526 GWAS Follow-Up 
12 52383641 rs2453069 GWAS Follow-Up 
12 52384811 rs2641530 GWAS Follow-Up 
12 52388891 rs2854464 GWAS Follow-Up 
12 52391833 rs2359997 GWAS Follow-Up 
12 52392200 rs877869 GWAS Follow-Up 
12 57390038 rs35493121 GWAS Follow-Up 
12 57397033 rs61752546 GWAS Follow-Up 
12 57397876 rs117805856 GWAS Follow-Up 
12 57422934 rs17119344 GWAS Follow-Up 
12 57457959 rs17546579 GWAS Follow-Up 
12 57503775 rs167769 GWAS Follow-Up 
12 57510511 rs2122692 Candidate 
12 57510661 rs324013 Candidate 
12 57513866 rs12322902 Candidate 
12 57515363 rs12298170 Candidate 
12 57527283 rs11172113 Candidate 
12 57567762 rs1800194 GWAS Follow-Up 
12 57616013 rs10783815 GWAS Follow-Up 
12 57624701 rs73338162 GWAS Follow-Up 
Page 97 of 133  AJRCMB Articles in Press. Published on 07-February-2017 as 10.1165/rcmb.2016-0331OC 
 Copyright © 2017 by the American Thoracic Society 
12 57648644 rs78607331 GWAS Follow-Up 
12 62260866 rs2359979 GWAS Follow-Up 
12 62264022 rs1031579 GWAS Follow-Up 
12 63179248 rs11174649 GWAS Follow-Up 
12 63179929 rs11174650 GWAS Follow-Up 
12 63196133 rs73130066 GWAS Follow-Up 
12 63199004 rs73130069 GWAS Follow-Up 
12 63200121 rs11615499 GWAS Follow-Up 
12 68430172 rs12231190 Candidate 
12 71639539 rs76062993 GWAS Follow-Up 
12 77282680 rs78008978 Candidate 
12 85421258 rs11609891 Candidate 
12 85428374 rs13377881 Candidate 
12 85511005 rs11612337 Candidate 
12 90311971 rs11105462 GWAS Follow-Up 
12 90360364 rs4503596 GWAS Follow-Up 
12 90367036 rs11105476 GWAS Follow-Up 
12 90375142 rs10858941 GWAS Follow-Up 
12 95491530 rs11107893 Candidate 
12 95493912 rs4762172 GWAS Follow-Up 
12 95494760 rs4762452 Candidate 
12 96124901 rs11108222 GWAS Follow-Up 
12 96131895 rs17288108 GWAS Follow-Up 
12 96149288 rs4341610 GWAS Follow-Up 
12 96237095 rs7306887 Candidate 
12 96237570 rs7307510 Candidate 
12 96241630 rs35834603 Candidate 
12 96249111 rs117885456 Candidate 
12 96266910 rs4762634 Candidate 
12 96288860 rs10859974 GWAS Follow-Up 
12 96292170 rs75959092 GWAS Follow-Up 
12 96312686 rs12368787 GWAS Follow-Up 
12 96316396 rs11108337 Candidate 
12 96323344 rs10161346 Candidate 
12 96332684 rs7964411 Candidate 
12 96332825 rs7967282 Candidate 
12 96337183 rs7955450 GWAS Follow-Up 
12 96350254 rs4762651 Candidate 
12 96355432 rs7485085 Candidate 
12 96359301 rs4762657 Candidate 
12 96365672 rs7976204 Candidate 
12 96374614 rs7297245 GWAS Follow-Up 
12 96813866 rs7304605 GWAS Follow-Up 
12 97916472 rs7963257 GWAS Follow-Up 
12 103553204 rs2271934 GWAS Follow-Up 
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12 103555364 rs1520186 GWAS Follow-Up 
12 103557292 rs10778216 GWAS Follow-Up 
12 103916279 rs73187844 GWAS Follow-Up 
12 116120720 rs1386030 GWAS Follow-Up 
12 116123751 rs9788243 GWAS Follow-Up 
12 116124357 rs872770 GWAS Follow-Up 
12 116125734 rs74664232 GWAS Follow-Up 
12 116227853 rs73212689 GWAS Follow-Up 
12 116228016 rs12307483 GWAS Follow-Up 
12 116601058 rs10444487 Candidate 
12 116705604 rs17614779 Candidate 
12 116711987 rs75639744 Candidate 
12 118011133 rs845753 GWAS Follow-Up 
12 118011284 rs816202 GWAS Follow-Up 
12 118624641 rs696345 Candidate 
12 123018475 rs11615433 Candidate 
12 124171658 rs7309528 Candidate 
12 124174234 rs7135660 Candidate 
12 124194438 rs2222060 Candidate 
12 125664357 rs3751178 Candidate 
12 125681761 rs12578774 GWAS Follow-Up 
12 125699977 rs12828711 GWAS Follow-Up 
12 133140237 rs4992763 GWAS Follow-Up 
12 133140262 rs67435543 GWAS Follow-Up 
12 133140840 rs12809318 GWAS Follow-Up 
12 133141973 rs5023077 GWAS Follow-Up 
12 133151607 rs11146943 GWAS Follow-Up 
13 24656545 rs7329133 GWAS Follow-Up 
13 27134495 rs75932629 GWAS Follow-Up 
13 35136291 rs928076 Candidate 
13 36387563 rs4943339 GWAS Follow-Up 
13 36388348 rs7995297 GWAS Follow-Up 
13 36393375 rs1926467 GWAS Follow-Up 
13 36401516 rs9531097 Candidate 
13 36401576 rs9531098 Candidate 
13 36598404 rs1578809 GWAS Follow-Up 
13 53441955 rs9596699 GWAS Follow-Up 
13 53478771 rs75111298 GWAS Follow-Up 
13 53479898 rs75574154 GWAS Follow-Up 
13 54061825 rs9536431 Candidate 
13 54087218 rs79571557 Candidate 
13 54114469 rs9536454 Candidate 
13 54117075 rs9536455 Candidate 
13 54132247 rs9536463 Candidate 
13 54192030 rs9536482 GWAS Follow-Up 
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13 54227768 rs4884605 GWAS Follow-Up 
13 54277828 rs2785828 GWAS Follow-Up 
13 54317234 rs9536534 Candidate 
13 54351529 rs9536542 Candidate 
13 69109747 rs73200286 Candidate 
13 69117890 rs11840657 Candidate 
13 69126008 rs17557610 Candidate 
13 69133985 rs12874564 Candidate 
13 72439407 rs1325340 Candidate 
13 72449211 rs6562684 Candidate 
13 78904133 rs77001198 GWAS Follow-Up 
13 78906075 rs80110846 GWAS Follow-Up 
13 78907306 rs75058988 GWAS Follow-Up 
13 90484030 rs7989426 GWAS Follow-Up 
13 90487155 rs1932306 GWAS Follow-Up 
13 98205979 rs190040278 GWAS Follow-Up 
13 98948140 rs9517248 GWAS Follow-Up 
13 98948788 rs9513394 GWAS Follow-Up 
13 106760961 rs1550602 GWAS Follow-Up 
13 106767807 rs9558679 GWAS Follow-Up 
13 106775049 rs4772755 GWAS Follow-Up 
13 107119360 rs9520081 GWAS Follow-Up 
13 107120452 rs61965324 GWAS Follow-Up 
13 107120760 rs9520084 GWAS Follow-Up 
13 107122961 rs9558771 GWAS Follow-Up 
13 107125157 rs9583089 GWAS Follow-Up 
13 107125691 rs2391297 GWAS Follow-Up 
14 25109648 rs1951596 GWAS Follow-Up 
14 25126957 rs5002199 GWAS Follow-Up 
14 25128141 rs2025211 GWAS Follow-Up 
14 25128180 rs17257138 GWAS Follow-Up 
14 26755671 rs1956481 Candidate 
14 26807298 rs12887777 Candidate 
14 26807731 rs12892878 Candidate 
14 34441865 rs946630 GWAS Follow-Up 
14 34442649 rs1628940 GWAS Follow-Up 
14 34483149 rs75543768 GWAS Follow-Up 
14 36638655 rs2774166 GWAS Follow-Up 
14 36639206 rs1820604 GWAS Follow-Up 
14 36640638 rs1834855 GWAS Follow-Up 
14 36666488 rs1766123 GWAS Follow-Up 
14 36670083 rs946068 GWAS Follow-Up 
14 36671982 rs1114365 GWAS Follow-Up 
14 36672026 rs1114852 GWAS Follow-Up 
14 42353448 rs7159901 GWAS Follow-Up 
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14 42547909 rs12888716 GWAS Follow-Up 
14 42548912 rs1542668 GWAS Follow-Up 
14 53349798 rs11157933 GWAS Follow-Up 
14 53353454 rs6572869 GWAS Follow-Up 
14 62740092 rs7492698 GWAS Follow-Up 
14 62742003 rs12894069 GWAS Follow-Up 
14 63799152 rs1609564 GWAS Follow-Up 
14 63809172 rs10133798 GWAS Follow-Up 
14 63811976 rs12433479 GWAS Follow-Up 
14 63813414 rs1956250 GWAS Follow-Up 
14 63815860 rs8015217 GWAS Follow-Up 
14 63816662 rs11628882 GWAS Follow-Up 
14 63817304 rs6573510 GWAS Follow-Up 
14 63818672 rs8012319 GWAS Follow-Up 
14 63820672 rs10498507 GWAS Follow-Up 
14 66209190 rs1054218 Candidate 
14 66211250 rs8003811 Candidate 
14 66212986 rs761830 Candidate 
14 66272647 rs6573632 GWAS Follow-Up 
14 66272664 rs6573633 GWAS Follow-Up 
14 86656481 rs76558268 GWAS Follow-Up 
14 86661632 rs9635280 GWAS Follow-Up 
14 93064786 rs76725931 Candidate 
14 93072317 rs35629566 GWAS Follow-Up 
14 93077611 rs72699818 GWAS Follow-Up 
14 93096391 rs11623779 Candidate 
14 93099867 rs4904964 Candidate 
14 93102251 rs17184313 Candidate 
14 93104072 rs11627032 GWAS Follow-Up 
14 93111715 rs78242330 GWAS Follow-Up 
14 93114787 rs72699866 Candidate 
14 93115410 rs754388 GWAS Follow-Up 
14 93116351 rs72699870 Candidate 
14 93118229 rs117068593 GWAS Follow-Up 
14 93155696 rs12435559 GWAS Follow-Up 
14 93157126 rs12895951 GWAS Follow-Up 
14 93160522 rs11849228 GWAS Follow-Up 
14 93195374 rs17736427 GWAS Follow-Up 
14 94672731 rs112458284 Candidate 
14 94844947 rs28929474 Candidate 
14 101235455 rs76006621 GWAS Follow-Up 
14 101237738 rs78437025 GWAS Follow-Up 
14 101239299 rs76859673 GWAS Follow-Up 
14 102382347 rs7157928 GWAS Follow-Up 
14 102383175 rs60089041 GWAS Follow-Up 
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15 49582017 rs62009832 GWAS Follow-Up 
15 49755019 rs34377746 GWAS Follow-Up 
15 49766857 rs35224895 GWAS Follow-Up 
15 49876773 rs34605270 GWAS Follow-Up 
15 49888242 rs12900911 GWAS Follow-Up 
15 49921464 rs16962673 GWAS Follow-Up 
15 49947688 rs11854482 GWAS Follow-Up 
15 49955738 rs12906970 GWAS Follow-Up 
15 49974412 rs62022673 GWAS Follow-Up 
15 49977187 rs1507617 GWAS Follow-Up 
15 49999463 rs72731157 GWAS Follow-Up 
15 50003084 rs1843147 GWAS Follow-Up 
15 55944517 rs572531 GWAS Follow-Up 
15 55949749 rs10851589 GWAS Follow-Up 
15 62717563 rs7179091 GWAS Follow-Up 
15 62720363 rs10519148 GWAS Follow-Up 
15 62721768 rs4775500 GWAS Follow-Up 
15 62752174 rs11637267 GWAS Follow-Up 
15 71551640 rs76818896 Candidate 
15 71571345 rs7174934 GWAS Follow-Up 
15 71599643 rs12917206 Candidate 
15 71604250 rs10851838 Candidate 
15 71608127 rs8023818 Candidate 
15 71608619 rs17786786 Candidate 
15 71609306 rs4337253 Candidate 
15 71609522 rs6494904 Candidate 
15 71610835 rs11855326 GWAS Follow-Up 
15 71612303 rs1837762 Candidate 
15 71612397 rs1441357 Candidate 
15 71612514 rs1441358 Candidate 
15 71621524 rs11853359 Candidate 
15 71621562 rs11856837 Candidate 
15 71621878 rs16955436 Candidate 
15 71622863 rs11854933 Candidate 
15 71624368 rs56379569 Candidate 
15 71631920 rs12916138 Candidate 
15 71635928 rs10851840 GWAS Follow-Up 
15 71637848 rs2028467 Candidate 
15 71639634 rs12915616 Candidate 
15 71640371 rs16955470 GWAS Follow-Up 
15 71641551 rs3759830 GWAS Follow-Up 
15 71643083 rs60193973 GWAS Follow-Up 
15 71643787 rs4777372 GWAS Follow-Up 
15 71645120 rs12899618 Candidate 
15 71645334 rs10459646 Candidate 
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15 71645663 rs11852640 GWAS Follow-Up 
15 71648497 rs2415115 Candidate 
15 71649544 rs1913768 Candidate 
15 71666166 rs1561711 Candidate 
15 71667478 rs11072277 Candidate 
15 71668140 rs11632680 Candidate 
15 71668512 rs1568010 Candidate 
15 71669115 rs11858454 Candidate 
15 71669872 rs56308303 Candidate 
15 71674189 rs7181363 Candidate 
15 71676939 rs55865815 Candidate 
15 71678178 rs1441355 Candidate 
15 71678480 rs10851842 GWAS Follow-Up 
15 71678963 rs7167951 GWAS Follow-Up 
15 71688979 rs4531689 Candidate 
15 71689855 rs4238435 Candidate 
15 71699681 rs1441363 Candidate 
15 71703827 rs35270398 Candidate 
15 71715312 rs12595821 Candidate 
15 71717044 rs6494924 GWAS Follow-Up 
15 71719084 rs920549 Candidate 
15 71719382 rs36098907 Candidate 
15 71720944 rs7177932 Candidate 
15 71722819 rs4776552 GWAS Follow-Up 
15 71727876 rs12593944 Candidate 
15 71728529 rs8027920 Candidate 
15 71729913 rs12902368 Candidate 
15 71730079 rs1441353 Candidate 
15 71730197 rs1441354 Candidate 
15 71730403 rs13380076 GWAS Follow-Up 
15 71731515 rs8025197 Candidate 
15 71734158 rs28579204 Candidate 
15 71739969 rs11632301 Candidate 
15 71740069 rs11632349 Candidate 
15 71741898 rs62015860 Candidate 
15 71802020 rs4316710 Candidate 
15 71802897 rs4349101 Candidate 
15 71803046 rs56081634 Candidate 
15 71805006 rs7183859 Candidate 
15 71862739 rs11072301 GWAS Follow-Up 
15 71888643 rs77984977 GWAS Follow-Up 
15 76083019 rs2655133 Candidate 
15 78712699 rs4887053 Candidate 
15 78718899 rs2869045 Candidate 
15 78724469 rs1394371 Candidate 
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15 78731808 rs924840 GWAS Follow-Up 
15 78733390 rs17483686 Candidate 
15 78733731 rs17483721 GWAS Follow-Up 
15 78739471 rs2915695 Candidate 
15 78740233 rs2568493 Candidate 
15 78740932 rs2656052 Candidate 
15 78740964 rs2568494 Candidate 
15 78742376 rs17483929 Candidate 
15 78745343 rs2656071 Candidate 
15 78750549 rs2656065 Candidate 
15 78752188 rs72738732 GWAS Follow-Up 
15 78754102 rs2009746 Candidate 
15 78757913 rs2938674 GWAS Follow-Up 
15 78766250 rs1504550 GWAS Follow-Up 
15 78766629 rs1504549 GWAS Follow-Up 
15 78767850 rs12910910 GWAS Follow-Up 
15 78768871 rs8043227 GWAS Follow-Up 
15 78769130 rs12916801 GWAS Follow-Up 
15 78772676 rs17484524 Candidate 
15 78774271 rs8042238 Candidate 
15 78778972 rs12903295 GWAS Follow-Up 
15 78779384 rs12904234 GWAS Follow-Up 
15 78783277 rs11858836 Candidate 
15 78789223 rs965604 GWAS Follow-Up 
15 78792527 rs1062980 Candidate 
15 78796282 rs5019044 GWAS Follow-Up 
15 78802586 rs9788682 GWAS Follow-Up 
15 78802869 rs9788721 GWAS Follow-Up 
15 78806023 rs8034191 GWAS Follow-Up 
15 78814681 rs7163730 GWAS Follow-Up 
15 78815298 rs61204066 GWAS Follow-Up 
15 78816057 rs8031948 GWAS Follow-Up 
15 78826180 rs931794 Candidate 
15 78828086 rs72738786 Candidate 
15 78832349 rs56117933 GWAS Follow-Up 
15 78833036 rs57064725 GWAS Follow-Up 
15 78837673 rs28498264 GWAS Follow-Up 
15 78845110 rs905739 GWAS Follow-Up 
15 78849918 rs7173514 GWAS Follow-Up 
15 78857896 rs503464 GWAS Follow-Up 
15 78858400 rs684513 Candidate 
15 78863472 rs667282 GWAS Follow-Up 
15 78865197 rs17486195 Candidate 
15 78867482 rs17486278 Candidate 
15 78869930 rs495956 GWAS Follow-Up 
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15 78870003 rs495090 Candidate 
15 78874555 rs116991229 Candidate 
15 78875623 rs1700006 GWAS Follow-Up 
15 78877150 rs11637635 Candidate 
15 78878541 rs951266 GWAS Follow-Up 
15 78882925 rs16969968 Candidate 
15 78883813 rs518425 Candidate 
15 78888400 rs578776 Candidate 
15 78894339 rs1051730 Candidate 
15 78896129 rs1317286 Candidate 
15 78898723 rs12914385 Candidate 
15 78898932 rs55676755 Candidate 
15 78907656 rs6495308 Candidate 
15 78909070 rs4887069 Candidate 
15 78910258 rs3825845 Candidate 
15 78911181 rs8040868 GWAS Follow-Up 
15 78912472 rs117832812 GWAS Follow-Up 
15 78914534 rs8039449 Candidate 
15 78915864 rs10851907 Candidate 
15 78915872 rs55958997 Candidate 
15 78920935 rs12593950 GWAS Follow-Up 
15 78923845 rs28534575 GWAS Follow-Up 
15 78923987 rs17487223 GWAS Follow-Up 
15 78925435 rs4887072 GWAS Follow-Up 
15 78926726 rs12440014 Candidate 
15 78928264 rs12441088 GWAS Follow-Up 
15 78928878 rs11636605 GWAS Follow-Up 
15 78929372 rs12441998 GWAS Follow-Up 
15 78930510 rs1316971 GWAS Follow-Up 
15 78931057 rs9920506 Candidate 
15 78934318 rs67426328 GWAS Follow-Up 
15 78934551 rs3813567 Candidate 
15 78936168 rs55988292 Candidate 
15 78946633 rs12594247 GWAS Follow-Up 
15 78948152 rs7181405 Candidate 
15 78948319 rs11638830 Candidate 
15 78952697 rs11072774 GWAS Follow-Up 
15 78953464 rs12595350 GWAS Follow-Up 
15 78953740 rs7163204 GWAS Follow-Up 
15 78953919 rs7164665 GWAS Follow-Up 
15 78960529 rs6495314 Candidate 
15 78964362 rs12905641 Candidate 
15 78965254 rs7178007 GWAS Follow-Up 
15 78966655 rs11639372 Candidate 
15 78967401 rs12902602 GWAS Follow-Up 
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15 78968268 rs11857532 GWAS Follow-Up 
15 78978364 rs4887077 Candidate 
15 78995801 rs12324870 GWAS Follow-Up 
15 78997076 rs11072791 Candidate 
15 79019024 rs11629637 Candidate 
15 79019610 rs3813565 GWAS Follow-Up 
15 79024016 rs11639181 GWAS Follow-Up 
15 79034276 rs8031513 GWAS Follow-Up 
15 79067951 rs7171916 Candidate 
15 79068328 rs12906691 Candidate 
15 79070438 rs12907764 Candidate 
15 79071095 rs12913260 GWAS Follow-Up 
15 79083814 rs11639044 GWAS Follow-Up 
15 79089111 rs3825807 GWAS Follow-Up 
15 79089734 rs7177699 Candidate 
15 79090606 rs28610385 Candidate 
15 79092750 rs7173267 GWAS Follow-Up 
15 79094325 rs11856536 GWAS Follow-Up 
15 79105350 rs11634042 GWAS Follow-Up 
15 79107355 rs12907065 GWAS Follow-Up 
15 79110302 rs9806363 Candidate 
15 79111093 rs4380028 GWAS Follow-Up 
15 79122948 rs72749206 GWAS Follow-Up 
15 79123753 rs7182716 Candidate 
15 80695115 rs2278701 GWAS Follow-Up 
15 86139866 rs16942046 GWAS Follow-Up 
15 86141702 rs56657677 GWAS Follow-Up 
15 86194209 rs72764205 GWAS Follow-Up 
15 86226666 rs7165537 GWAS Follow-Up 
15 94282614 rs7495918 GWAS Follow-Up 
15 94283185 rs11857245 GWAS Follow-Up 
15 94681150 rs10468110 GWAS Follow-Up 
15 96758020 rs74702350 GWAS Follow-Up 
15 96758441 rs7167152 GWAS Follow-Up 
15 96758498 rs7171335 GWAS Follow-Up 
15 101315569 rs34659386 GWAS Follow-Up 
15 101320663 rs34023462 GWAS Follow-Up 
15 101560504 rs59609022 GWAS Follow-Up 
15 101561092 rs11633278 GWAS Follow-Up 
15 101713301 rs11634552 GWAS Follow-Up 
15 101714653 rs1975753 GWAS Follow-Up 
15 101720143 rs1993338 GWAS Follow-Up 
15 101742965 rs12443106 GWAS Follow-Up 
16 392392 rs118100148 Candidate 
16 927873 rs8043613 GWAS Follow-Up 
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16 931686 rs4984954 Candidate 
16 932087 rs13334877 Candidate 
16 16260443 rs8057824 GWAS Follow-Up 
16 16268230 rs4577106 GWAS Follow-Up 
16 16271409 rs9924755 GWAS Follow-Up 
16 16273374 rs150465 GWAS Follow-Up 
16 17128503 rs149143200 GWAS Follow-Up 
16 17558034 rs62030329 GWAS Follow-Up 
16 24853115 rs7195553 Candidate 
16 25208036 rs62034915 GWAS Follow-Up 
16 25209195 rs12325483 GWAS Follow-Up 
16 26352382 rs7202468 GWAS Follow-Up 
16 26357471 rs17581662 GWAS Follow-Up 
16 26357720 rs17503574 GWAS Follow-Up 
16 28490517 rs151181 GWAS Follow-Up 
16 28499291 rs34835 GWAS Follow-Up 
16 28510393 rs40834 GWAS Follow-Up 
16 28510537 rs40836 GWAS Follow-Up 
16 28510845 rs40837 GWAS Follow-Up 
16 28517709 rs26528 GWAS Follow-Up 
16 28519096 rs153109 GWAS Follow-Up 
16 28536473 rs62034323 GWAS Follow-Up 
16 28549823 rs151226 GWAS Follow-Up 
16 28563026 rs151228 GWAS Follow-Up 
16 28574615 rs480400 GWAS Follow-Up 
16 28587389 rs7186573 GWAS Follow-Up 
16 28593347 rs17707300 GWAS Follow-Up 
16 28595700 rs17640009 GWAS Follow-Up 
16 53724970 rs13334070 GWAS Follow-Up 
16 53816275 rs8050136 GWAS Follow-Up 
16 53899008 rs2024471 GWAS Follow-Up 
16 53901208 rs12918206 GWAS Follow-Up 
16 53901293 rs12918363 GWAS Follow-Up 
16 53906851 rs7206324 GWAS Follow-Up 
16 53906852 rs7188378 GWAS Follow-Up 
16 53907347 rs9673307 GWAS Follow-Up 
16 53909185 rs10521303 GWAS Follow-Up 
16 53910195 rs4784328 GWAS Follow-Up 
16 53910261 rs4784329 GWAS Follow-Up 
16 53911023 rs7191718 GWAS Follow-Up 
16 53911770 rs1362571 GWAS Follow-Up 
16 53912364 rs8061064 GWAS Follow-Up 
16 53914302 rs67386617 GWAS Follow-Up 
16 53926790 rs17820875 GWAS Follow-Up 
16 53927323 rs11076008 GWAS Follow-Up 
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16 53930993 rs12933928 GWAS Follow-Up 
16 53933547 rs1362570 GWAS Follow-Up 
16 53937632 rs2111112 GWAS Follow-Up 
16 53963063 rs11864972 GWAS Follow-Up 
16 54234313 rs12445261 GWAS Follow-Up 
16 54238008 rs10153048 GWAS Follow-Up 
16 57935442 rs112002818 GWAS Follow-Up 
16 57935470 rs79889567 GWAS Follow-Up 
16 57937788 rs2303785 GWAS Follow-Up 
16 57949224 rs10459809 GWAS Follow-Up 
16 57954448 rs2161703 GWAS Follow-Up 
16 57957216 rs12927214 GWAS Follow-Up 
16 57993841 rs61745888 GWAS Follow-Up 
16 57996960 rs13336595 GWAS Follow-Up 
16 58019396 rs9934227 GWAS Follow-Up 
16 58054099 rs16959641 GWAS Follow-Up 
16 58075282 rs12447804 Candidate 
16 58252843 rs2550370 Candidate 
16 69191420 rs13332128 GWAS Follow-Up 
16 69277073 rs12933098 GWAS Follow-Up 
16 70690166 rs4985555 GWAS Follow-Up 
16 70804743 rs1551528 GWAS Follow-Up 
16 70804766 rs1551529 GWAS Follow-Up 
16 70826868 rs713511 GWAS Follow-Up 
16 71790812 rs11075901 GWAS Follow-Up 
16 71804287 rs7204967 GWAS Follow-Up 
16 75247245 rs7202877 GWAS Follow-Up 
16 75281964 rs1862737 GWAS Follow-Up 
16 75301838 rs148519476 GWAS Follow-Up 
16 75306890 rs12919951 Candidate 
16 75313258 rs8050367 Candidate 
16 75318988 rs66885758 Candidate 
16 75340231 rs4888379 Candidate 
16 75342846 rs10871308 Candidate 
16 75344476 rs10514393 Candidate 
16 75346788 rs1862705 Candidate 
16 75347690 rs4888380 Candidate 
16 75477714 rs37586 Candidate 
16 75478051 rs72787179 Candidate 
16 75481215 rs451589 Candidate 
16 75497840 rs116475745 Candidate 
16 75513433 rs118144424 GWAS Follow-Up 
16 75563330 rs3826107 GWAS Follow-Up 
16 75590092 rs3743601 GWAS Follow-Up 
16 76898620 rs118068599 GWAS Follow-Up 
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16 80298569 rs62049540 GWAS Follow-Up 
16 80299191 rs13336279 GWAS Follow-Up 
16 80405292 rs2881978 GWAS Follow-Up 
16 80408261 rs1484027 GWAS Follow-Up 
16 80441136 rs1126264 GWAS Follow-Up 
16 80442198 rs9935300 GWAS Follow-Up 
16 80500455 rs72820465 GWAS Follow-Up 
16 80501358 rs72820466 GWAS Follow-Up 
16 86445086 rs56177656 GWAS Follow-Up 
16 86446344 rs12929431 GWAS Follow-Up 
16 86447328 rs12446923 GWAS Follow-Up 
16 86447371 rs12448517 GWAS Follow-Up 
16 86455653 rs34830546 GWAS Follow-Up 
16 86463695 rs2178146 GWAS Follow-Up 
16 87701433 rs13333847 GWAS Follow-Up 
16 87701468 rs13330384 GWAS Follow-Up 
17 701827 rs504607 Candidate 
17 704042 rs655377 Candidate 
17 7363088 rs9217 GWAS Follow-Up 
17 7366348 rs78260319 GWAS Follow-Up 
17 7366619 rs34914463 GWAS Follow-Up 
17 7402600 rs2228129 GWAS Follow-Up 
17 7417663 rs6761 GWAS Follow-Up 
17 7462969 rs3803800 GWAS Follow-Up 
17 7468277 rs35596387 GWAS Follow-Up 
17 7484101 rs9901673 GWAS Follow-Up 
17 7484782 rs17607 GWAS Follow-Up 
17 7484812 rs9901675 GWAS Follow-Up 
17 7490810 rs10852891 GWAS Follow-Up 
17 7495219 rs190521854 GWAS Follow-Up 
17 7529902 rs13894 GWAS Follow-Up 
17 7534678 rs6258 GWAS Follow-Up 
17 7536527 rs6259 GWAS Follow-Up 
17 7557419 rs1642763 GWAS Follow-Up 
17 7592168 rs2287499 GWAS Follow-Up 
17 7606722 rs7640 GWAS Follow-Up 
17 7633692 rs16956936 GWAS Follow-Up 
17 7637789 rs3744255 GWAS Follow-Up 
17 7669761 rs35788701 GWAS Follow-Up 
17 7674784 rs73232344 GWAS Follow-Up 
17 7698599 rs4233018 GWAS Follow-Up 
17 7721542 rs1105813 Candidate 
17 12326885 rs237322 GWAS Follow-Up 
17 12327922 rs34321002 GWAS Follow-Up 
17 12329031 rs10521196 GWAS Follow-Up 
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17 12339928 rs237279 GWAS Follow-Up 
17 15224673 rs2610065 GWAS Follow-Up 
17 15226933 rs397523 GWAS Follow-Up 
17 15230379 rs230899 GWAS Follow-Up 
17 29111368 rs11867457 Candidate 
17 34330987 rs75456429 GWAS Follow-Up 
17 34336633 rs76141508 GWAS Follow-Up 
17 35270922 rs55955238 Candidate 
17 35274282 rs12185265 Candidate 
17 35282364 rs10048172 Candidate 
17 39078825 rs2269862 GWAS Follow-Up 
17 39083591 rs3785768 GWAS Follow-Up 
17 39191533 rs147545279 GWAS Follow-Up 
17 39525750 rs12450621 GWAS Follow-Up 
17 39607035 rs12449652 GWAS Follow-Up 
17 43549526 rs17631676 GWAS Follow-Up 
17 43885291 rs62057101 Candidate 
17 43903842 rs62057151 Candidate 
17 43907896 rs16940665 Candidate 
17 43968415 rs7210728 GWAS Follow-Up 
17 44788310 rs183211 Candidate 
17 44791643 rs199438 GWAS Follow-Up 
17 44795234 rs142167 Candidate 
17 44800046 rs7224296 Candidate 
17 44800110 rs199454 GWAS Follow-Up 
17 44824213 rs199534 GWAS Follow-Up 
17 44828931 rs199533 Candidate 
17 44836302 rs9912530 Candidate 
17 44837217 rs199529 Candidate 
17 44847707 rs199526 Candidate 
17 44847834 rs199525 GWAS Follow-Up 
17 44848517 rs199523 Candidate 
17 44853456 rs199521 GWAS Follow-Up 
17 44853924 rs199519 GWAS Follow-Up 
17 44862613 rs199501 Candidate 
17 44863133 rs916888 GWAS Follow-Up 
17 44865439 rs2074404 Candidate 
17 44865498 rs199499 GWAS Follow-Up 
17 44865603 rs199498 GWAS Follow-Up 
17 47056753 rs72833620 Candidate 
17 47065115 rs68106312 Candidate 
17 58125948 rs59950371 GWAS Follow-Up 
17 59358141 rs35886429 GWAS Follow-Up 
17 68937753 rs35883109 Candidate 
17 68950506 rs4793515 Candidate 
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17 68962577 rs11077536 Candidate 
17 68978215 rs72864792 Candidate 
17 69007761 rs4793324 Candidate 
17 69073192 rs9898686 GWAS Follow-Up 
17 69073670 rs68193035 GWAS Follow-Up 
17 69074779 rs9906150 GWAS Follow-Up 
17 69108753 rs1859962 GWAS Follow-Up 
17 69125606 rs11654749 Candidate 
17 69198109 rs2215050 Candidate 
17 69233083 rs8076167 GWAS Follow-Up 
17 70025377 rs73352505 GWAS Follow-Up 
17 74498585 rs4238992 GWAS Follow-Up 
17 75096857 rs2585851 GWAS Follow-Up 
17 75099917 rs11077889 GWAS Follow-Up 
17 75114727 rs485018 GWAS Follow-Up 
17 76700063 rs7220955 GWAS Follow-Up 
17 76751234 rs77154538 Candidate 
17 76799795 rs1057040 GWAS Follow-Up 
17 76799860 rs3088040 GWAS Follow-Up 
17 76802344 rs34121152 GWAS Follow-Up 
17 76803659 rs3744795 GWAS Follow-Up 
17 76817090 rs3744793 GWAS Follow-Up 
17 76893671 rs3744787 Candidate 
17 77078069 rs12937557 GWAS Follow-Up 
17 77081788 rs4789879 GWAS Follow-Up 
17 77082174 rs117014247 GWAS Follow-Up 
18 2287899 rs12458161 GWAS Follow-Up 
18 8799709 rs4797331 GWAS Follow-Up 
18 10889678 rs10853191 Candidate 
18 10908861 rs11080467 Candidate 
18 13843246 rs12956045 GWAS Follow-Up 
18 20727611 rs4800452 Candidate 
18 20731930 rs4239436 Candidate 
18 20732224 rs4239437 Candidate 
18 20744658 rs10853502 Candidate 
18 20746829 rs28589524 Candidate 
18 20748733 rs4800455 Candidate 
18 20758310 rs34302357 Candidate 
18 20815612 rs117025081 Candidate 
18 23915553 rs41306966 GWAS Follow-Up 
18 24007303 rs80005603 GWAS Follow-Up 
18 24024531 rs4800259 GWAS Follow-Up 
18 33191702 rs8096745 Candidate 
18 33199916 rs12959333 Candidate 
18 35105203 rs12607040 GWAS Follow-Up 
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18 35106036 rs55927401 GWAS Follow-Up 
18 39815648 rs2126258 Candidate 
18 39815876 rs2169382 Candidate 
18 58430041 rs76388103 GWAS Follow-Up 
18 62112791 rs2959494 GWAS Follow-Up 
18 77052242 rs7239390 GWAS Follow-Up 
18 77138068 rs3591 GWAS Follow-Up 
19 8540260 rs7507621 GWAS Follow-Up 
19 8547457 rs6603083 GWAS Follow-Up 
19 8552167 rs12608524 GWAS Follow-Up 
19 8557966 rs58034536 GWAS Follow-Up 
19 13710380 rs503084 GWAS Follow-Up 
19 21383250 rs8111954 GWAS Follow-Up 
19 21383587 rs12973927 GWAS Follow-Up 
19 21384253 rs8101643 GWAS Follow-Up 
19 21393187 rs7248088 GWAS Follow-Up 
19 21394226 rs4609982 GWAS Follow-Up 
19 21398889 rs6511215 GWAS Follow-Up 
19 32535207 rs2240660 GWAS Follow-Up 
19 32545548 rs1001377 GWAS Follow-Up 
19 32545763 rs1005161 GWAS Follow-Up 
19 40329178 rs117967160 GWAS Follow-Up 
19 40890840 rs73046355 GWAS Follow-Up 
19 40898209 rs73046364 GWAS Follow-Up 
19 41208981 rs2288451 Candidate 
19 41218611 rs2604913 GWAS Follow-Up 
19 41221513 rs4802085 GWAS Follow-Up 
19 41225299 rs1469427 GWAS Follow-Up 
19 41227968 rs890934 Candidate 
19 41244887 rs2607420 Candidate 
19 41246378 rs2290692 GWAS Follow-Up 
19 41255500 rs2254343 GWAS Follow-Up 
19 41256131 rs1870087 Candidate 
19 41256519 rs1870086 GWAS Follow-Up 
19 41257176 rs1457141 GWAS Follow-Up 
19 41257816 rs2604874 GWAS Follow-Up 
19 41269076 rs2305797 Candidate 
19 41269288 rs2279011 Candidate 
19 41283693 rs2604869 Candidate 
19 41289397 rs12973666 GWAS Follow-Up 
19 41291119 rs17726276 GWAS Follow-Up 
19 41292404 rs2604894 GWAS Follow-Up 
19 41295859 rs7245595 GWAS Follow-Up 
19 41299015 rs2644898 Candidate 
19 41301115 rs7252227 Candidate 
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19 41302706 rs7937 Candidate 
19 41302949 rs2644899 Candidate 
19 41309150 rs117391664 Candidate 
19 41310571 rs3733829 Candidate 
19 41311922 rs117139969 Candidate 
19 41313202 rs3736329 GWAS Follow-Up 
19 41315318 rs4802091 GWAS Follow-Up 
19 41318899 rs12052092 Candidate 
19 41333441 rs4803378 Candidate 
19 41340573 rs10853742 Candidate 
19 41341589 rs7251418 Candidate 
19 41356310 rs8192720 GWAS Follow-Up 
19 41363765 rs8102683 Candidate 
19 41363898 rs8105704 Candidate 
19 41366134 rs1496402 GWAS Follow-Up 
19 41393760 rs5007415 Candidate 
19 41414481 rs72480748 Candidate 
19 41546992 rs55927443 GWAS Follow-Up 
19 41559511 rs73039249 GWAS Follow-Up 
19 41734560 rs4803448 GWAS Follow-Up 
19 41847860 rs1800472 Candidate 
19 41869392 rs2241714 GWAS Follow-Up 
19 41903220 rs10853751 GWAS Follow-Up 
19 41938222 rs2231943 GWAS Follow-Up 
19 41939297 rs1043413 GWAS Follow-Up 
19 41944237 rs2231940 GWAS Follow-Up 
19 41947635 rs7260605 GWAS Follow-Up 
19 42034033 rs62119375 Candidate 
19 42035481 rs73933643 Candidate 
19 50271924 rs10404868 GWAS Follow-Up 
19 50275358 rs12971721 GWAS Follow-Up 
19 53351869 rs59829511 GWAS Follow-Up 
19 53358889 rs6509698 GWAS Follow-Up 
19 53374032 rs4803017 GWAS Follow-Up 
19 54781541 rs450937 Candidate 
19 54792761 rs386000 GWAS Follow-Up 
19 54792769 rs386003 GWAS Follow-Up 
19 54796719 rs384116 GWAS Follow-Up 
19 54797848 rs103294 GWAS Follow-Up 
19 56498629 rs306458 GWAS Follow-Up 
19 56509695 rs417952 GWAS Follow-Up 
20 2258798 rs6075875 Candidate 
20 2259016 rs6106447 Candidate 
20 3541382 rs17782078 GWAS Follow-Up 
20 3562866 rs118065662 GWAS Follow-Up 
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20 3577062 rs3886999 GWAS Follow-Up 
20 3651472 rs2853209 Candidate 
20 3651765 rs3918396 GWAS Follow-Up 
20 3655219 rs3918392 GWAS Follow-Up 
20 3660597 rs4987245 Candidate 
20 3667081 rs6084436 Candidate 
20 3672046 rs143489222 GWAS Follow-Up 
20 3674309 rs61734522 GWAS Follow-Up 
20 3675333 rs3746638 GWAS Follow-Up 
20 3675498 rs709012 GWAS Follow-Up 
20 3682126 rs34924243 GWAS Follow-Up 
20 3684729 rs625372 GWAS Follow-Up 
20 3685032 rs74553328 Candidate 
20 3686307 rs76788623 Candidate 
20 3686436 rs6037651 GWAS Follow-Up 
20 3726565 rs6076550 GWAS Follow-Up 
20 3776175 rs3761218 GWAS Follow-Up 
20 3784110 rs1056720 GWAS Follow-Up 
20 3803446 rs6052095 GWAS Follow-Up 
20 3827309 rs4815617 GWAS Follow-Up 
20 3838441 rs17857295 GWAS Follow-Up 
20 3843027 rs7262903 GWAS Follow-Up 
20 3844929 rs45437096 GWAS Follow-Up 
20 3846397 rs7269320 GWAS Follow-Up 
20 10456485 rs857011 GWAS Follow-Up 
20 18214242 rs2144143 GWAS Follow-Up 
20 20233939 rs6046759 GWAS Follow-Up 
20 20236581 rs6046764 GWAS Follow-Up 
20 21615147 rs4813436 GWAS Follow-Up 
20 21619401 rs6047531 GWAS Follow-Up 
20 21620667 rs2424386 GWAS Follow-Up 
20 21623633 rs2424388 GWAS Follow-Up 
20 30699632 rs6058526 GWAS Follow-Up 
20 30701513 rs2295034 GWAS Follow-Up 
20 30747080 rs6061196 GWAS Follow-Up 
20 30782543 rs1056776 GWAS Follow-Up 
20 30797628 rs11905172 GWAS Follow-Up 
20 30863169 rs67208722 GWAS Follow-Up 
20 30892996 rs66948641 GWAS Follow-Up 
20 30922399 rs13111 GWAS Follow-Up 
20 31087935 rs80061974 GWAS Follow-Up 
20 32296681 rs6057884 Candidate 
20 38555808 rs2208649 GWAS Follow-Up 
20 38570656 rs62212405 GWAS Follow-Up 
20 44470575 rs148674138 GWAS Follow-Up 
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20 44505973 rs2903808 GWAS Follow-Up 
20 44511257 rs35972756 GWAS Follow-Up 
20 44511533 rs3746500 GWAS Follow-Up 
20 44512082 rs45447691 GWAS Follow-Up 
20 44576502 rs7679 GWAS Follow-Up 
20 44582435 rs41280276 GWAS Follow-Up 
20 44596207 rs6032606 GWAS Follow-Up 
20 44637635 rs144023823 GWAS Follow-Up 
20 44640225 rs17576 GWAS Follow-Up 
20 44642406 rs2250889 GWAS Follow-Up 
20 44643111 rs17577 GWAS Follow-Up 
20 44653107 rs6094238 Candidate 
20 44664493 rs77659338 GWAS Follow-Up 
20 44740196 rs6074022 GWAS Follow-Up 
20 44747947 rs4810485 GWAS Follow-Up 
20 48851333 rs6122892 GWAS Follow-Up 
20 48867761 rs4811014 GWAS Follow-Up 
20 55454659 rs6099314 GWAS Follow-Up 
20 58353445 rs1182499 GWAS Follow-Up 
20 59569156 rs4810215 Candidate 
20 59570371 rs6124047 Candidate 
20 59572324 rs13044193 Candidate 
20 59581209 rs13036423 Candidate 
20 59597631 rs34306377 Candidate 
20 59612913 rs6129015 Candidate 
20 59621304 rs4812257 Candidate 
20 61015611 rs2427345 Candidate 
21 19487468 rs2824630 GWAS Follow-Up 
21 19488183 rs2824632 GWAS Follow-Up 
21 19488826 rs2824634 GWAS Follow-Up 
21 19488983 rs1491773 GWAS Follow-Up 
21 19489216 rs1491772 GWAS Follow-Up 
21 26206434 rs76554345 GWAS Follow-Up 
21 26209468 rs78747692 GWAS Follow-Up 
21 35468605 rs35707420 GWAS Follow-Up 
21 35514749 rs61910679 GWAS Follow-Up 
21 35515333 rs3746864 GWAS Follow-Up 
21 35596002 rs6517219 Candidate 
21 35599128 rs9982601 GWAS Follow-Up 
21 35641215 rs73205216 Candidate 
21 35652239 rs9978142 Candidate 
21 35656197 rs2834438 Candidate 
21 35690786 rs2834442 GWAS Follow-Up 
21 35690852 rs73205245 Candidate 
21 35699797 rs73900502 Candidate 
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21 35699798 rs73902803 Candidate 
21 35757915 rs34016792 GWAS Follow-Up 
21 35820324 rs11909074 GWAS Follow-Up 
21 35825266 rs1012944 Candidate 
21 40488747 rs447988 GWAS Follow-Up 
22 17760183 rs56893401 GWAS Follow-Up 
22 17781035 rs8140080 GWAS Follow-Up 
22 17781555 rs4819994 GWAS Follow-Up 
22 30614437 rs2078856 GWAS Follow-Up 
22 33549485 rs713697 GWAS Follow-Up 
22 33558767 rs2227080 GWAS Follow-Up 
22 33559508 rs987640 GWAS Follow-Up 
22 34397453 rs243243 GWAS Follow-Up 
22 34400253 rs20065 GWAS Follow-Up 
22 34400330 rs739029 GWAS Follow-Up 
22 34414616 rs1874353 GWAS Follow-Up 
22 35660875 rs1053593 GWAS Follow-Up 
22 35663523 rs2413338 GWAS Follow-Up 
22 35702704 rs117971694 Candidate 
22 35711098 rs138777 GWAS Follow-Up 
22 35728466 rs138786 GWAS Follow-Up 
22 35796652 rs743813 Candidate 
22 35802661 rs2307340 GWAS Follow-Up 
22 35968294 rs5750118 Candidate 
22 42980678 rs2285137 GWAS Follow-Up 
22 45072514 rs916400 GWAS Follow-Up 
22 45073320 rs75655022 GWAS Follow-Up 
22 47099954 rs16995604 GWAS Follow-Up 
 
Supplemental Table 1. SNP Provenance 
SNPs tested in the moderate-to-severe (GOLD spirometric stage 2-4) and severe (GOLD spirometric stage 3-4) 
association analysis are ordered by chromosome (CHR) and base-pair position (BP).  The Source column 
indicates the SNPs provenance for consideration in our analysis.  "GWAS Follow-Up" refers to SNPs in regions 
derived from regions of genome-wide or sub-genome wide significance (p < 1x10
-4
) in previous association 
studies of COPD; "Candidate" refers to SNPs in regions derived from SNPs investigated by Castaldi et al(10);  
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SUPPLEMENTAL TABLE 2 
 
rs ID Chromosome Base 
Position 
Effect 
Allele 
p-value Odds 
Ratio 
Upper 
95% 
CI 
Lower 
95% CI 
Effect Allele 
Frequency 
Nearest   
Gene 
rs6604615 1 218634362 T 7.62x10-9 1.19 1.26 1.12 0.72 TGFB2 
rs4416442 4 89866713 T 1.84x10-17 0.79 0.84 0.75 0.57 FAM13A 
rs13141641 4 145506456 T 1.26x10-18 1.29 1.36 1.22 0.61 HHIP 
rs754388 14 93115410 C 3.62x10-8 1.22 1.31 1.14 0.83 RIN3 
rs12914385 15 78898723 T 7.50x10-22 1.31 1.38 1.24 0.58 CHRNA3 
rs40834 16 28510393 T 1.90x10-8 1.17 1.24 1.11 0.45 IL27 
Supplemental Table 2.  Genome-wide Significant Moderate-to-Severe COPD Associations  
Most significant associations for GOLD spirometric stage II-IV COPD, organized by chromosome.  In each case, the lead SNP  
for the locus is presented.   Effect alleles represent the allele that is associated with the stated odds ratio for COPD-risk.   
Base Position was calculated using hg19 coordinates. 
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SUPPLEMENTAL TABLE 3 
MODERATE-TO-
SEVERE COPDGene NHW COPDGene AA GenKOLS ECLIPSE NETT/NAS TCGS Poland TCGS Korea ICGN EOCOPD 
SNP Allele Case Control Case Control Case Control Case Control Case Control Case Control Case Control Case Control Case Control 
rs6604615 T 0.761 0.739 0.558 0.536 0.780 0.802 0.737 0.774 0.735 0.779 0.791 0.749 0.252 0.253 0.765 0.714 0.775 0.765 
rs4416442 T 0.569 0.624 0.444 0.466 0.603 0.554 0.648 0.562 0.645 0.563 0.531 0.560 0.396 0.511 0.576 0.620 0.583 0.607 
rs13141641 T 0.622 0.573 0.897 0.879 0.534 0.586 0.522 0.603 0.578 0.657 0.576 0.476 0.718 0.671 0.635 0.596 0.699 0.652 
rs754388 C 0.834 0.802 0.872 0.845 0.831 0.839 0.793 0.830 0.794 0.847 0.824 0.824 1.000 1.000 0.838 0.835 0.842 0.854 
rs12914385 T 0.559 0.617 0.780 0.823 0.626 0.563 0.563 0.538 0.627 0.528 0.465 0.311 0.322 0.304 0.500 0.432 0.471 0.432 
rs40834 T 0.477 0.441 0.385 0.369 0.491 0.491 0.424 0.471 0.419 0.462 0.433 0.516 0.312 0.269 0.474 0.419 0.448 0.439 
  
SEVERE   COPDGene NHW COPDGene AA GenKols ECLIPSE NETT/NAS Poland Korea ICGN EOCOPD 
SNP Allele Case Control Case Control Case Control Case Control Case Control Case Control Case Control Case Control Case Control 
rs1890995 A 0.240 0.275 0.319 0.361 0.240 0.206 0.275 0.234 0.275 0.234 0.214 0.254 0.779 0.767 0.236 0.297 0.233 0.246 
rs4416442 T 0.562 0.624 0.418 0.466 0.603 0.542 0.645 0.563 0.645 0.563 0.531 0.560 0.396 0.511 0.575 0.620 0.582 0.607 
rs13141641 T 0.636 0.573 0.915 0.879 0.534 0.599 0.578 0.657 0.578 0.657 0.576 0.476 0.718 0.671 0.636 0.596 0.711 0.652 
rs6860095 A 0.775 0.737 0.709 0.650 0.728 0.766 0.707 0.748 0.707 0.748 0.765 0.738 0.117 0.112 0.755 0.734 0.769 0.757 
rs679620 T 0.458 0.500 0.606 0.660 0.522 0.551 0.507 0.571 0.507 0.571 0.508 0.480 0.315 0.311 0.539 0.515 0.522 0.487 
rs112458284 T 0.956 0.966 0.983 0.994 0.972 0.948 0.962 0.959 0.962 0.959 0.936 0.958 1.000 1.000 0.966 0.968 0.948 0.966 
rs17486278 A 0.587 0.658 0.666 0.719 0.689 0.599 0.667 0.573 0.667 0.573 0.574 0.718 0.681 0.694 0.523 0.614 0.558 0.619 
Supplemental Table 3a. Effect Allele Frequencies in Cases and Controls 
ICGN = International COPD Genetics Network; ECLIPSE = Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points, GenKOLS = Genetics of Chronic  
Obstructive Lung Disease, Norway, NETT = National Emphysema Treatment Trial, NAS = Normative Aging Study, EOCOPD = Boston Early-Onset COPD Study, TCGS = 
Transcontinental COPD Genetics Study.  Significantly associated SNPs are listed along with the effect allele.  Allele frequencies of the effect alleles are listed in cases and controls  
in each study. 
SEVERE   COPDGene NHW COPDGene AA GenKols ECLIPSE NETT/NAS Poland Korea ICGN EOCOPD 
SNP Allele Case Control Case Control Case Control Case Control Case Control Case Control Case Control Case Control Case Control 
rs28929474 T 0.028 0.018 0.012 0.003 0.016 0.034 0.031 0.034 0.024 0.037 0.030 0.005 0.000 0.000 0.020 0.017 0.034 0.022 
Supplemental Table 3b. Alpha-1 Antitrypsin Deficiency Z-Allele Frequencies in Cases and Controls 
ICGN = International COPD Genetics Network; ECLIPSE = Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points, GenKOLS = Genetics of Chronic  
Obstructive Lung Disease, Norway, NETT = National Emphysema Treatment Trial, NAS = Normative Aging Study, EOCOPD = Boston Early-Onset COPD Study, TCGS = 
Transcontinental COPD Genetics Study.  Significantly associated SNPs are listed along with the effect allele.  Allele frequencies of the effect alleles are listed in cases and controls  
in each study. 
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SUPPLEMENTAL TABLE 4 
 
Previously Reported Variant 
Lead Variant in Meta-
Analysis 
Linkage Disequilibrium
Between Previously 
Reported and Lead 
Variants 
Chromosome rsID 
Base 
Position 
Nearest      
Gene 
Meta-
analysis 
p-value 
rsID 
Meta-
analysis 
p-value 
r
2 
D' 
1 rs12745189 110186563 GSTM1 0.29 rs11102001
‡ 0.06 0.01 0.35 
1 rs1554286 206944233 IL10 0.23 rs4845140
‡ 0.02 0.01 1.00 
1 rs3738037 225965803 EPHX1 0.12 rs3738037 0.12 N/A N/A 
2 rs17736515 85866118 SFTPB 0.32 rs2001593 0.01 0.01 1.00 
2 rs3917386 113579866 IL1B 0.11 rs4849140
‡
 3.64x10
-3 0.03 1.00 
2 rs16865545 224947170 SERPINE2 0.34 rs34078713 0.24 0.03 1.00 
2 rs7580152 229892748 PID1 0.03 rs11903631
‡
 3.89x10
-3 0.00 0.21 
4 rs17622933 24790680 SOD3 0.75 rs8192287 0.08 0.12 1.00 
4 rs9291163 72699705 GC 0.23 rs72607837
‡
 0.06 0.07 1.00 
5 rs11134242 7564015 ADCY2 0.10 rs6881726 1.97x10-3 0.02 0.44 
5 rs20541 131995964 IL13 0.62 rs17690923
‡
 0.05 0.02 0.41 
5 rs17108817 148215902 ADRB2 0.01 rs17108817
‡
 0.01 N/A N/A 
6 rs2736172 31590898 TNF 0.28 rs2763977 0.01 0.17 0.94 
6 rs12206691 39748040 DAAM2 0.33 rs2446651
‡
 2.77x10
-3 0.00 1.00 
9 rs8176707 136135108 ABO 0.19 rs2285487
‡
 8.09x10
-4 0.01 0.82 
11 rs676653 67339536 GSTP1 0.61 rs72936320
‡
 3.59x10
-5 0.00 0.12 
11 rs645419 102716321 MMP1/MMP12 
1.36 
x10
-5 
rs679620
‡
 3.56x10
-6 1.00 1.00 
17 rs6258 7534678 TP53 0.80 rs1105813
‡
 0.01 0.00 0.12 
17 rs3744787 76893671 TIMP2 0.72 rs12937557 0.02 0.01 1.00 
19 rs1800472 41847860 TGFB1 0.12 rs62119375
‡
 0.04 0.00 1.00 
20 rs2853209 3651472 ADAM33 
2.06 
x10
-3 
rs2853209
‡
 2.06x10
-3 N/A N/A 
20 rs6094238 44653107 MMP9 0.01 rs6094238
‡
 0.01 N/A N/A 
22 rs743813 35796652 HMOX1 0.89 rs5750118
‡
 0.01 0.03 0.17 
Supplemental Table 4.  Additional Candidate Genes 
     
For each previously reported variant and lead variant, the p-value refers to the association with moderate-to-severe COPD in  
our analysis.  Nominally significant associations (p<0.05) among previously reported variants are shown in bold.  Lead variants 
marked with ‡ had a smaller P-value than the top-ranked SNP in the analogous locus in the gene-based investigation by Castaldi, 
et al(10).  
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SUPPLEMENTAL TABLE 5 
rsID Chromosome 
Base Pair 
Position 
Gene Locus Allele1 Allele2 
COPD7 
Score 
rs2284746 1 17306675 MFAP2 G C   
rs4846480 1 218598469 TGFB2 A T X 
rs993925 1 218860068 TGFB2-LYPLAL1 C T   
rs7594321 2 230224031 DNER C T   
rs12477314 2 239877148 
HDAC4- 
FLJ43879 
C T   
rs1529672 3 25520582 RARB A C   
rs1344555 3 169300219 MECOM/EVI1 T C   
rs4416442 4 89866713 FAM13A C T X 
rs10516526 4 106688904 
GSTCD/INTS12/ 
NPNT 
A G   
rs13141641 4 145506456 HHIP C T X 
rs153916 5 95036700 
SPATA9- 
RHOBTB3 
T C   
rs11168048 5 147842353 HTR4 C T   
rs6903823 6 28322296 ZKSCAN3 A G   
rs2857595 6 31568469 NCR3-AIF1 G A   
rs2070600 6 32151443 AGER/PPT2 T C   
rs7765379 6 32680928 HLA-DQB1 G T   
rs2798641 6 109268050 ARMC2 C T   
rs3817928 6 142750516 GPR126 A G   
rs16909898 9 98231008 PTCH1 A G   
rs7068966 10 12277992 CDC123 C T   
rs11001819 10 78315224 C10orf11 A G   
rs626750 11 102720945 MMP12 G A X 
rs11172113 12 57527283 LRP1 C T   
rs754388 14 93115410 RIN3 C G X 
rs12899618 15 71645120 THSD4 A G   
rs12914385 15 78898723 CHRNA3 C T X 
rs12447804 16 58075282 MMP15 C T   
rs11654749 17 69125606 KCNJ2/ CASC17 G T   
rs7937 19 41302706 
RAB4B/ 
EGLN2/ 
MIA/CYP2A6 
C T X 
rs9978142 21 35652239 
KCNE2- 
LINC00310/ 
C21orf82 
A T   
Supplemental Table 5. COPD7 and LUNG30 Risk Score Loci 
rsID, chromosome, position, gene locus, and the two alleles for each risk score SNP in the LUNG30 score are 
shown in the table above. SNPs included in the COPD7 score are marked in the COPD7 Score column. 
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SUPPLEMENTAL TABLE 6 
  
FEV1 % per Risk Allele 
(adjusted) 
p-value 
 COPD7 -2.40 (-2.02, -2.79) <2.0x10
-16 
 LUNG30 -1.11 (-0.92,-1.29) <2.0x10
-16 
Supplemental Table 6a. Genetic Risk Scores: Lung Function in COPDGene NHW 
For each risk score (COPD7, FX25, and LUNG30), the linear mixed model coefficient is presented with  
95% confidence interval in parentheses and p-value. Final model included adjustment for age, 
pack years, and principal components for genetic ancestry. FEV1 % represents the unit change in FEV1  
percent predicted.COPD7: 7 COPD risk SNPs (14 risk alleles); LUNG30: 30 COPD and lung function SNPs (60 
risk alleles.) 
 
 
      
  Moderate COPD  p-value Severe COPD  p-value 
COPD7 OR per Risk Allele 1.22 (1.17, 1.26) 3.17x10-27 1.30 (1.24, 1.36) 4.61x10-30 
 AUC 0.61 (0.60, 0.63)  0.65 (0.63, 0.66)  
 NRI 0.094 (0.070-0.118) 9.85x10
-15 0.103 (0.073, 0.133) 2.01x10-11 
 Event NRI 4.34%  9.57%  
 Nonevent NRI 5.05%  0.75%  
LUNG30 OR per Risk Allele 1.09 (1.07, 1.11) 3.70x10-24 1.12 (1.09, 1.14) 9.19x10-24 
 AUC 0.61 (0.59, 0.62)  0.64 (0.62, 0.65)  
 NRI 0.095 (0.071, 0.118) 5.97x10
-15 0.098 (0.068, 0.127) 7.65x10-11 
 Event NRI 4.48%  8.56%  
 Nonevent NRI 4.97%  1.18%  
Supplemental Table 6b. Genetic Risk Scores: Affection Status in COPDGene NHW 
For each risk score (COPD7, FX25, and LUNG30), OR represents the odds ratio of each additional risk 
allele on the outcome of either Moderate COPD (GOLD II-IV) or Severe COPD (GOLD III-IV).  AUC 
represents Area Under the Curve of a model including only the genetic data of risk score alleles 
adjusted for principal components of genetic ancestry. NRI represents the three-tiered net 
reclassification index value of the model combining genetic risk score, age, pack-years of 
smoking, and principal components of genetic ancestry compared to the model containing age 
and pack-years alone.  Event NRI represents the percentage of subjects with the outcome of COPD adding  
correctly reclassified to a higher risk group after adding genetic data.  Nonevent NRI represents the 
percentage of subjects without the outcome of COPD correctly reclassified to a lower risk group after 
genetic data.  Data is presented with 95% confidence intervals in parentheses. COPD7: 14 COPD risk 
alleles; LUNG30: 60 COPD and lung function risk alleles 
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SUPPLEMENTAL TABLE 7 
  
FEV1 % per Risk 
Allele (adjusted) 
p-value 
 COPD7 -3.51 (-1.92,-5.09) 1.65x10
-7 
 LUNG30 -2.69 (-1.84, -3.54) 8.56x10
-10 
Supplemental Table 7a. Genetic Risk Scores: Lung Function in TCGS Poland 
For each risk score (COPD7 and LUNG30), the linear mixed model coefficient is presented with  
95% confidence interval in parentheses and p-value. Final model included adjustment for age, 
pack years, and principal components for genetic ancestry. FEV1 % represents the unit change in FEV1  
percent predicted.COPD7: 7 COPD risk SNPs (14 risk alleles); LUNG30: 30 COPD and lung function SNPs 
(60 risk alleles.) 
 
 
    
  Severe COPD  p-value 
COPD7 OR per Risk Allele 1.25 (1.13, 1.38) 9.30x10-6 
 AUC 0.62 (0.58, 0.67)  
 NRI 0.157 (0.080-0.233) 6.20x10
-5 
 Event NRI 3.28%  
 Nonevent NRI 12.38%  
LUNG30 OR per Risk Allele 1.17 (1.11, 1.24) 2.25x10-8 
 AUC 0.64 (0.60, 0.68)  
 NRI 0.183 (0.095, 0.271) 4.50x10
-5 
 Event NRI 3.95%  
 Nonevent NRI 14%  
Supplemental Table 7b. Genetic Risk Scores: Affection Status in TCGS Poland 
For each risk score (COPD7 and LUNG30), OR represents the odds ratio of each additional risk 
allele on the outcome of either Moderate COPD (GOLD II-IV) or Severe COPD (GOLD III-IV).  AUC 
represents Area Under the Curve of a model including only the genetic data of risk score alleles 
adjusted for principal components of genetic ancestry. NRI represents the three-tiered net 
reclassification index value of the model combining genetic risk score, age, pack-years of 
smoking, and principal components of genetic ancestry compared to the model containing age 
and pack-years alone.  Event NRI represents the percentage of subjects with the outcome of COPD adding  
correctly reclassified to a higher risk group after adding genetic data.  Nonevent NRI represents the 
percentage of subjects without the outcome of COPD correctly reclassified to a lower risk group after 
genetic data.  Data is presented with 95% confidence intervals in parentheses. COPD7: 14 COPD risk 
alleles; LUNG30: 60 COPD and lung function risk alleles 
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SUPPLEMENTAL TABLE 8 
KEGG Pathway Name p-value 
FDR-corrected 
q-value 
Pathways in cancer - Homo 
sapiens (human) 
0.0004 0.0077 
Malaria - Homo sapiens (human) 0.0066 0.0308 
Hedgehog signaling pathway - 
Homo sapiens (human) 
0.0071 0.0308 
Basal cell carcinoma - Homo 
sapiens (human) 
0.0083 0.0308 
Supplemental Table 8a. LUNG30 Score KEGG Pathway Enrichment 
Pathway enrichment among Kyoto Encyclopedia of Genes and Genomes pathways  
was performed using the online tool ConsensusPathDB.  KEGG pathway name  
is presented with p-value and FDR-corrected q-value. 
 
    
Reactome Pathway Name p-value 
FDR-corrected 
q-value 
Ligand-receptor interactions 0.0002 0.0069 
Molecules associated with elastic 
fibres 
0.0025 0.0235 
Collagen degradation 0.0030 0.0235 
Elastic fibre formation 0.0034 0.0235 
Extracellular matrix organization 0.0039 0.0235 
Hedgehog ,on, state 0.0040 0.0235 
Supplemental Table 8b. LUNG30 Score Reactome Pathway Enrichment 
Pathway enrichment among Reactome pathways was performed using the online 
tool ConsensusPathDB.  Reactome Pathway name is presented with p-value and 
FDR-corrected q-value. 
  
 
GO Biological Process Ontology Term p-value 
FDR-
corrected q-
value 
GO 
Identifier 
GO Level 
response to endogenous stimulus 9.04E-05 0.0028 GO:0009719 2 
cell proliferation 0.0001 0.0028 GO:0008283 2 
response to abiotic stimulus 0.0010 0.0143 GO:0009628 2 
cellular component organization 0.0014 0.0143 GO:0016043 2 
response to chemical 0.0016 0.0143 GO:0042221 2 
cellular response to stimulus 0.0017 0.0143 GO:0051716 2 
anatomical structure morphogenesis 0.0020 0.0143 GO:0009653 2 
single organism signaling 0.0025 0.0153 GO:0044700 2 
single-organism cellular process 0.0065 0.0334 GO:0044763 2 
cell motility 0.0078 0.0334 GO:0048870 2 
localization of cell 0.0078 0.0334 GO:0051674 2 
regulation of molecular function 0.0082 0.0334 GO:0065009 2 
muscle adaptation 0.0087 0.0334 GO:0043500 2 
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leukocyte homeostasis 0.0098 0.0352 GO:0001776 2 
response to drug 8.47E-07 0.0001 GO:0042493 3 
extracellular structure organization 7.66E-05 0.0050 GO:0043062 3 
positive regulation of biological process 0.0001 0.0050 GO:0048518 3 
muscle cell proliferation 0.0001 0.0050 GO:0033002 3 
tissue development 0.0003 0.0086 GO:0009888 3 
cellular response to chemical stimulus 0.0005 0.0124 GO:0070887 3 
tube development 0.0008 0.0187 GO:0035295 3 
response to organic substance 0.0009 0.0187 GO:0010033 3 
response to hormone 0.0013 0.0227 GO:0009725 3 
heart development 0.0016 0.0251 GO:0007507 3 
multicellular organismal metabolic 
process 
0.0022 0.0312 GO:0044236 3 
regulation of localization 0.0024 0.0312 GO:0032879 3 
appendage morphogenesis 0.0027 0.0329 GO:0035107 3 
positive regulation of molecular function 0.0033 0.0329 GO:0044093 3 
regulation of multicellular organismal 
process 
0.0035 0.0329 GO:0051239 3 
epithelial cell proliferation 0.0039 0.0329 GO:0050673 3 
appendage development 0.0039 0.0329 GO:0048736 3 
cell adhesion mediated by integrin 0.0041 0.0329 GO:0033627 3 
cellular potassium ion transport 0.0042 0.0329 GO:0071804 3 
embryonic morphogenesis 0.0046 0.0329 GO:0048598 3 
ossification 0.0047 0.0329 GO:0001503 3 
cellular response to endogenous 
stimulus 
0.0047 0.0329 GO:0071495 3 
cell migration 0.0050 0.0329 GO:0016477 3 
regulation of developmental process 0.0050 0.0329 GO:0050793 3 
tissue morphogenesis 0.0052 0.0329 GO:0048729 3 
regulation of cell killing 0.0056 0.0345 GO:0031341 3 
response to mechanical stimulus 0.0060 0.0353 GO:0009612 3 
organ morphogenesis 0.0068 0.0382 GO:0009887 3 
morphogenesis of a branching structure 0.0071 0.0382 GO:0001763 3 
organ development 0.0072 0.0382 GO:0048513 3 
cellular developmental process 0.0087 0.0400 GO:0048869 3 
embryonic organ development 0.0087 0.0400 GO:0048568 3 
nephron morphogenesis 0.0094 0.0400 GO:0072028 3 
regulation of response to stimulus 0.0094 0.0400 GO:0048583 3 
regulation of locomotion 0.0094 0.0400 GO:0040012 3 
response to transforming growth factor 
beta 
0.0097 0.0400 GO:0071559 3 
head development 0.0097 0.0400 GO:0060322 3 
reactive oxygen species metabolic 
process 
0.0099 0.0400 GO:0072593 3 
muscle cell migration 2.84E-06 0.0006 GO:0014812 4 
regulation of system process 1.26E-05 0.0014 GO:0044057 4 
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extracellular matrix organization 7.55E-05 0.0045 GO:0030198 4 
response to steroid hormone 9.95E-05 0.0045 GO:0048545 4 
response to organic cyclic compound 0.0001 0.0045 GO:0014070 4 
neuron death 0.0001 0.0054 GO:0070997 4 
regulation of cellular component 
movement 
0.0003 0.0088 GO:0051270 4 
regulation of ossification 0.0003 0.0088 GO:0030278 4 
muscle system process 0.0005 0.0115 GO:0003012 4 
smooth muscle cell proliferation 0.0006 0.0133 GO:0048659 4 
mesonephric tubule development 0.0009 0.0154 GO:0072164 4 
positive regulation of metabolic process 0.0009 0.0154 GO:0009893 4 
mesonephros development 0.0010 0.0154 GO:0001823 4 
negative regulation of developmental 
process 
0.0010 0.0154 GO:0051093 4 
regulation of heart rate by cardiac 
conduction 
0.0012 0.0158 GO:0086091 4 
regulation of membrane repolarization 0.0012 0.0158 GO:0060306 4 
regulation of cell proliferation 0.0013 0.0167 GO:0042127 4 
regulation of cell differentiation 0.0014 0.0171 GO:0045595 4 
multicellular organismal macromolecule 
metabolic process 
0.0016 0.0179 GO:0044259 4 
morphogenesis of an epithelium 0.0018 0.0179 GO:0002009 4 
embryonic appendage morphogenesis 0.0018 0.0179 GO:0035113 4 
membrane repolarization 0.0018 0.0179 GO:0086009 4 
renal system development 0.0019 0.0179 GO:0072001 4 
membrane invagination 0.0022 0.0189 GO:0010324 4 
embryonic digestive tract development 0.0022 0.0189 GO:0048566 4 
limb morphogenesis 0.0027 0.0226 GO:0035108 4 
urogenital system development 0.0030 0.0235 GO:0001655 4 
vesicle-mediated transport 0.0031 0.0235 GO:0016192 4 
response to lipid 0.0031 0.0235 GO:0033993 4 
epithelium development 0.0034 0.0248 GO:0060429 4 
branching morphogenesis of an 
epithelial tube 
0.0035 0.0248 GO:0048754 4 
limb development 0.0039 0.0255 GO:0060173 4 
regulation of transport 0.0040 0.0255 GO:0051049 4 
cellular response to organic substance 0.0041 0.0255 GO:0071310 4 
potassium ion transmembrane transport 0.0042 0.0255 GO:0071805 4 
muscle tissue development 0.0042 0.0255 GO:0060537 4 
cell differentiation 0.0044 0.0256 GO:0030154 4 
positive regulation of cellular process 0.0051 0.0261 GO:0048522 4 
positive regulation of locomotion 0.0051 0.0261 GO:0040017 4 
positive regulation of transport 0.0052 0.0261 GO:0051050 4 
regulation of cell adhesion 0.0052 0.0261 GO:0030155 4 
regulation of muscle adaptation 0.0053 0.0261 GO:0043502 4 
nervous system development 0.0055 0.0261 GO:0007399 4 
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cellular response to drug 0.0056 0.0261 GO:0035690 4 
inflammatory response 0.0058 0.0261 GO:0006954 4 
cardiac conduction 0.0058 0.0261 GO:0061337 4 
morphogenesis of a branching 
epithelium 
0.0059 0.0261 GO:0061138 4 
cardiovascular system development 0.0059 0.0261 GO:0072358 4 
circulatory system development 0.0059 0.0261 GO:0072359 4 
regulation of cell death 0.0060 0.0261 GO:0010941 4 
regulation of cell motility 0.0063 0.0269 GO:2000145 4 
signal transduction 0.0066 0.0276 GO:0007165 4 
heart morphogenesis 0.0075 0.0306 GO:0003007 4 
circulatory system process 0.0077 0.0306 GO:0003013 4 
skeletal system morphogenesis 0.0078 0.0306 GO:0048705 4 
cellular response to mechanical stimulus 0.0080 0.0306 GO:0071260 4 
positive regulation of transporter 
activity 
0.0080 0.0306 GO:0032411 4 
negative regulation of multicellular 
organismal process 
0.0082 0.0306 GO:0051241 4 
phagocytosis 0.0084 0.0309 GO:0006909 4 
collagen catabolic process 0.0091 0.0331 GO:0030574 4 
negative regulation of locomotion 0.0096 0.0335 GO:0040013 4 
cellular response to transforming growth 
factor beta stimulus 
0.0096 0.0335 GO:0071560 4 
negative regulation of response to 
stimulus 
0.0100 0.0340 GO:0048585 4 
regulation of muscle system process 1.71E-06 0.0002 GO:0090257 5 
neuron apoptotic process 4.63E-05 0.0025 GO:0051402 5 
hindlimb morphogenesis 5.26E-05 0.0025 GO:0035137 5 
regulation of neuron death 7.97E-05 0.0029 GO:1901214 5 
heart process 0.0004 0.0110 GO:0003015 5 
macromolecule deacylation 0.0005 0.0112 GO:0098732 5 
regulation of smooth muscle cell 
proliferation 
0.0006 0.0112 GO:0048660 5 
positive regulation of cell proliferation 0.0007 0.0112 GO:0008284 5 
ureteric bud development 0.0008 0.0112 GO:0001657 5 
regulation of blood circulation 0.0009 0.0112 GO:1903522 5 
negative regulation of cartilage 
development 
0.0010 0.0112 GO:0061037 5 
negative regulation of cell proliferation 0.0010 0.0112 GO:0008285 5 
regulation of osteoblast differentiation 0.0011 0.0112 GO:0045667 5 
positive regulation of biosynthetic 
process 
0.0011 0.0112 GO:0009891 5 
phagocytosis, engulfment 0.0013 0.0124 GO:0006911 5 
collagen metabolic process 0.0014 0.0124 GO:0032963 5 
positive regulation of epidermis 
development 
0.0016 0.0135 GO:0045684 5 
potassium ion import 0.0017 0.0135 GO:0010107 5 
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embryonic limb morphogenesis 0.0018 0.0135 GO:0030326 5 
regulation of epithelial cell proliferation 0.0019 0.0138 GO:0050678 5 
embryonic eye morphogenesis 0.0021 0.0138 GO:0048048 5 
muscle contraction 0.0021 0.0138 GO:0006936 5 
kidney epithelium development 0.0023 0.0144 GO:0072073 5 
positive regulation of macromolecule 
metabolic process 
0.0026 0.0149 GO:0010604 5 
regulation of cell development 0.0027 0.0149 GO:0060284 5 
regulation of reactive oxygen species 
metabolic process 
0.0027 0.0149 GO:2000377 5 
cardiac muscle cell action potential 0.0034 0.0173 GO:0086001 5 
positive regulation of cell differentiation 0.0034 0.0173 GO:0045597 5 
regulation of actin filament-based 
movement 
0.0036 0.0175 GO:1903115 5 
striated muscle tissue development 0.0037 0.0175 GO:0014706 5 
positive regulation of nitrogen 
compound metabolic process 
0.0040 0.0182 GO:0051173 5 
regulation of programmed cell death 0.0042 0.0182 GO:0043067 5 
positive regulation of cellular metabolic 
process 
0.0043 0.0182 GO:0031325 5 
muscle cell differentiation 0.0044 0.0182 GO:0042692 5 
positive regulation of cell adhesion 0.0045 0.0182 GO:0045785 5 
positive regulation of cellular 
component movement 
0.0047 0.0182 GO:0051272 5 
cellular response to organic cyclic 
compound 
0.0047 0.0182 GO:0071407 5 
neurogenesis 0.0055 0.0200 GO:0022008 5 
regulation of epidermis development 0.0058 0.0200 GO:0045682 5 
response to estrogen 0.0059 0.0200 GO:0043627 5 
endocytosis 0.0059 0.0200 GO:0006897 5 
regulation of reactive oxygen species 
biosynthetic process 
0.0060 0.0200 GO:1903426 5 
regulation of cartilage development 0.0060 0.0200 GO:0061035 5 
osteoblast differentiation 0.0063 0.0206 GO:0001649 5 
negative regulation of cellular 
component movement 
0.0073 0.0218 GO:0051271 5 
negative regulation of ossification 0.0074 0.0218 GO:0030279 5 
regulation of smoothened signaling 
pathway 
0.0074 0.0218 GO:0008589 5 
blood circulation 0.0076 0.0218 GO:0008015 5 
regulation of phosphorus metabolic 
process 
0.0076 0.0218 GO:0051174 5 
regulation of transmembrane receptor 
protein serine/threonine kinase 
signaling pathway 
0.0076 0.0218 GO:0090092 5 
regulation of plasma membrane 
organization 
0.0078 0.0219 GO:1903729 5 
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negative regulation of cell 
differentiation 
0.0084 0.0232 GO:0045596 5 
nephron epithelium morphogenesis 0.0089 0.0241 GO:0072088 5 
Supplemental Table 8c. LUNG30 Score Gene Ontology Biological Process Enrichment 
Enrichment among Gene Ontology (GO) terms within the Biological Processes ontology  
was performed using the online tool ConsensusPathDB.  The GO term is presented with 
p-value, FDR-corrected q-value, GO identifier, and GO Level. 
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SUPPLEMENTAL TABLE 9 
Tissue Type p-value     
Appendix 0.0017     
Trigeminal_Ganglion 0.0078     
Superior_Cervical_Ganglion 0.0176     
Fetal_Lung 0.0238     
Cardiac_Myocytes 0.0241     
Olfactory_Bulb 0.0287     
Placenta 0.0484     
Fetal_Thyroid 0.0545     
Trachea 0.0548     
Smooth_Muscle 0.0551     
Skeletal_Muscle 0.0680     
Lymphoma_Burkitts_Daudi 0.0746     
Testis_Leydig_cell 0.0793     
Salivary_Gland 0.0859     
Supplemental Table 9. SNPsea tissue-specific enrichment of gene expression 
Listed tissue types represent tissues enriched for gene expression of genes in  
linkage disequilibrium with LUNG30 risk SNPs.  P-values were calculated against 
null distributions as per the SNPsea algorithm.    
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Supplemental Figure 1: Network Relationships of LUNG30 Score Loci 
In the network diagram above (generated using string-db.org), each node represents a gene name of the 
nearest gene within the region of the LUNG30 SNPs or a gene from the first "shell" of proteins known to 
interact with this nearest gene, while edges represent protein-protein associations.  Turquoise and 
magenta edges represent interactions from curated databases and experimentally determined interactions, 
respectively.   Light green edges represent protein-protein associations from unsupervised textmining of 
relevant literature, while light purple edges represent protein homology. 
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